Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3010726	s-hevohie	— (—)	3402	3511	100.00%	Distribution not available
3010726	s-hevohie	u/ml (u/ml)	2132	2273	4.71%
3010726	s-hevonee	u/ml (—)	1689	1769	100.00%	Distribution not available
3010726	hevonen	— (—)	614	647	100.00%	Distribution not available
3010726	hevonee	u/ml (—)	163	174	100.00%	Distribution not available
3010726	s-hevonhie	u/ml (—)	124	125	100.00%	Distribution not available
3010726	igehevonen	u/ml (—)	122	128	100.00%	Distribution not available
3010726	s-hevosenhilse,igevasta-aineet	u/ml (—)	98	100	100.00%	Distribution not available
3010726	hevonen	u/ml (u/ml)	81	82	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Desensitization to allergens

455

634

8.68

320.14

1.1

2.40

2.58

u/ml

0.11

171

167

Other diseases of upper respiratory tract

2054

3849

2.83

307.65

1.1

1.0

2.42

2.34

u/ml

0.07

594

871

Asthma and allergy, excluding more controls

947

980

10.86

307.65

1.2

1.0

3.76

1.75

u/ml

3.02

400

223

Asthma-related infections

1498

3585

4.26

307.65

1.2

1.1

3.03

1.90

u/ml

2.14

541

810

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1534

4583

3.41

307.65

1.1

2.67

2.05

u/ml

0.94

475

1066

Asthma (only as main-diagnosis)

2313

2498

5.82

307.65

1.1

1.0

3.01

1.85

u/ml

2.20

792

506

Asthma (mode)

2440

2507

5.56

307.65

1.1

1.0

2.90

1.84

u/ml

2.01

826

508

Pollen allergy

1494

2025

8.52

307.65

1.2

1.1

3.30

1.97

u/ml

2.14

486

523

Asthma, hospital admissions , main diagnosis only

2458

5389

4.25

307.65

1.1

1.0

3.14

1.84

u/ml

3.28

848

1188

Asthma, unspecified (mode)

1056

2048

4.19

307.65

1.1

1.0

2.37

1.86

u/ml

0.45

286

414

Asthma (diagnoses ohter than nonallergic)

2533

5253

4.29

307.65

1.1

1.0

3.11

1.88

u/ml

3.01

871

1155

Asthma

2444

2498

5.45

307.65

1.1

1.0

2.91

1.85

u/ml

2.01

826

506

Asthma, hospital admission 2, infections

1498

3585

4.26

307.65

1.2

1.1

3.03

1.90

u/ml

2.14

541

810

Allergic rhinitis

1889

2819

7.38

307.65

1.2

1.1

3.33

1.73

u/ml

4.08

624

682

Asthma/COPD (KELA code 203)

2495

4796

3.78

307.65

1.1

1.0

3.14

1.75

u/ml

4.11

827

1018

Asthma, excluding more controls

2432

2476

5.45

307.65

1.1

1.0

2.92

1.87

u/ml

1.95

822

500

Asthma and allergy

946

967

10.99

307.65

1.2

1.0

3.76

1.76

u/ml

2.97

400

221

Allergic asthma (mode)

1296

1572

8.82

307.65

1.2

1.0

3.64

1.92

u/ml

2.50

531

338

Allergic conjunctivitis

1587

4862

3.33

307.65

1.1

2.77

2.15

u/ml

0.92

495

1145

Chronic lower respiratory diseases

3165

4846

3.64

307.65

1.1

1.0

2.97

1.75

u/ml

3.47

1033

1029

Vasomotor and allergic rhinitis

1973

2895

7.31

307.65

1.1

1.0

3.29

2.54

u/ml

0.89

647

664

Asthma, including avohilmo

3453

4573

4.55

307.65

1.1

1.0

3.02

1.61

u/ml

4.72

1095

965

Atopic dermatitis

1652

4802

3.04

307.65

1.1

4.20

1.89

u/ml

5.90

554

1133

Allergic asthma (mode), excluding more controls

1296

1573

8.81

307.65

1.2

1.0

3.64

1.93

u/ml

2.48

531

340

Disorders of conjunctiva

1880

5867

2.75

307.65

1.1

2.85

2.30

u/ml

0.81

575

1440

1304

3058

4.42

307.65

1.2

1.1

3.10

1.94

u/ml

1.88

471

703

Conjunctivitis

1845

5752

2.88

307.65

1.1

2.85

2.33

u/ml

0.74

564

1415

Asthma, unspecified (mode), excluding more controls

1055

2037

4.18

307.65

1.1

1.0

2.37

1.88

u/ml

0.44

285

410

Asthma (only as main-diagnosis), excluding more controls

2309

2476

5.80

307.65

1.1

1.0

3.01

1.87

u/ml

2.11

792

500

Chronic sinusitis

885

2322

3.92

293.18

1.1

1.0

0.81

2.19

u/ml

4.24

244

488

Dermatitis and eczema

2137

5747

2.48

292.58

1.1

3.66

1.74

u/ml

5.49

664

1343

Atopic dermatitis, strict definition with reimbursement

1080

3233

3.40

280.17

1.2

1.1

4.90

2.07

u/ml

5.59

417

790

Suggestive for eosinophilic asthma

283

271

11.23

260.76

1.2

1.0

1.05

1.54

u/ml

0.42

119

Chronic rhinitis, nasopharyngitis and pharyngitis

705

1737

4.20

255.67

1.1

1.0

1.14

2.01

u/ml

1.60

186

389

Obesity related asthma

642

1531

4.33

243.00

1.1

1.0

2.70

1.15

u/ml

1.70

201

287

Nasal polyp

404

665

6.32

234.83

1.2

1.0

0.99

1.97

u/ml

1.44

142

136

Other pulmonary diagnosis

1420

2543

2.84

232.37

1.1

1.0

2.15

1.88

u/ml

0.30

391

521

COPD differential diagnosis

1398

2507

2.84

228.19

1.1

1.0

2.14

1.84

u/ml

0.34

388

508

ILD differential diagnosis

1398

2507

2.84

228.17

1.1

1.0

2.14

1.84

u/ml

0.34

388

508

Atopic dermatitis, strict definition

1051

3547

3.04

227.27

1.1

5.02

2.20

u/ml

5.38

402

903

Excluding asthma or asthma-COPD overlap

1401

2543

2.80

223.90

1.1

1.0

2.15

1.88

u/ml

0.31

389

521

Childhood asthma (age<16), excluding more controls

600

1108

4.56

219.83

1.1

1.0

4.31

2.05

u/ml

2.88

252

266

Childhood asthma (age<16)

600

1109

4.56

219.73

1.1

1.0

4.31

2.05

u/ml

2.88

252

266

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

860

2681

3.21

209.88

1.1

1.0

1.64

2.33

u/ml

0.79

234

572

Oral corticosteroids

1790

5130

2.14

172.25

1.1

2.90

1.98

u/ml

1.65

553

1170

Asthma-related pneumonia

549

1511

3.71

169.35

1.1

2.83

1.90

u/ml

0.82

203

318

Asthma-related pneumonia or sepsis

551

1521

3.70

169.21

1.1

2.83

1.89

u/ml

0.84

204

320

Asthma, hospital admissions 3, pneumonia

551

1521

3.70

169.21

1.1

2.83

1.89

u/ml

0.84

204

320

ILD medications: prednisolone, methylprednisolone, prednisone

1916

5314

2.07

165.25

1.1

2.94

2.04

u/ml

1.66

591

1238

Cough

755

2458

3.02

164.75

1.1

2.48

2.23

u/ml

0.11

201

643

Diseases of the respiratory system

1028

1884

2.77

161.70

1.1

1.0

2.39

1.59

u/ml

1.01

281

368

Childhood allergy (age < 16)

733

2031

3.17

160.12

1.2

1.1

4.92

2.56

u/ml

2.84

289

568

Undetermined asthma

269

452

6.18

153.11

1.1

1.0

1.77

1.01

u/ml

0.39

Undetermined asthma, excluding more controls

269

454

6.15

152.43

1.1

1.0

1.77

1.01

u/ml

0.39

Abnormalities of breathing

1652

4929

2.02

136.00

1.1

2.61

2.32

u/ml

0.31

435

1249

Deviated nasal septum

456

1333

3.49

128.54

1.1

1.0

1.37

1.96

u/ml

0.72

128

275

ILD medications

1925

5668

1.89

128.23

1.1

2.95

2.22

u/ml

1.15

599

1362

Inflammatory bowel disease treatment related agents

1878

5796

1.86

121.32

1.1

2.84

2.22

u/ml

0.91

570

1370

Symptoms and signs involving the circulatory and respiratory systems

1854

4981

1.89

121.05

1.1

2.55

2.29

u/ml

0.30

485

1268

FESS (DNB20)

309

738

4.39

117.77

1.2

1.1

0.66

1.79

u/ml

3.06

105

175

Ethmoidectomy

312

768

4.25

114.19

1.2

1.1

0.66

1.75

u/ml

2.99

107

179

First line medication for Crohn's disease

1850

5591

1.83

111.27

1.1

2.83

2.21

u/ml

0.93

569

1351

Dermatitis due to ingested food

264

572

5.14

111.10

1.2

1.1

5.19

2.06

u/ml

2.13

105

174

Chronic diseases of tonsils and adenoids

1225

3785

2.07

110.55

1.1

1.0

1.73

2.36

u/ml

1.03

322

863

Adverse effects, not elsewhere classified

503

1725

3.03

110.01

1.1

3.87

2.26

u/ml

1.13

162

455

Other medical care

524

1894

2.75

97.69

1.1

2.49

2.11

u/ml

0.32

182

454

Personal history of allergy to analgesic agent

38.94

96.36

1.5

1.0

0.52

3.93

u/ml

—

Biological medicines for asthma

14.99

89.54

1.3

1.0

4.18

4.70

u/ml

0.07

Acute upper respiratory infections

1513

5466

1.75

82.30

1.1

2.54

2.21

u/ml

0.35

426

1334

Urticaria

618

2745

2.31

78.94

1.1

2.08

2.28

u/ml

0.14

187

716

Other and unspecified effects of external causes

592

2587

2.35

78.68

1.1

3.61

2.32

u/ml

0.97

180

691

Diseases of the skin and subcutaneous tissue

1554

4520

1.74

78.66

1.1

2.84

1.83

u/ml

1.83

459

1030

Dyspnoea

1147

4838

1.83

75.94

1.1

2.28

2.25

u/ml

0.03

310

1196

Urticaria and erythema

679

3196

2.17

74.93

1.1

2.61

2.27

u/ml

0.24

205

825

Personal history of allergy to drugs, medicaments and biological substances

13.92

72.50

1.4

1.0

0.53

3.09

u/ml

0.86

Bronchitis

1537

6101

1.67

70.82

1.1

2.50

2.18

u/ml

0.38

424

1508

Acute upper respiratory infections of multiple and unspecified sites

1198

5167

1.76

68.30

1.1

2.47

2.28

u/ml

0.19

338

1276

1562

5039

1.65

66.25

1.1

2.33

2.12

u/ml

0.23

432

1201

Asthma mixed form (mode)

113

190

6.18

64.60

1.2

1.0

1.82

1.04

u/ml

0.54

Asthma mixed form (mode), excluding more controls

113

190

6.18

64.59

1.2

1.0

1.82

1.04

u/ml

0.54

D07AA Corticosteroids, weak (group I)

404

1645

2.54

63.27

1.2

1.1

6.06

2.33

u/ml

3.72

173

458

Diseases of the eye and adnexa

1508

4627

1.65

62.72

1.1

2.78

2.44

u/ml

0.34

433

1152

Any reimbursement code in KELA

1259

3726

1.71

60.27

1.1

2.98

1.87

u/ml

1.90

394

822

Acute sinusitis

849

4381

1.83

57.69

1.1

2.18

2.14

u/ml

0.03

242

1075

Non-allergic asthma (mode)

239

768

3.13

57.14

1.1

1.0

1.27

1.96

u/ml

0.56

167

Non-allergic asthma (mode), excluding more controls

239

769

3.13

57.00

1.1

1.0

1.27

1.97

u/ml

0.57

166

Polypectomy (DHB20)

126

265

4.94

56.42

1.2

1.1

0.66

2.78

u/ml

1.98

Early onset COPD, excluding more controls

169

462

3.70

52.96

1.1

1.0

2.39

1.48

u/ml

0.59

Dermatitis

689

3744

1.86

50.17

1.1

1.75

1.45

u/ml

0.24

199

847

Other acute lower respiratory infections

736

3934

1.81

48.30

1.2

1.1

3.15

2.44

u/ml

0.57

228

1041

Sleep apnoea, including avohilmo

1103

4497

1.60

43.95

1.1

1.74

1.96

u/ml

0.21

272

1057

Allergic contact dermatitis

236

913

2.65

41.19

1.1

2.28

1.24

u/ml

0.83

198

Voice disturbances

320

1445

2.25

39.40

1.2

1.1

1.77

1.66

u/ml

0.06

334

COPD/asthma related infections

1425

4809

1.49

39.31

1.1

2.31

2.08

u/ml

0.26

392

1158

COPD/asthma/ILD related infections

1425

4809

1.49

39.31

1.1

2.31

2.08

u/ml

0.26

392

1158

Chronic laryngitis and laryngotracheitis

148

462

3.26

38.05

1.1

1.0

1.37

1.70

u/ml

0.21

Other and unspecified dermatitis

554

3114

1.80

36.33

1.1

1.09

1.53

u/ml

0.80

161

717

Pain in joint

825

3401

1.62

34.51

1.1

2.01

2.51

u/ml

0.45

231

865

Other and unspecified urticaria

347

1710

2.07

34.38

1.1

1.66

2.45

u/ml

0.57

430

Asthma and opportunity respiratory infection

6.58

33.82

1.1

1.0

1.47

1.33

u/ml

0.04

Bronchiectasis

116

5.62

33.80

1.1

1.0

1.40

3.81

u/ml

0.52

Recurrent or chronic depression

652

2795

1.70

33.56

1.1

2.78

2.24

u/ml

0.39

164

677

Dermatographic urticaria

147

499

3.06

33.21

1.1

1.35

2.13

u/ml

0.54

115

Idiopathic urticaria

143

5.28

32.99

1.1

1.08

6.23

u/ml

1.93

Sleep apnoea

956

4257

1.53

31.89

1.1

1.95

1.90

u/ml

0.04

235

999

Triptan medication for migraine, single purchase ok

1183

5505

1.47

31.68

1.1

2.07

2.37

u/ml

0.32

303

1399

Migraine, single triptan purchase ok & required. ICD-code if available is included

1183

5505

1.47

31.68

1.1

2.07

2.37

u/ml

0.32

303

1399

Symptoms and signs involving speech and voice

342

1730

2.00

31.29

1.1

2.00

1.52

u/ml

0.34

400

Gastro-oesophageal reflux disease

728

4043

1.61

31.14

1.1

1.47

2.24

u/ml

1.26

170

978

COPD

215

733

2.43

31.07

1.1

1.0

2.03

1.15

u/ml

0.80

129

Medical observation and evaluation for suspected diseases and conditions

942

3139

1.55

30.99

1.1

1.87

2.39

u/ml

0.71

260

780

Headache

956

5342

1.51

30.46

1.1

1.96

2.51

u/ml

0.62

234

1382

Other chronic obstructive pulmonary disease

201

682

2.46

29.94

1.1

1.0

2.14

1.00

u/ml

1.12

118

Depression or dysthymia

884

3229

1.54

29.25

1.1

2.09

u/ml

0.00

224

774

Special screening examination for infectious and parasitic diseases

510

2205

1.75

29.21

1.1

1.0

1.67

2.43

u/ml

0.82

123

561

Migraine

830

4637

1.54

29.01

1.1

2.48

2.44

u/ml

0.02

205

1182

Acute bronchitis

466

2622

1.76

28.48

1.1

2.64

2.23

u/ml

0.26

134

679

Episodal and paroxysmal disorders

1563

5866

1.37

27.68

1.1

2.20

2.51

u/ml

0.37

427

1514

Neurotic, stress-related and somatoform disorders

1237

6309

1.40

26.45

1.1

2.33

2.30

u/ml

0.03

333

1577

Anxiety disorders

1241

6320

1.40

26.28

1.1

2.33

2.29

u/ml

0.03

335

1576

Other special examinations and investigations of persons without complaint or reported diagnosis

921

3139

1.49

25.84

1.1

2.51

2.39

u/ml

0.09

252

780

Diabetes, insulin treatment (Kela reimbursement)

542

5316

0.62

25.65

1.1

1.47

2.14

u/ml

1.22

145

1295

Malignant neoplasm

462

4565

0.60

25.63

1.1

1.67

1.95

u/ml

0.24

1094

Irritable bowel syndrome

370

2055

1.82

25.59

1.1

2.60

2.00

u/ml

0.24

503

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

647

2028

1.61

25.33

1.1

2.72

2.51

u/ml

0.14

163

544

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

501

4799

0.61

24.80

1.1

1.68

2.01

u/ml

0.31

107

1155

Malignant neoplasm, wide definition for exclusion

501

4799

0.61

24.79

1.1

1.68

2.01

u/ml

0.31

107

1155

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

502

4803

0.61

24.72

1.1

1.68

2.05

u/ml

0.36

107

1158

Conjunctivitis (acute, non atopic)

386

2191

1.78

24.56

1.1

3.57

2.26

u/ml

0.85

124

583

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

536

5207

0.63

24.53

1.1

1.49

2.12

u/ml

1.10

143

1259

All anxiety disorders

990

5601

1.43

24.42

1.1

2.39

2.35

u/ml

0.04

272

1408

Abnormalities of heart beat

359

1999

1.80

23.79

1.1

2.09

1.85

u/ml

0.16

496

Anxiety disorders, excluding more controls

1127

5380

1.40

23.40

1.1

2.29

2.33

u/ml

0.03

304

1313

Atopic conjunctivitis

101

342

3.07

23.11

1.1

3.85

2.32

u/ml

0.46

Exposure to unspecified factor

1216

6923

1.37

23.04

1.1

2.25

2.39

u/ml

0.14

327

1772

Any event in cancer register

569

5225

0.64

23.00

1.1

1.72

2.14

u/ml

0.39

115

1282

Eosinophilic disease (BM)

8.50

22.83

1.2

1.0

0.76

1.62

u/ml

—

Sleep disorders (combined)

1117

5286

1.39

22.73

1.1

1.78

2.23

u/ml

0.54

285

1301

Anxiety (asthma-related co-morbidities)

958

5353

1.42

22.54

1.1

2.43

2.31

u/ml

0.09

258

1338

Diabetes mellitus

683

6052

0.67

22.47

1.1

1.88

2.16

u/ml

0.34

193

1460

Diabetes, varying definitions

675

6000

0.67

22.42

1.1

1.90

2.16

u/ml

0.29

189

1449

Pain (limb, back, neck, head abdominally)

1020

3623

1.42

21.94

1.1

2.12

2.63

u/ml

0.64

280

953

Diabetes medication

662

5980

0.67

21.94

1.1

1.69

2.14

u/ml

0.66

179

1448

Examination and observation for other reasons

758

3114

1.49

21.88

1.1

1.64

2.41

u/ml

1.22

177

770

Temporomandibular joint disorders, including avohilmo

656

4399

1.50

21.32

1.1

1.58

2.53

u/ml

1.89

196

1103

Pain in throat and chest

983

4312

1.40

20.54

1.1

2.08

2.23

u/ml

0.16

249

1056

Early onset COPD

169

798

2.14

18.87

1.1

1.0

2.39

1.59

u/ml

0.52

181

Abnormal findings on diagnostic imaging of lung

274

1498

1.79

18.24

1.1

1.92

1.54

u/ml

0.27

338

Coxibs

340

1047

1.74

18.22

1.1

3.13

2.65

u/ml

0.24

297

Acute bronchiolitis

206

961

2.00

18.01

1.2

1.1

5.04

3.12

u/ml

0.69

309

Tonsillectomy and adenotomy

1047

5437

1.35

17.93

1.1

2.39

2.48

u/ml

0.08

285

1437

Other disorders of lacrimal gland

321

1902

1.70

17.84

1.1

2.47

1.58

u/ml

0.45

435

Disorders of lacrimal system

388

2422

1.61

17.56

1.1

2.37

1.69

u/ml

0.39

558

Low back pain

875

4908

1.38

17.53

1.1

1.71

2.35

u/ml

0.87

220

1210

Dental caries 2, only avohilmo

1069

6343

1.34

17.45

1.1

2.19

2.49

u/ml

0.35

295

1609

Other headache syndromes

506

3359

1.52

17.45

1.1

2.82

2.21

u/ml

0.36

133

796

Triptan medication for migraine, min. 3 purchases

869

5010

1.38

17.27

1.1

1.98

2.48

u/ml

0.49

212

1252

Other dorsopathies, not elsewhere classified

1335

5426

1.30

17.13

1.1

1.91

2.46

u/ml

0.83

367

1368

Depression

1202

6343

1.31

16.82

1.1

2.25

2.29

u/ml

0.04

312

1585

Type 2 diabetes

582

4994

0.69

16.71

1.1

1.77

1.81

u/ml

0.04

164

1155

Acetic acid derivatives and related substances

332

1018

1.71

16.70

1.1

2.46

2.47

u/ml

0.01

285

Other anxiety disorders

733

4658

1.41

16.68

1.1

2.26

2.47

u/ml

0.15

205

1201

Opioids

1302

5269

1.30

16.65

1.1

1.68

2.40

u/ml

1.45

328

1307

Diseases of the musculoskeletal system and connective tissue

979

3635

1.36

16.53

1.1

2.19

2.90

u/ml

0.89

269

988

Allergic urticaria

146

693

2.16

16.38

1.1

3.86

2.80

u/ml

0.28

179

Diseases of middle ear and mastoid

875

5295

1.36

16.30

1.1

1.65

2.64

u/ml

2.34

251

1407

Dental caries 2 and operation codes

1054

6353

1.33

16.28

1.1

2.12

2.53

u/ml

0.54

286

1619

Dental caries 2

1069

6386

1.32

16.25

1.1

2.16

2.54

u/ml

0.48

295

1626

Neurological diseases

1318

5139

1.30

16.18

1.1

2.38

2.56

u/ml

0.16

371

1344

Soft tissue disorders

1417

5769

1.28

15.92

1.1

1.90

2.63

u/ml

1.30

361

1524

Codeine

1192

5038

1.31

15.67

1.1

1.45

2.37

u/ml

2.19

321

1239

Bronchitis, not specified as acute or chronic

317

2.69

15.66

1.1

1.0

1.21

1.60

u/ml

0.22

Persons encountering health services for examination and investigation

856

3139

1.37

15.53

1.1

2.15

2.39

u/ml

0.23

222

780

Propionic acid derivatives

422

1352

1.58

15.50

1.1

2.71

3.32

u/ml

0.33

109

387

Parasetamol

1165

4561

1.31

15.43

1.1

2.04

2.56

u/ml

0.63

298

1141

Exfoliative dermatitis

7.87

14.97

1.0

13.98

2.91

u/ml

—

Mood [affective] disorders

1240

6371

1.29

14.97

1.1

2.19

2.29

u/ml

0.08

323

1593

Codeine or tramadol medication

1309

5681

1.28

14.94

1.1

1.44

2.31

u/ml

2.25

344

1372

Other (not insulin) diabetes medications

524

4552

0.69

14.90

1.1

1.68

1.82

u/ml

0.13

140

1052

Renal tubulo-interstitial diseases

482

5382

0.68

14.88

1.1

2.16

2.38

u/ml

0.13

125

1341

Type 2 diabetes, strict (exclude DM1)

521

4481

0.69

14.79

1.1

1.81

u/ml

0.00

145

1027

COPD (mode)

117

412

2.26

14.62

1.0

1.44

1.23

u/ml

0.16

Mood disorders

1238

6374

1.28

14.55

1.1

2.19

2.29

u/ml

0.08

323

1594

Type 2 diabetes, definitions combined

522

4472

0.69

14.54

1.1

1.80

u/ml

0.00

146

1024

Selective serotonin reuptake inhibitors

1216

4986

1.29

14.45

1.1

1.91

2.19

u/ml

0.34

307

1246

Myalgia

280

1698

1.67

14.42

1.1

1.41

1.92

u/ml

0.46

409

Other antidepressants

1197

4863

1.29

14.23

1.1

2.20

2.18

u/ml

0.01

320

1206

Haemorrhage from respiratory passages

220

1157

1.77

14.23

1.1

2.74

1.90

u/ml

0.47

273

Gastrointestinal diseases

1033

3951

1.32

14.21

1.1

2.36

2.51

u/ml

0.13

280

1043

Other diseases of hard tissues of teeth

777

4286

1.36

14.18

1.1

2.16

2.63

u/ml

0.37

214

1058

Type 2 diabetes, definitions combined, including avohilmo

543

4551

0.70

13.97

1.1

1.77

1.82

u/ml

0.05

153

1038

Biguanides

496

4393

0.69

13.97

1.1

1.59

1.80

u/ml

0.20

132

1010

Eosinophilia

5.05

13.94

1.2

1.1

0.76

5.77

u/ml

—

Dorsalgia

1252

5330

1.28

13.93

1.1

2.11

2.38

u/ml

0.26

342

1334

Pain and other conditions associated with female genital organs and menstrual cycle

349

2165

1.56

13.74

1.1

1.52

2.59

u/ml

0.89

571

Dorsopathies

1375

5582

1.26

13.73

1.1

2.02

2.50

u/ml

0.65

356

1417

Temporomandibular joint disorders

216

1244

1.76

13.52

1.1

0.54

2.46

u/ml

5.27

308

Abdominal and pelvic pain

1269

5038

1.27

13.43

1.1

1.92

2.50

u/ml

0.83

322

1324

Persons encountering health services for specific procedures and health care

1299

6401

1.26

13.42

1.1

1.89

2.42

u/ml

0.89

390

1578

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

1433

0.40

13.21

1.0

1.1

0.23

1.53

u/ml

—

324

Simple and mucopurulent chronic bronchitis

4.00

13.19

1.1

0.48

2.88

u/ml

—

Other chronic obstructive pulmonary disease, including avohilmo

268

1368

1.64

12.74

1.1

1.81

1.48

u/ml

0.27

316

Other bacterial diseases

539

5174

0.72

12.60

1.1

2.91

2.14

u/ml

0.66

139

1301

Symptoms and signs involving the skin and subcutaneous tissue

701

5211

1.35

12.55

1.1

2.70

2.05

u/ml

0.47

169

1300

Soft tissue disorders related to use, overuse and pressure

220

1301

1.70

12.49

1.0

1.1

1.16

1.79

u/ml

0.52

291

Fenamates

168

606

1.89

12.48

1.1

2.68

1.82

u/ml

0.17

147

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1325

6068

1.25

12.45

1.1

1.89

2.48

u/ml

1.05

342

1556

Symptoms and signs involving the digestive system and abdomen

1261

5039

1.26

12.33

1.1

1.92

2.51

u/ml

0.83

314

1325

Schizophrenia

1325

0.36

12.30

1.0

1.1

0.75

2.32

u/ml

—

339

Schizophrenia, schizotypal and delusional disorders

155

2780

0.55

12.24

1.1

0.33

2.31

u/ml

12.36

707

Schizophrenia or delusion

155

2776

0.55

12.18

1.1

0.33

2.31

u/ml

12.36

707

Allergic colitis

436

2.31

12.07

1.2

1.1

3.57

4.58

u/ml

0.23

140

Other specific joint derangements/joint disorders

1011

5323

1.28

11.91

1.1

1.99

2.49

u/ml

0.53

269

1360

Anti-inflammatory and antirheumatic products, non-steroids

402

1355

1.50

11.89

1.1

2.89

3.31

u/ml

0.20

101

389

ILD, hospital admissions 1, main diag only

290

2.50

11.84

1.1

2.64

1.38

u/ml

0.43

Mouth breathing

405

2797

1.46

11.61

1.1

2.32

2.13

u/ml

0.07

733

Parodontitis or/and operation codes

408

3485

0.69

11.60

1.1

2.70

1.79

u/ml

0.51

110

847

ILD, hospital admissions

324

2.40

11.52

1.1

2.64

1.50

u/ml

0.38

Acute pharyngitis

257

1609

1.61

11.49

1.1

3.77

2.57

u/ml

0.50

446

Insulin medication

278

3649

0.65

11.48

1.1

1.32

2.10

u/ml

1.31

926

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

178

1989

0.58

11.47

1.1

0.97

1.52

u/ml

0.76

426

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

178

1989

0.58

11.47

1.1

0.97

1.52

u/ml

0.76

426

Suppurative and unspecified otitis media

627

4140

1.35

11.45

1.1

1.55

2.76

u/ml

3.02

194

1119

Other interstitial pulmonary diseases

325

2.39

11.45

1.1

2.64

1.50

u/ml

0.38

Cystitis

978

4690

1.28

11.44

1.1

1.82

2.47

u/ml

0.99

232

1182

Other soft tissue disorders, not elsewhere classified

1120

5521

1.26

11.38

1.1

1.73

2.67

u/ml

2.05

276

1451

Interstitial lung disease

326

2.38

11.37

1.1

2.64

1.50

u/ml

0.38

Interstitial lung disease endpoints

326

2.38

11.37

1.1

2.64

1.50

u/ml

0.38

Exposure to other specified factors

883

6474

1.28

11.31

1.1

2.55

2.32

u/ml

0.14

241

1650

Lichen simplex chronicus and prurigo

228

2.67

11.18

1.1

1.0

1.96

1.19

u/ml

0.26

Migraine with aura

360

2455

1.48

11.17

1.1

2.73

2.54

u/ml

0.08

621

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

432

2814

1.43

11.15

1.1

1.57

1.63

u/ml

0.05

113

665

COPD, hospital admissions

200

1000

1.70

11.11

1.1

1.0

2.14

1.35

u/ml

0.62

217

COPD, early/later onset

201

1005

1.69

11.06

1.1

1.0

2.14

1.34

u/ml

0.63

219

Intestinal infectious diseases

1094

6843

1.25

10.84

1.1

2.58

2.38

u/ml

0.11

287

1766

Depression medications

666

2506

1.35

10.80

1.1

2.78

2.64

u/ml

0.08

170

652

Kela-code for severe mental illness

192

3136

0.61

10.65

1.1

0.74

2.17

u/ml

3.10

790

Diseases of the ear and mastoid process

1475

6160

1.22

10.58

1.1

1.80

2.45

u/ml

1.33

401

1547

Vocal cord dysfunction

168

897

1.76

10.58

1.2

1.1

2.57

2.41

u/ml

0.03

211

Paracetamol of NSAID medication

306

1005

1.54

10.42

1.1

2.41

3.60

u/ml

0.71

299

Mood disorders, excluding more controls

1093

5352

1.25

10.34

1.1

2.24

2.22

u/ml

0.02

277

1301

Dental caries 2 and operation codes, only avohilmo

904

4424

1.27

10.28

1.1

2.26

2.63

u/ml

0.39

245

1159

Neurological diseases, wide definition

625

2342

1.35

10.26

1.1

2.24

3.21

u/ml

0.87

172

670

Accidents

1087

4367

1.25

10.24

1.1

2.31

2.26

u/ml

0.03

294

1088

Other joint disorders

1270

5527

1.23

10.21

1.1

1.91

2.59

u/ml

1.23

354

1424

Schizophrenia or delusion, excluding more controls

155

2606

0.59

10.02

1.1

0.33

2.02

u/ml

9.79

641

Lower back pain or/and sciatica

1106

6221

1.24

9.97

1.1

2.10

2.25

u/ml

0.13

276

1549

Other respiratory diseases principally affecting the interstitium

417

2.12

9.97

1.1

2.25

1.33

u/ml

0.38

109

Oxicams

198

671

1.69

9.96

1.1

0.89

1.78

u/ml

1.25

171

Migraine with aura and triptan purchases

250

1623

1.56

9.94

1.1

3.28

2.36

u/ml

0.33

403

Other and unspecified nonorganic psychotic disorders

107

2001

0.53

9.92

1.1

0.31

2.32

u/ml

10.72

525

Pruritus

107

549

1.97

9.83

1.1

2.83

1.04

u/ml

0.32

115

Disturbances of skin sensation

322

2209

1.47

9.74

1.1

3.15

1.84

u/ml

0.68

545

Chronic conjunctivitis

176

2.80

9.71

1.1

3.19

3.01

u/ml

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

286

2.18

9.56

1.1

2.30

2.50

u/ml

0.05

Malignant neoplasm of breast

178

2088

0.61

9.50

1.1

0.95

1.40

u/ml

0.60

434

Nummular dermatitis

286

2.34

9.37

1.1

1.0

4.14

1.25

u/ml

0.39

Type 2 diabetes, wide definition

335

3113

0.70

9.28

1.1

1.71

1.58

u/ml

0.10

697

Mental and behavioural disorders due to alcohol, excluding acute intoxication

187

2969

0.63

9.27

1.1

2.43

2.23

u/ml

0.07

730

General symptoms and signs

1383

5763

1.21

9.24

1.1

2.12

2.43

u/ml

0.37

343

1509

Other external causes of accidental injury

1074

4367

1.24

9.14

1.1

2.29

2.26

u/ml

0.02

297

1088

Chronic gastritis

143

828

1.73

8.90

1.1

1.0

1.16

1.85

u/ml

0.55

181

Alcohol use disorder, ICD-based

173

2762

0.62

8.78

1.1

2.52

2.27

u/ml

0.08

681

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

100

523

1.94

8.76

1.1

2.07

2.75

u/ml

0.27

132

Polyarthropathies

436

3926

0.74

8.72

1.1

0.75

2.32

u/ml

7.02

105

945

Somatoform disorder

187

1172

1.61

8.68

1.1

1.04

2.03

u/ml

1.56

288

Provisional assignment of new diseases of uncertain etiology

529

4021

1.32

8.63

1.1

2.73

2.33

u/ml

0.21

141

1060

Codes for special purposes

529

4023

1.32

8.60

1.1

2.73

2.33

u/ml

0.21

141

1061

Acute suppurative otitis media

499

3518

1.34

8.56

1.1

2.78

u/ml

0.00

161

974

Persons encountering health services in other circumstances, wide

1397

6087

1.19

8.50

1.1

1.94

2.47

u/ml

0.82

369

1561

Prurigo nodularis

3.95

8.46

1.0

0.14

1.23

u/ml

—

Heart failure, not strict

267

2681

0.68

8.44

1.1

1.32

1.72

u/ml

0.39

641

Functional dyspepsia

238

1585

1.51

8.40

1.1

2.32

1.82

u/ml

0.21

371

Dentofacial anomalies [including malocclusion]

386

2783

1.38

8.37

1.1

0.67

2.85

u/ml

9.71

112

705

Other and unspecified rosacea

421

2.02

8.33

1.1

1.0

1.42

2.18

u/ml

0.51

Disorders of skin appendages

569

4392

1.30

8.29

1.1

2.25

2.42

u/ml

0.12

148

1149

External causes of morbidity and mortality

922

3731

1.24

8.29

1.1

2.42

2.32

u/ml

0.08

248

938

Alcohol use disorder, Swedish definition

263

3531

0.69

8.23

1.1

2.05

2.08

u/ml

0.02

874

Disorders of synovium and tendon

536

3695

1.31

8.21

1.1

1.74

2.29

u/ml

0.58

135

898

Insulin, combination of fast acting with intermediate-acting or long-acting

278

3667

0.70

8.18

1.1

1.32

2.12

u/ml

1.36

930

Trochanteric bursitis

102

549

1.87

8.18

1.0

1.1

0.30

2.22

u/ml

2.72

120

Other noninfective gastroenteritis and colitis

271

1864

1.46

8.14

1.1

2.17

2.91

u/ml

0.47

513

Diseases of oesophagus, stomach and duodenum

1119

5633

1.21

8.10

1.1

1.65

2.30

u/ml

1.19

282

1403

Injuries to the wrist and hand

1135

6845

1.21

8.08

1.1

3.39

2.15

u/ml

1.08

304

1732

Infective dermatitis

502

1.91

8.07

1.1

3.12

1.78

u/ml

0.24

Heartburn

107

588

1.84

8.07

1.1

1.15

2.28

u/ml

0.74

155

Malignant neoplasm of breast, HER2-negative

172

1987

0.63

8.03

1.1

0.95

1.22

u/ml

0.32

409

Other and unspecified tonsillitis

540

3527

1.31

7.94

1.1

1.81

2.29

u/ml

0.52

148

940

Follow-up examination after treatment for conditions other than malignant neoplasms

490

2423

1.33

7.93

1.1

1.0

1.90

2.34

u/ml

0.39

110

574

Cervicocranial syndrome

105

577

1.84

7.92

1.1

0.43

2.07

u/ml

2.40

137

Alcohol dependence

1509

0.52

7.91

1.1

0.51

1.99

u/ml

3.82

355

ILD, hospital admission 2, with pulmonary infections

177

2.56

7.90

1.1

1.35

2.16

u/ml

0.28

Other diseases of urinary system

1133

5300

1.21

7.84

1.1

1.89

2.39

u/ml

0.60

286

1359

Migraine without aura

323

2318

1.41

7.78

1.1

2.45

2.29

u/ml

0.05

598

Other inflammation of eyelid

120

690

1.76

7.78

1.1

2.98

2.42

u/ml

0.12

170

TMD related operations

197

1284

1.55

7.78

1.1

1.83

2.30

u/ml

0.14

316

Organic, including symptomatic, mental disorders

896

0.47

7.74

1.0

1.1

0.30

1.72

u/ml

3.56

207

Other enthesopathies

270

1876

1.45

7.73

1.1

1.22

1.68

u/ml

0.37

425

332

4089

0.72

7.72

1.1

2.43

2.13

u/ml

0.15

100

1031

Enthesopathies of lower limb, excluding foot

214

1421

1.52

7.72

1.1

2.38

1.93

u/ml

0.20

326

Unspecified mental disorder

255

3656

0.69

7.71

1.1

0.64

2.21

u/ml

5.24

928

Dysphagia

160

995

1.62

7.68

1.1

1.17

1.62

u/ml

0.51

236

Inflammatory diseases of female pelvic organs

733

4430

1.25

7.60

1.1

2.29

2.07

u/ml

0.17

168

1087

Generalized anxiety disorder

245

1684

1.47

7.52

1.1

2.73

2.37

u/ml

0.11

454

Peritonsillar abscess

209

1389

1.51

7.52

1.1

1.0

1.90

2.30

u/ml

0.23

321

305

3882

0.72

7.49

1.1

2.60

2.20

u/ml

0.18

984

Cerebrovascular diseases

224

2356

0.68

7.47

1.1

0.73

1.47

u/ml

1.65

545

Chondrocostal junction syndrome [Tietze]

177

2.53

7.46

1.1

2.41

4.26

u/ml

0.39

Hypertrophy of breast in women and men

210

1403

1.51

7.40

1.1

1.73

u/ml

0.00

335

Renal failure

1370

0.54

7.28

1.0

1.1

2.14

2.21

u/ml

0.02

340

Substance abuse

331

4306

0.73

7.28

1.1

2.64

2.10

u/ml

0.28

1084

Mental and behavioural disorders due to psychoactive substance use

347

4426

0.74

7.28

1.1

2.59

2.07

u/ml

0.29

102

1108

Subjective visual disturbances

222

1506

1.48

7.25

1.1

1.30

1.99

u/ml

0.66

374

Urticaria due to cold and heat

3.95

7.21

1.3

1.0

3.45

4.95

u/ml

—

Other menopausal disorders

245

961

1.48

7.19

1.1

0.76

2.20

u/ml

1.55

201

Parodontitis

505

4786

0.78

7.19

1.1

2.46

1.80

u/ml

0.40

126

1121

Parodontitis or operation codes

506

4789

0.78

7.17

1.1

2.44

1.80

u/ml

0.39

127

1121

Factors influencing health status and contact with health services

372

1363

1.37

7.16

1.1

3.01

2.84

u/ml

0.08

102

314

Injuries to the ankle and foot

889

6688

1.22

7.16

1.1

2.94

2.36

u/ml

0.49

249

1718

Rosacea

112

648

1.75

7.16

1.1

1.80

1.59

u/ml

0.13

150

Disorders of eyelid, lacrimal system and orbit

747

4744

1.24

7.13

1.1

2.06

2.13

u/ml

0.05

184

1163

Unspecified threat to breathing

3.46

7.11

1.1

2.17

4.70

u/ml

—

Hard cardiovascular diseases

296

2632

0.72

7.04

1.1

1.59

1.64

u/ml

0.03

613

STROKE

248

2445

0.70

6.94

1.1

0.66

1.57

u/ml

2.66

554

Other and unspecified drugs and medicaments

450

1.89

6.94

1.1

2.39

2.83

u/ml

0.13

106

Chronic periodontitis, including avohilmo

505

4775

0.78

6.87

1.1

2.46

1.80

u/ml

0.40

126

1119

Emphysema

3.27

6.82

1.2

1.0

4.42

3.08

u/ml

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

231

1603

1.45

6.79

1.1

3.58

1.93

u/ml

0.74

408

Diseases of external ear

304

2211

1.38

6.77

1.1

1.68

2.43

u/ml

0.70

568

Transport accidents

540

3769

1.28

6.76

1.1

1.85

2.22

u/ml

0.32

141

947

Mental and behavioural disorders due to alcohol

269

3633

0.72

6.74

1.1

2.70

2.20

u/ml

0.22

926

Non-allergic asthma

370

1.96

6.72

1.0

1.26

1.42

u/ml

0.04

Otitis externa

230

1597

1.45

6.71

1.1

2.05

2.30

u/ml

0.13

409

COPD, hospital admission 2, with asthma infections

125

643

1.66

6.66

1.1

1.0

1.46

1.71

u/ml

0.14

146

Other diseases of oesophagus

303

2.06

6.64

1.1

1.18

1.92

u/ml

0.39

Emergency coronary revascularization (for ACS)

979

0.54

6.49

1.0

0.26

1.66

u/ml

3.48

226

Stroke, including SAH

154

1747

0.65

6.48

1.1

0.68

1.66

u/ml

1.68

408

Herpesviral [herpes simplex] infections

122

744

1.66

6.46

1.1

4.99

1.84

u/ml

0.73

185

Allergic contact dermatitis due to drugs in contact with skin

2.95

6.37

1.0

1.1

5.71

3.13

u/ml

—

Metabolic disorders

612

4717

0.80

6.35

1.1

1.69

2.13

u/ml

0.52

160

1130

Coronary revascularization (ANGIO or CABG)

917

0.54

6.35

1.0

0.32

1.74

u/ml

—

206

Acute and transient psychotic disorders

899

0.45

6.31

1.1

0.24

2.17

u/ml

—

223

Later onset COPD, excluding more controls

2.82

6.27

1.0

0.54

0.26

u/ml

—

Substance abuse, excluding more controls

331

3853

0.75

6.27

1.1

2.64

1.89

u/ml

0.43

935

Diarrhoea and gastroenteritis of presumed infectious origin

801

6035

1.21

6.25

1.1

1.97

2.33

u/ml

0.37

214

1576

Migraine without aura and triptan purchases

246

1756

1.41

6.23

1.1

2.47

2.21

u/ml

0.07

453

Unspecified acute lower respiratory infection

152

986

1.55

6.23

1.1

2.75

2.12

u/ml

0.19

238

Restless leg syndrome

555

1.74

6.20

1.1

0.84

1.85

u/ml

1.25

132

Exclusions for E4_PCOS_CONSORTIUM

658

5061

0.81

6.20

1.1

1.42

2.34

u/ml

1.13

137

1281

Glucagon-like peptide-1 (GLP-1) analogues

127

1647

0.63

6.17

1.0

1.1

1.01

1.46

u/ml

0.43

382

Hyperkinetic disorders, excluding more controls

231

1594

1.43

6.13

1.1

3.05

2.81

u/ml

0.08

458

Oedema, not elsewhere classified

221

1541

1.43

6.13

1.1

1.58

2.03

u/ml

0.35

394

Injury, poisoning and certain other consequences of external causes

762

3130

1.22

6.13

1.1

2.13

2.26

u/ml

0.10

218

773

Pain in thoracic spine

149

967

1.55

6.10

1.1

2.41

2.38

u/ml

0.01

219

Striking against or struck by other objects

396

3046

1.31

6.09

1.1

2.35

2.67

u/ml

0.15

839

Hypertrophy of breast

188

1282

1.48

6.09

1.1

1.63

1.46

u/ml

0.11

300

Other/unspecified dorsalgia

335

2510

1.33

6.00

1.1

0.96

1.94

u/ml

2.54

601

Otalgia

102

609

1.70

5.93

1.2

1.1

4.56

3.27

u/ml

0.19

165

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

1170

0.58

5.93

1.0

3.98

1.84

u/ml

0.46

276

Other degenerative diseases of the nervous system

884

0.53

5.92

1.0

0.36

1.44

u/ml

3.59

192

Dermatitis due to substances taken internally

304

2.00

5.91

1.1

5.64

1.20

u/ml

1.42

Insulin, intermediate and long-acting

249

3346

0.73

5.84

1.0

1.1

1.44

2.17

u/ml

1.00

842

Vasomotor rhinitis (mode)

347

1.92

5.84

1.1

2.19

2.86

u/ml

0.17

Preparation and fitting of bite rail to mouth

156

1035

1.52

5.81

1.1

2.15

2.02

u/ml

0.03

254

Selective deficiency of immunoglobulin G [IgG] subclasses

4.84

5.80

1.2

1.0

8.35

3.39

u/ml

—

Autoimmune diseases excluding thyroid diseases

943

6180

0.84

5.77

1.1

1.62

2.59

u/ml

1.64

235

1637

COPD, hospital admissions 1, only main diagnosis

128

688

1.59

5.75

1.1

1.75

1.69

u/ml

0.03

153

Diaphragmatic hernia

196

1361

1.45

5.75

1.1

1.22

1.38

u/ml

0.10

315

Unspecified chronic bronchitis

3.48

5.73

1.3

1.0

3.71

4.16

u/ml

—

Other and unspecified polyneuropathies, also in other diseases

538

1.72

5.72

1.1

3.12

1.61

u/ml

0.30

124

908

4792

1.19

5.71

1.1

2.73

2.08

u/ml

0.63

268

1152

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

908

4792

1.19

5.71

1.1

2.73

2.08

u/ml

0.63

268

1152

Other general symptoms and signs

528

1.74

5.69

1.1

3.04

3.61

u/ml

0.07

169

Acute appendicitis, no complications

630

5152

1.22

5.64

1.1

2.34

2.08

u/ml

0.17

165

1254

Autoimmune diseases excluding thyroid diseases, strict definition

926

6088

0.85

5.63

1.1

1.64

2.60

u/ml

1.54

230

1620

Inflammatory diseases of prostate (prostatitis)

439

1.79

5.56

1.1

3.02

2.96

u/ml

—

107

Tinnitus

171

1168

1.47

5.51

1.1

2.10

1.83

u/ml

0.08

275

Fibromyalgia

100

608

1.66

5.44

1.1

1.32

2.14

u/ml

0.56

144

Internal derangement of knee

357

2754

1.30

5.33

1.1

1.39

1.73

u/ml

0.35

642

Dislocation, sprain and strain of joints and ligaments of knee

694

5365

1.21

5.31

1.1

2.25

2.15

u/ml

0.07

196

1326

COPD related to multimorbidity

129

701

1.55

5.29

1.1

1.0

3.04

1.45

u/ml

0.73

152

Benign neoplasm: Liver/bile ducts

126

2.51

5.25

1.0

0.37

1.92

u/ml

1.07

Any operation in hilmo

246

1.78

5.20

1.1

1.0

2.53

2.97

u/ml

0.11

Disorders of breast

488

3641

1.25

5.20

1.1

1.70

1.95

u/ml

0.21

109

855

Stroke, excluding SAH

140

1546

0.67

5.17

1.1

0.46

1.77

u/ml

3.21

357

Acute tubulo-interstitial nephritis

351

3994

0.78

5.16

1.1

2.64

2.28

u/ml

0.18

1023

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

337

2606

1.30

5.09

1.1

3.82

2.29

u/ml

0.46

106

670

Arthropathies

1266

5612

1.15

5.09

1.1

2.04

2.58

u/ml

0.76

338

1454

Panic disorder

224

1634

1.38

5.08

1.1

1.72

2.10

u/ml

0.32

430

Visual disturbances

410

3249

1.27

5.07

1.1

1.72

2.26

u/ml

0.61

118

823

Parodontitis and operation codes

485

4657

0.81

5.06

1.1

2.52

1.78

u/ml

0.44

122

1093

Transplanted organ and tissue status

633

0.42

5.04

1.0

1.1

0.26

2.84

u/ml

—

170

Ocular pain

576

1.65

5.01

1.1

1.16

2.47

u/ml

1.06

136

GASTRO-related operations

1181

5142

1.16

5.00

1.1

2.23

2.62

u/ml

0.41

303

1358

Any gastric operation

1181

5142

1.16

5.00

1.1

2.23

2.62

u/ml

0.41

303

1358

Mental retardation, wide definition

569

0.40

4.99

1.2

4.01

3.93

u/ml

—

182

Appendicitis, broad definition

775

5992

1.19

4.97

1.1

2.62

1.99

u/ml

0.56

201

1464

Ischaemic Stroke, excluding all haemorrhages

122

1396

0.66

4.96

1.1

0.48

1.60

u/ml

2.46

323

Schizoaffective disorder

628

0.43

4.96

1.1

0.70

2.07

u/ml

—

151

Other disorders of eye and adnexa

151

1031

1.48

4.96

1.1

1.66

2.04

u/ml

0.16

259

Benign neoplasm: Liver/bile ducts

130

2.44

4.94

1.0

0.37

2.18

u/ml

1.12

Diseases of appendix

778

6001

1.18

4.93

1.1

2.62

1.99

u/ml

0.57

201

1466

Sub-endpoint used in defining T1D endpoints

180

2478

0.71

4.93

1.1

1.44

2.47

u/ml

1.34

666

Hypermobility syndrome

542

1.67

4.90

1.1

1.74

1.91

u/ml

0.07

128

Infections of the skin and subcutaneous tissue

611

5051

1.21

4.89

1.1

2.48

2.29

u/ml

0.16

173

1325

Condition for Implicit Sepsis (Organ dysfunction codes)

528

4680

0.82

4.87

1.1

2.52

2.06

u/ml

0.36

127

1187

Pain in limb

823

5059

1.18

4.84

1.1

1.77

2.59

u/ml

1.36

197

1305

Disorders of the thyroid gland

973

5475

1.16

4.80

1.1

1.39

2.21

u/ml

1.67

211

1401

Speech therapy

186

1330

1.40

4.74

1.1

0.35

2.14

u/ml

5.00

321

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

218

2.06

4.72

1.0

1.1

1.66

1.87

u/ml

0.06

Mental retardation

554

0.41

4.71

1.2

4.01

3.97

u/ml

—

178

Visual disturbances and blindness

428

3441

1.25

4.70

1.1

1.74

2.20

u/ml

0.51

124

880

Other disorders of patella

199

1444

1.39

4.68

1.1

2.05

1.47

u/ml

0.31

336

Benign neoplasm: Colon, unspecified

624

1.59

4.68

1.1

1.98

1.69

u/ml

0.07

142

Cervicalgia

159

1109

1.44

4.67

1.1

1.26

1.79

u/ml

0.50

245

Cerebrovascular diseases (FINNGEN)

167

1684

0.71

4.66

1.1

0.93

1.71

u/ml

1.10

375

Occupational exposure to risk-factors

140

2.32

4.64

1.2

1.1

0.56

2.56

u/ml

—

Female infertility, cervigal, vaginal, other or unspecified origin

376

1986

1.27

4.64

1.1

2.61

2.31

u/ml

0.18

506

Universal erythroderma, KELA reimbursement

3.41

4.64

1.1

1.0

14.72

5.29

u/ml

—

Type 1 diabetes

182

2510

0.72

4.63

1.1

1.44

2.46

u/ml

1.32

663

Unspecified privation

100

635

1.59

4.62

1.1

1.99

2.27

u/ml

0.10

153

Other disorders of white blood cells

240

1.98

4.61

1.2

1.1

4.36

2.67

u/ml

—

Type 1 diabetes, wide definition

163

2285

0.71

4.59

1.1

2.11

2.42

u/ml

0.15

606

Sulfonylureas

566

0.48

4.58

1.0

1.1

3.67

1.65

u/ml

—

118

Persons encountering health services in other circumstances

411

3300

1.25

4.57

1.1

2.75

2.60

u/ml

0.06

881

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

761

6069

0.85

4.55

1.1

1.48

2.33

u/ml

1.83

183

1553

Acute laryngitis and tracheitis

212

1539

1.37

4.54

1.2

1.1

2.96

2.97

u/ml

0.00

432

Diseases of male genital organs

489

2003

1.24

4.54

1.1

1.49

2.71

u/ml

1.60

120

580

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

117

1417

0.67

4.53

1.1

1.13

1.11

u/ml

0.02

290

Acute appendicitis

733

5882

1.18

4.46

1.1

2.35

2.01

u/ml

0.26

191

1439

Oesophagitis

195

2.07

4.45

1.1

0.47

2.91

u/ml

1.46

Benign neoplasm: Liver

118

2.42

4.44

1.0

0.40

1.76

u/ml

0.69

Benign neoplasm: Liver

118

2.42

4.44

1.0

1.1

0.40

1.98

u/ml

0.90

Dementia, including avohilmo

466

0.47

4.43

1.0

0.25

1.23

u/ml

—

116

Disorders of muscles

556

1.61

4.42

1.1

1.36

2.56

u/ml

0.54

124

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

730

0.50

4.37

1.1

1.76

2.53

u/ml

—

188

Candidiasis

122

821

1.50

4.35

1.1

0.81

1.69

u/ml

0.87

211

Benign neoplasm: Colon, unspecified

634

1.56

4.31

1.1

1.98

1.87

u/ml

0.03

132

Disturbance of activity and attention

228

1696

1.34

4.31

1.1

2.85

3.00

u/ml

0.05

508

Type 1 diabetes, strict (exclude DM2)

1459

0.65

4.28

1.1

1.52

2.93

u/ml

1.28

394

Recurring oral aphthae, including avohilmo

130

890

1.47

4.27

1.1

0.52

2.84

u/ml

4.48

245

Other and unspecified vaccines and biological substances

3.41

4.26

1.1

0.82

5.16

u/ml

—

General examination and investigation of persons without complaint and reported diagnosis

698

3139

1.19

4.26

1.1

2.20

2.39

u/ml

0.15

181

780

Coronary angioplasty

740

0.57

4.24

1.0

0.28

1.98

u/ml

3.07

170

Septicaemia

143

1947

0.70

4.23

1.1

3.90

2.37

u/ml

0.51

486

Type 1 diabetes, wide definition, subgroup 1

158

2193

0.72

4.23

1.1

1.54

2.39

u/ml

0.85

581

Injury of muscle and tendon at shoulder and upper arm level

195

1436

1.36

4.20

1.1

1.40

1.83

u/ml

0.18

328

Inflammatory disease of uterus

178

1295

1.39

4.19

1.2

1.1

1.73

1.71

u/ml

0.01

316

Dialysis, with operation codes

627

0.48

4.18

1.0

1.1

0.56

2.60

u/ml

—

162

Nephropathy related operations

613

0.47

4.17

1.0

1.1

0.31

2.38

u/ml

—

160

Hypothyroidism, other/unspecified

907

5189

1.16

4.17

1.1

1.36

2.26

u/ml

1.78

195

1320

Dementia

427

0.47

4.16

1.0

0.25

1.29

u/ml

—

102

L04AD Calcineurin inhibitors

835

0.55

4.15

1.0

1.1

6.44

2.89

u/ml

0.51

225

Irregular menses

627

4297

1.19

4.13

1.1

2.15

2.18

u/ml

0.01

136

1073

Atypical facial pain

243

1.91

4.13

1.1

0.86

1.99

u/ml

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

287

1.84

4.11

1.2

1.1

6.19

2.32

u/ml

0.43

Dislocation, sprain and strain of joints and ligaments at neck level

196

1453

1.36

4.10

1.1

2.96

2.26

u/ml

0.32

379

Delirium, not induced by alcohol and other psychoactive substances

215

0.23

4.09

1.0

—

2.20

—

Genitourinary diseases

829

3573

1.17

4.09

1.1

1.94

2.90

u/ml

1.32

211

1039

Suppurative otitis media, unspecified

210

1.99

4.06

1.0

1.1

2.31

2.18

u/ml

—

Endometriosis of pelvic peritoneum

196

1436

1.36

4.05

1.1

0.66

2.17

u/ml

2.80

351

Disorders of sclera, cornea, iris and ciliary body

485

4019

1.21

4.05

1.1

3.45

2.09

u/ml

0.97

133

1002

Separation of retinal layers (serosa)

169

2.10

4.03

1.1

1.0

0.55

2.92

u/ml

—

Other and unspecified disorders of vitreous body

182

1328

1.37

4.03

1.0

1.1

2.41

1.43

u/ml

0.22

271

Mental retardation, excluding more controls

509

0.44

4.02

1.2

4.01

4.25

u/ml

—

160

Noninfective enteritis and colitis

473

3910

1.21

4.01

1.1

2.48

2.54

u/ml

0.03

132

1044

Spinal osteochondrosis

3.10

4.00

1.1

1.83

4.35

u/ml

—

Impetigo

502

1.62

4.00

1.2

1.1

2.15

2.59

u/ml

0.22

148

Other specified/unspecified bacterial intestinal infections

267

1.85

4.00

1.1

1.24

3.10

u/ml

0.87

Other disorders of breast

123

845

1.47

4.00

1.1

0.74

1.27

u/ml

0.72

207

Disorders of gallbladder, biliary tract and pancreas

630

4783

0.85

3.99

1.1

1.10

1.87

u/ml

2.23

134

1115

Other specified disorders of external ear

2.45

3.98

1.0

2.58

3.78

u/ml

—

Single spontaneous delivery

304

2051

0.79

3.97

1.1

1.44

2.76

u/ml

1.82

538

Anomalies of dental arch relationship, including avohilmo

296

2095

1.28

3.94

1.1

2.29

3.11

u/ml

0.48

600

Type 1 diabetes, strict definition

1333

0.65

3.91

1.1

2.66

2.89

u/ml

0.07

369

Viral pneumonia

113

767

1.48

3.91

1.1

5.16

2.09

u/ml

0.62

202

Postpartum care and examination

174

1503

0.73

3.88

1.1

1.95

3.20

u/ml

0.64

382

Lichen simplex chronicus

132

2.22

3.88

1.1

4.00

1.12

u/ml

—

Type 1 diabetes, strict definition, subgroup 1

1258

0.64

3.88

1.1

1.68

2.91

u/ml

0.85

345

Type 1 diabetes, definitions combined

1462

0.67

3.87

1.1

2.43

2.85

u/ml

0.14

394

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

405

3019

1.23

3.86

1.1

3.35

3.03

u/ml

0.15

114

892

Any dementia, excluding more controls

359

0.44

3.84

1.0

0.19

0.85

u/ml

—

Drug-induced adrenocortical insufficiency

2.53

3.84

1.2

1.1

0.72

1.72

u/ml

—

Exposure to other and unspecified forces of nature

3.50

3.83

1.1

0.38

1.68

u/ml

—

Disorders of lipoprotein metabolism and other lipidaemias

393

3027

0.81

3.83

1.1

1.45

1.67

u/ml

0.20

669

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

582

3190

1.19

3.82

1.1

2.20

2.29

u/ml

0.05

158

801

Valvular heart disease excluding rheumatic fever

166

1651

0.73

3.82

1.0

1.1

1.84

2.28

u/ml

0.16

413

Crossbite

151

1010

1.41

3.80

1.2

1.1

2.24

3.38

u/ml

0.82

307

Other diseases of the respiratory system

594

1.54

3.78

1.1

2.19

2.07

u/ml

0.03

159

Other respiratory disorders and diseases

594

1.54

3.78

1.1

2.19

2.07

u/ml

0.03

159

Other neurological diseases

311

3127

0.80

3.78

1.1

0.96

1.67

u/ml

1.14

757

Heart failure,strict

114

1190

0.69

3.77

1.1

1.71

2.01

u/ml

0.12

286

Keratitis

311

2481

1.26

3.77

1.1

4.45

1.96

u/ml

1.46

605

Mental and behavioural disorders due to opioids

378

0.36

3.76

1.0

1.1

0.22

2.24

u/ml

—

102

Other nutritional deficiencies

675

5663

1.17

3.76

1.1

2.26

2.31

u/ml

0.03

169

1388

Ganglion

210

1594

1.32

3.76

1.1

2.70

2.09

u/ml

0.27

372

Other extrapyramidal and movement disorders in other diseases

139

989

1.41

3.74

1.1

2.15

2.01

u/ml

0.05

223

Seborrhoeic dermatitis

408

1.65

3.74

1.1

0.63

1.33

u/ml

0.92

Other contact dermatitis

447

1.62

3.73

1.1

4.06

1.32

u/ml

0.98

Peripheral artery disease

827

0.61

3.73

1.0

0.11

1.39

u/ml

—

181

Other otitis externa (chronic)

371

1.69

3.72

1.0

1.1

3.68

2.90

u/ml

0.14

Hypertensive diseases

633

4196

0.85

3.71

1.1

1.80

1.98

u/ml

0.17

158

992

Major coronary heart disease event

198

1746

0.76

3.69

1.1

2.01

1.59

u/ml

0.24

409

Correction of physiology of bite - very demanding therapy visit

204

1.95

3.67

1.1

0.39

2.96

u/ml

2.20

Hyperkinetic disorders

239

1835

1.30

3.66

1.1

2.99

2.91

u/ml

0.03

552

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

607

4221

1.18

3.65

1.1

2.01

2.00

u/ml

0.00

136

1004

Rotator cuff syndrome

414

2530

1.22

3.62

1.0

1.1

1.14

1.78

u/ml

0.82

100

566

COPD-related respiratory insufficiency

190

1.95

3.62

1.1

1.0

1.83

1.76

u/ml

0.01

Malaise and fatigue

383

2611

1.23

3.61

1.1

1.07

2.16

u/ml

2.53

112

681

Subacute thyroiditis

184

1.98

3.60

1.0

0.07

1.35

u/ml

—

Lumbar disc prolapse

545

3663

1.18

3.58

1.1

1.76

1.84

u/ml

0.07

148

850

Heart failure, strict

117

1200

0.70

3.58

1.1

1.0

1.71

2.02

u/ml

0.12

282

Hypertension

634

4187

0.85

3.57

1.1

1.80

1.99

u/ml

0.18

159

988

Insulin, fast-acting

209

2710

0.77

3.56

1.1

1.46

2.29

u/ml

1.03

707

Implicit Sepsis

387

3651

0.82

3.55

1.1

2.58

1.94

u/ml

0.45

917

Benign neoplasm: Choroid

171

2.00

3.54

1.1

1.0

0.13

2.06

u/ml

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

919

5329

1.14

3.54

1.1

1.35

2.22

u/ml

1.69

196

1343

Insulin, fast-acting or short human

209

2708

0.77

3.54

1.1

1.46

2.30

u/ml

1.05

704

Embedded and impacted teeth

467

3324

1.20

3.53

1.1

1.90

2.88

u/ml

1.33

134

940

Substance use, excluding alcohol

122

1711

0.71

3.53

1.1

2.88

2.42

u/ml

0.18

424

Adenomyosis (Endometriosis of uterus)

101

686

1.48

3.52

1.1

1.25

1.59

u/ml

0.20

152

Radiculopathy

613

1.51

3.51

1.2

1.1

3.83

2.11

u/ml

0.19

129

Suicide or other Intentional self-harm

171

2273

0.75

3.50

1.1

1.61

2.36

u/ml

0.82

582

Other disorders of eyelid

190

1388

1.33

3.48

1.1

1.07

1.51

u/ml

0.59

297

Nonsuppurative otitis media

382

2716

1.22

3.48

1.1

3.35

3.16

u/ml

0.07

118

771

Spondylolisthesis/Spondylolysis

123

869

1.42

3.48

1.1

0.44

1.95

u/ml

3.05

195

Hypothyroidism, strict autoimmune

777

4478

1.15

3.45

1.1

1.50

2.26

u/ml

1.17

174

1148

Other enthesopathy of foot (+metatarsalgia)

584

1.52

3.45

1.1

2.38

2.26

u/ml

0.02

133

Female infertility

409

2084

1.22

3.44

1.1

2.36

2.39

u/ml

0.02

542

Other obstetric conditions, not elsewhere classified

583

3232

1.18

3.42

1.1

2.34

2.29

u/ml

0.03

157

806

Non-rheumatic valve diseases

161

1576

0.74

3.40

1.0

1.1

1.89

2.13

u/ml

0.08

386

Olecranon bursitis

202

1.90

3.39

1.0

1.1

3.11

u/ml

0.00

Benign neoplasm: Choroid

174

1.97

3.39

1.1

1.0

0.13

1.88

u/ml

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

172

1561

0.75

3.38

1.1

0.68

1.41

u/ml

1.05

350

Covid-19 confirmed case

254

2008

1.27

3.37

1.1

2.76

2.15

u/ml

0.21

533

Thyroiditis

452

1.59

3.37

1.1

2.76

1.81

u/ml

—

105

Finngen Rheumatological endpoints

910

5876

0.88

3.36

1.1

1.22

2.40

u/ml

2.96

229

1473

All influenza

220

1710

1.29

3.35

1.1

1.59

2.29

u/ml

0.68

457

Other disorders of bone

204

1571

1.31

3.35

1.1

1.95

2.41

u/ml

0.25

389

Any dementia

353

0.48

3.32

1.0

0.19

1.26

u/ml

—

Disorders of thyroid, IBD co-morbidities

215

1210

1.30

3.32

1.1

1.53

2.20

u/ml

0.46

320

Redundant prepuce, phimosis and paraphimosis

187

1418

1.32

3.32

1.1

1.40

2.99

u/ml

1.67

401

Other intervertebral disc disorders

756

4031

1.15

3.31

1.1

1.60

1.97

u/ml

0.46

197

942

Dental operations

563

2455

1.18

3.30

1.1

1.46

2.05

u/ml

0.85

130

588

Benign neoplasm of other and ill-defined parts of digestive system

638

1.48

3.30

1.1

1.08

2.09

u/ml

0.82

150

Other septicaemia

124

1683

0.72

3.30

1.1

3.84

2.16

u/ml

0.51

426

Other diseases of stomach and duodenum

197

1.89

3.30

1.1

1.0

5.60

2.93

u/ml

—

Insulin, fast-acting (human)

1325

0.68

3.29

1.0

1.1

1.78

2.06

u/ml

0.15

334

Sequelae of other external causes

241

1.80

3.28

1.1

0.45

2.62

u/ml

2.04

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

142

2.06

3.27

1.0

1.1

0.65

4.51

u/ml

—

Combinations of oral blood glucose lowering drugs

989

0.64

3.27

1.0

2.47

1.71

u/ml

0.17

221

Thyroiditis, ILD-related definition

123

881

1.41

3.27

1.0

1.1

1.66

1.98

u/ml

0.11

211

Peroneal tendinitis

2.43

3.26

1.0

0.73

3.48

u/ml

—

Struck by thrown, projected or falling objec

348

1.66

3.23

1.1

3.37

2.79

u/ml

0.07

Reimbursement for rheumatic diseases

345

4170

0.82

3.22

1.1

1.18

2.18

u/ml

1.17

1018

All influenza (not pneumonia)

155

1156

1.35

3.20

1.1

1.22

2.53

u/ml

1.55

294

Unspecific neurodegenerative disorder

312

0.46

3.19

1.0

0.38

0.80

u/ml

—

Chronic kidney disease

880

0.62

3.18

1.0

1.1

2.37

2.83

u/ml

0.14

219

Dental operations, only avohilmo

592

2597

1.17

3.17

1.1

1.42

2.00

u/ml

0.89

136

625

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

144

2.03

3.17

1.0

0.65

4.05

u/ml

—

Other disorders of urethra and urinary system

637

4131

1.16

3.16

1.1

2.31

2.28

u/ml

0.02

155

1012

Correction of physiology of bite - demanding therapy visit

548

1.51

3.16

1.1

0.96

1.88

u/ml

1.13

135

Bacterial Sepsis

141

1690

0.74

3.16

1.0

1.1

1.96

1.84

u/ml

0.05

414

Presence of cardiac and vascular implants and grafts

982

0.68

3.16

1.0

1.69

1.87

u/ml

0.06

237

Coeliac disease

126

913

1.39

3.14

1.1

2.92

2.83

u/ml

0.02

243

Lichen planus

460

1.55

3.13

1.1

2.40

2.15

u/ml

0.05

108

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

511

0.51

3.11

1.1

0.12

2.11

u/ml

—

118

Disorders of eyelid in diseases classified elsewhere

159

1.97

3.11

1.2

1.0

1.95

3.33

u/ml

0.45

Benign neoplasm of middle ear and respiratory system

275

1.72

3.10

1.1

0.38

3.61

u/ml

2.17

Nonalcoholic fatty liver disease

526

1.51

3.09

1.1

0.46

2.29

u/ml

2.61

127

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

578

0.63

3.09

1.0

1.1

1.17

1.56

u/ml

0.24

134

Other reaction to severe stress, and adjustment disorders

453

3839

1.18

3.08

1.1

2.58

2.22

u/ml

0.20

124

965

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

2.73

3.08

1.3

1.0

0.37

4.00

u/ml

—

Bleeding

444

3818

0.84

3.08

1.1

3.81

2.05

u/ml

0.62

110

957

Care involving use of rehabilitation procedures

544

4437

1.17

3.08

1.1

1.49

2.16

u/ml

0.65

155

1082

Benign neoplasm of middle ear and respiratory system

276

1.71

3.06

1.1

0.38

3.59

u/ml

2.15

Other immunodeficiencies

2.37

3.06

1.1

0.29

1.17

u/ml

—

Adrenocortical insufficiency

203

1.85

3.05

1.2

1.1

0.54

2.67

u/ml

1.79

Mycoses

204

1592

1.29

3.05

1.1

0.93

1.82

u/ml

1.26

402

Certain infectious and parasitic diseases

1209

5450

1.11

3.04

1.1

2.61

2.27

u/ml

0.33

315

1400

All-cause Heart Failure

117

1164

0.72

3.03

1.1

1.0

1.71

2.04

u/ml

0.13

274

Leiomyoma of uterus

364

2468

0.83

3.03

1.1

1.99

1.73

u/ml

0.11

551

Benign neoplasm of eye and adnexa

377

1.60

3.03

1.0

1.1

0.28

2.53

u/ml

2.67

Atherosclerosis, excluding cerebral and coronary sclerosis

651

0.61

3.03

1.0

0.11

1.56

u/ml

—

141

Faecal incontinence

262

1.73

3.02

1.1

1.0

0.10

2.66

u/ml

—

Rheumatism, unspecified

651

1.45

3.02

1.1

0.70

2.00

u/ml

1.40

143

Fever of other and unknown origin

510

4049

1.17

3.01

1.1

2.74

2.46

u/ml

0.16

139

1080

110

736

1.41

3.01

1.1

1.0

1.29

1.39

u/ml

0.04

165

Other systemic involvement of connective tissue

185

1429

1.30

3.00

1.1

1.09

1.90

u/ml

0.79

346

Use of disulfiram, acamprosate or naltrexone

568

0.54

3.00

1.0

1.1

0.20

2.17

u/ml

4.44

134

ILD, hospital admissions 3, with pneumonia sepsis

147

1.98

2.99

1.2

1.0

0.46

1.49

u/ml

0.83

Trigger finger

100

702

1.43

2.99

1.1

0.91

2.20

u/ml

1.16

155

Otitis media, unspecified

204

1471

1.29

2.99

1.2

1.1

3.00

3.45

u/ml

0.15

439

Deep bite

185

1251

1.31

2.99

1.1

2.51

3.51

u/ml

0.39

381

Other systemic involvement of connective tissue (FG)

183

1403

1.30

2.98

1.1

1.09

1.70

u/ml

0.57

341

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

197

1.84

2.97

1.0

3.63

1.32

u/ml

—

Metatarsalgia

531

1.50

2.97

1.1

2.49

2.33

u/ml

0.03

119

Explicit Sepsis

188

2308

0.78

2.95

1.1

3.04

2.32

u/ml

0.28

590

Cervicobrachial syndrome

176

1355

1.30

2.94

1.1

1.88

1.81

u/ml

0.02

305

Lichen planus, including avohilmo

102

722

1.42

2.92

1.1

2.02

1.85

u/ml

0.04

164

Polyneuropathies and other disorders of the peripheral nervous system

104

739

1.41

2.91

1.1

2.71

1.69

u/ml

0.23

167

Cardiovascular diseases

1081

5290

1.12

2.91

1.1

2.16

2.62

u/ml

0.53

266

1431

Excessive attrition of teeth

479

2210

1.18

2.91

1.1

2.20

2.92

u/ml

0.51

135

557

Flat foot [pes planus] (acquired)

493

1.51

2.90

1.1

0.47

2.29

u/ml

2.46

111

Delivery

325

2083

0.82

2.90

1.1

1.24

2.72

u/ml

2.48

549

malignant neoplasm of male genital organs

599

0.65

2.89

1.0

1.1

0.96

1.48

u/ml

0.36

139

Appendectomy

689

5830

1.14

2.89

1.1

2.03

2.10

u/ml

0.05

183

1428

Benign neoplasm of eye and adnexa

382

1.58

2.88

1.0

1.1

0.28

2.40

u/ml

2.68

Ovarian cyst

440

2152

1.19

2.88

1.1

1.37

2.34

u/ml

1.08

116

562

Other viral hepatitis

559

0.55

2.87

1.2

1.1

0.66

2.14

u/ml

—

136

Complications predominantly related to the puerperium

307

2531

1.22

2.86

1.1

1.43

1.77

u/ml

0.19

605

Immunodeficiencies

329

1.63

2.85

1.1

3.49

3.78

u/ml

0.03

Inhalation and ingestion of food causing obstruction of respiratory tract

2.84

2.85

1.5

1.2

0.41

4.67

u/ml

—

Coronary atherosclerosis

210

1711

0.79

2.84

1.0

1.1

2.49

1.52

u/ml

0.58

393

Symptoms and signs involving the nervous and musculoskeletal systems

478

4095

1.17

2.84

1.1

2.58

2.15

u/ml

0.22

123

1075

Benign neoplasm: Colon

213

1652

1.26

2.83

1.1

1.45

1.32

u/ml

0.06

374

Cervical disc disorders

227

1813

1.26

2.83

1.1

2.48

1.67

u/ml

0.34

390

Acute lymphadenitis

538

1.48

2.82

1.1

2.06

2.67

u/ml

0.16

135

Pericarditis

123

2.05

2.82

1.2

1.0

1.75

3.41

u/ml

—

Falls/tendency to fall

1353

6161

1.10

2.82

1.1

2.71

2.21

u/ml

0.54

371

1564

Gluteal tendinitis

158

1.92

2.81

1.0

1.1

1.45

0.88

u/ml

—

Lateral epicondylitis

109

788

1.39

2.79

1.1

0.92

2.16

u/ml

1.20

171

Benign neoplasm of other and ill-defined parts of digestive system

662

1.43

2.79

1.1

1.08

2.48

u/ml

1.27

150

Maternal care for other known or suspected fetal problems

307

2380

0.82

2.78

1.1

1.24

2.57

u/ml

3.01

591

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

126

1684

0.74

2.78

1.1

1.60

2.25

u/ml

0.48

441

Inflammatory disorders of breast

532

1.48

2.77

1.1

1.18

1.22

u/ml

0.03

133

Extrapyramidal and movement disorders

191

1499

1.28

2.76

1.1

2.11

1.86

u/ml

0.11

341

Statin medication

603

3877

0.87

2.76

1.1

1.52

2.00

u/ml

0.60

146

927

Covid-19 suspected case

262

2135

1.23

2.76

1.1

2.94

2.18

u/ml

0.28

575

Other spirochaetal diseases

174

1351

1.29

2.75

1.1

1.71

1.97

u/ml

0.10

320

Chondropathies

156

1195

1.31

2.74

1.1

2.29

2.28

u/ml

0.01

304

Ischemic heart diseases

321

2420

0.83

2.74

1.1

2.06

1.58

u/ml

0.35

549

Atrial septal defect

494

0.53

2.74

1.0

1.2

1.04

4.54

u/ml

—

165

Otitis externa, unspecified

112

817

1.38

2.74

1.1

0.54

2.47

u/ml

3.83

215

Pre-eclampsia or poor fetal growth

279

3376

0.82

2.74

1.1

1.50

2.01

u/ml

0.32

815

Gingivitis and periodontal diseases

924

4261

1.12

2.73

1.1

1.37

2.55

u/ml

3.29

246

1031

Endometriosis

393

1969

1.19

2.73

1.1

0.72

2.39

u/ml

5.11

504

Other specified/unspecified soft tissue disorders

167

1.87

2.72

1.1

1.0

3.07

2.34

u/ml

—

Other disorders of penis

600

1.44

2.71

1.1

3.28

3.03

u/ml

0.05

187

Injuries to the knee and lower leg

1279

6661

1.10

2.71

1.1

2.14

2.43

u/ml

0.29

317

1709

Endometriosis of rectovaginal septum and vagina

453

1.51

2.70

1.1

0.54

1.41

u/ml

1.33

103

Type1 diabetes, definitions combined, early onset

1171

0.70

2.70

1.1

1.84

2.90

u/ml

0.42

327

Excessive, frequent and irregular menstruation

508

2433

1.17

2.68

1.1

2.45

2.49

u/ml

0.02

118

652

Lichen ruber planus, wide definition including periferal and oral lichen planus

119

879

1.36

2.68

1.1

1.70

1.94

u/ml

0.06

192

Short Achilles tendon (acquired)

119

2.04

2.67

1.1

0.49

3.44

u/ml

1.71

L04AA Selective immunosuppressants

116

1560

0.74

2.67

1.1

0.83

2.11

u/ml

2.30

387

Continuous positive airway pressure

154

1018

1.31

2.65

1.1

0.86

3.21

u/ml

3.87

268

Sciatica+with lumbago

411

3327

1.18

2.63

1.1

2.87

1.86

u/ml

0.57

104

777

Erysipelas

221

2497

0.81

2.62

1.1

2.32

1.48

u/ml

0.59

587

Superficial injury of hip and thigh

671

1.41

2.60

1.1

1.77

2.11

u/ml

0.20

171

Certain disorders involving the immune mechanism

154

1187

1.30

2.60

1.1

4.86

2.31

u/ml

0.51

284

Nausea and vomiting

233

1856

1.24

2.60

1.1

0.94

2.88

u/ml

4.69

516

Lyme disease

169

1319

1.29

2.59

1.1

1.71

1.98

u/ml

0.10

311

Demyelinating diseases of the central nervous system

728

0.63

2.59

1.0

1.1

0.41

1.61

u/ml

—

178

MS-disease / Multiple Sclerosis

629

0.60

2.58

1.0

1.1

0.46

1.72

u/ml

—

159

Stenosis and insufficiency of lacrimal passages

401

1.53

2.58

1.1

3.25

2.59

u/ml

0.15

Dysplasia of cervi uteri

295

1891

1.21

2.57

1.1

1.28

2.24

u/ml

0.97

478

Other complications of surgical and medical care, not elsewhere classified

557

1.45

2.56

1.1

1.88

2.71

u/ml

0.28

135

Other acute skin changes due to ultraviolet radiation

121

2.00

2.56

1.1

1.0

0.59

2.39

u/ml

0.92

Acne

186

1474

1.27

2.56

1.1

2.89

2.59

u/ml

0.09

428

Immunodeficiency with predominantly antibody defects

186

1.80

2.56

1.2

1.1

4.75

3.99

u/ml

0.06

Disorders of choroid and retina

374

3207

0.85

2.55

1.1

1.24

1.63

u/ml

0.42

753

Vulvovaginal ulceration/inflammation in other diseases

567

1.44

2.55

1.1

2.05

1.31

u/ml

0.24

132

Haemangioma and lymphangioma, any site

558

1.44

2.55

1.1

1.80

2.75

u/ml

0.55

143

Localized swelling, mass and lump of skin and subcutaneous tissue

240

1957

1.23

2.53

1.1

1.01

1.81

u/ml

1.27

508

Heart failure and antihypertensive medication

774

0.71

2.52

1.1

2.11

2.66

u/ml

0.18

172

Viral hepatitis

599

0.60

2.51

1.1

0.66

2.18

u/ml

—

144

Other/unspecified synovitis and tenosynovitis

643

1.41

2.51

1.0

1.1

1.66

2.41

u/ml

0.30

151

Haemangioma and lymphangioma, any site

560

1.44

2.51

1.1

1.80

2.80

u/ml

0.58

139

Other/unspecified enthesopathies, not elsewhere classified

364

1.55

2.50

1.2

1.1

0.72

3.12

u/ml

1.58

Shoulder lesions

600

3221

1.14

2.50

1.1

1.04

1.89

u/ml

1.70

133

743

Fitting and adjustment of other devices

135

956

1.32

2.47

1.1

0.16

1.81

u/ml

4.32

211

Diseases of arteries, arterioles and capillaries

220

2022

0.81

2.46

1.0

1.1

2.82

1.42

u/ml

0.43

471

Obsessive-compulsive disorder

108

800

1.36

2.46

1.1

2.41

2.47

u/ml

0.02

222

Acute alcohol intoxication, ICD10

108

1447

0.74

2.46

1.1

3.69

2.42

u/ml

0.35

365

Intermittent heterotropia

765

0.65

2.46

1.1

7.06

3.36

u/ml

0.54

241

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

420

3575

1.17

2.45

1.1

2.16

2.49

u/ml

0.26

116

970

Oter anti-inflammatory and antirheumatic agents, non-steroids

112

455

1.37

2.45

1.1

2.99

1.65

u/ml

0.21

107

Blepharochalasis

106

781

1.36

2.45

1.1

1.0

0.57

1.17

u/ml

0.76

159

Ischaemic heart disease, wide definition

308

2301

0.84

2.44

1.1

2.11

1.58

u/ml

0.38

518

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

234

1.69

2.44

1.1

7.14

2.81

u/ml

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

570

3932

1.14

2.44

1.1

2.01

1.95

u/ml

0.03

130

937

Other/unspecified soft tissue disorders related to use, overuse and pressure

152

1.86

2.44

1.1

1.0

0.23

4.55

u/ml

—

Pure hypercholesterolaemia

311

2486

0.84

2.44

1.1

1.29

1.56

u/ml

0.23

557

Other viral diseases

384

3276

1.17

2.43

1.1

1.90

2.83

u/ml

1.02

113

915

Acute alcohol intoxication

125

1636

0.76

2.41

1.1

3.47

2.31

u/ml

0.38

399

Umbilical hernia

189

1511

1.25

2.40

1.1

2.70

1.73

u/ml

0.34

365

Idiopathic pulmonary fibrosis

110

2.01

2.40

1.0

2.02

1.93

u/ml

—

Atrial fibrillation and flutter

168

1389

0.79

2.40

1.0

1.1

5.37

1.66

u/ml

0.77

301

Patellar tendinitis

132

1.93

2.39

1.0

1.1

5.77

4.76

u/ml

0.10

Impacted teeth

338

2668

1.19

2.38

1.1

2.20

2.99

u/ml

0.71

758

Major coronary heart disease event excluding revascularizations

172

1497

0.79

2.38

1.1

1.0

2.19

1.62

u/ml

0.30

338

Diseases of oral cavity, salivary glands and jaws

946

4380

1.11

2.37

1.1

1.64

2.63

u/ml

1.85

255

1087

Other disorders of adrenal gland

314

1.58

2.37

1.1

0.60

3.47

u/ml

2.59

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

983

0.70

2.37

1.0

1.1

0.54

1.10

u/ml

0.80

212

Other local infections of skin and subcutaneous tissue

575

1.42

2.37

1.1

2.22

3.23

u/ml

0.36

139

Leiomyoma of uterus

419

2767

0.86

2.36

1.1

1.72

1.60

u/ml

0.05

613

Toxic effect of contact with venomous animals

252

1.64

2.35

1.0

1.1

6.34

2.57

u/ml

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

315

1.57

2.34

1.0

1.1

0.71

2.81

u/ml

1.78

Iron deficiency

215

1.71

2.32

1.1

0.13

2.75

u/ml

—

L02BG Aromatase inhibitors

1124

0.72

2.32

1.1

0.91

1.53

u/ml

0.55

234

Haemangioma, any site

494

1.45

2.32

1.2

1.1

1.50

2.99

u/ml

0.93

128

Pulmonary embolism

130

996

1.31

2.32

1.1

1.38

1.79

u/ml

0.24

228

Polyuria

117

884

1.33

2.31

1.1

0.92

1.82

u/ml

0.82

206

Postmenopausal atrophic vaginitis

137

631

1.31

2.30

1.1

1.0

0.41

1.92

u/ml

1.83

138

Obesity

618

5433

1.13

2.30

1.1

1.97

2.23

u/ml

0.20

155

1333

Haemangioma, any site

495

1.44

2.30

1.2

1.1

1.50

2.92

u/ml

0.88

132

Obesity and other hyperalimentation

620

5448

1.13

2.30

1.1

1.97

2.23

u/ml

0.20

155

1333

Other inflammation of vagina/vulva

341

1.54

2.29

1.0

1.31

1.70

u/ml

—

Mental and behavioural disorders due to cannabinoids

354

0.50

2.29

1.2

1.1

2.03

2.43

u/ml

—

Pulmonary heart disease

130

998

1.31

2.29

1.1

1.38

1.78

u/ml

0.24

229

Chronic viral hepatitis

483

0.57

2.28

1.1

0.66

2.16

u/ml

—

122

Single delivery by caesarean section

229

1611

0.82

2.28

1.1

1.87

2.32

u/ml

0.33

420

Other puerperal infections

123

942

1.32

2.26

1.1

3.05

1.33

u/ml

0.44

240

Impingement syndrome of shoulder

142

1106

1.29

2.26

1.0

0.73

1.65

u/ml

0.97

248

Menorrhagia

355

1669

1.18

2.26

1.1

1.61

2.13

u/ml

0.36

402

Other noninflammatory disorders of vagina

464

1.45

2.25

1.1

0.72

1.65

u/ml

1.25

105

Perforation of tympanic membrane

623

1.39

2.25

1.1

0.91

2.69

u/ml

2.23

154

Other abnormal products of conception

479

2784

1.15

2.25

1.1

1.88

2.30

u/ml

0.36

120

644

Benign lipomatous neoplasm

182

1462

1.25

2.24

1.0

1.1

1.07

1.84

u/ml

1.07

340

Injuries to the neck

239

1978

1.21

2.23

1.1

2.79

2.41

u/ml

0.18

520

Pre-eclampsia

150

1895

0.79

2.23

1.1

2.11

1.56

u/ml

0.17

453

Pain, not elsewhere classified

248

2060

1.21

2.22

1.1

1.29

2.22

u/ml

1.17

533

Deforming dorsopathies

237

1960

1.21

2.22

1.1

1.46

1.98

u/ml

0.44

490

Unspecified/other endometriosis

123

944

1.31

2.22

1.1

0.83

2.09

u/ml

2.20

244

Secondary uncertain malignant neoplasm

365

0.52

2.22

1.2

1.1

0.12

2.03

u/ml

—

Post-traumatic stress disorder

126

971

1.31

2.22

1.1

2.84

2.34

u/ml

0.13

262

Heart failure and coronary heart disease

379

0.59

2.22

1.1

3.94

2.00

u/ml

—

Monoplegia

2.44

2.21

1.0

1.1

0.10

3.04

u/ml

—

Benign neoplasm: Ascending colon

303

1.56

2.21

1.1

1.0

2.85

1.49

u/ml

—

Other and unspecified local infections of skin and subcutaneous tissue

550

1.41

2.20

1.1

2.32

3.29

u/ml

0.33

135

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

688

0.65

2.20

1.0

1.1

2.33

1.43

u/ml

—

154

TMD related pain

265

1.60

2.19

1.1

0.25

1.95

u/ml

3.10

Other diseases of lip and oral mucosa

104

780

1.34

2.19

1.1

3.02

2.45

u/ml

0.12

175

Erosion of teeth, including avohilmo

233

1862

1.21

2.19

1.1

3.47

3.08

u/ml

0.11

455

Other symptoms and signs involving the nervous and musculoskeletal systems

360

3093

1.17

2.18

1.1

2.26

2.19

u/ml

0.02

794

Other diseases of liver

128

990

1.30

2.17

1.1

0.45

2.20

u/ml

3.61

233

Pre-eclampsia or eclampsia

158

1977

0.80

2.17

1.1

1.97

1.52

u/ml

0.14

473

Sequelae of injuries of upper limb

595

1.39

2.14

1.1

1.33

1.83

u/ml

0.36

142

Postpartum haemorrhage due to anatomy

151

1197

1.27

2.14

1.1

0.88

1.34

u/ml

0.82

303

Retinal breaks without detachment

561

1.40

2.14

1.1

0.94

1.87

u/ml

0.71

126

Complications associated with artificial fertilization

190

1.72

2.13

1.0

1.1

4.03

1.91

u/ml

—

Complications of medical and surgical care

564

4751

1.13

2.13

1.1

1.78

2.05

u/ml

0.25

146

1122

Bacterial infection, other or unspecified

216

2358

0.82

2.12

1.1

2.12

1.71

u/ml

0.25

589

Other erythematous conditions

145

1.81

2.11

1.1

1.0

1.61

3.56

u/ml

—

Injury of muscle and tendon at lower leg level

107

811

1.32

2.11

1.1

0.87

2.01

u/ml

2.05

201

Other/unspecified enthesopathies of lower limb, excluding foot

446

1.44

2.11

1.1

0.72

1.77

u/ml

1.24

104

Sacrococcygeal disorders, not elsewhere classified

175

1.73

2.11

1.1

0.23

2.41

u/ml

—

Benign neoplasm: Ascending colon

307

1.54

2.10

1.1

1.0

2.85

2.25

u/ml

—

Noninflammatory disorders of female genital tract

583

2599

1.13

2.09

1.1

1.82

2.66

u/ml

0.72

141

708

Injury of muscle and tendon at hip and thigh level

514

1.41

2.08

1.1

0.28

2.26

u/ml

3.33

121

Sequelae of injuries, of poisoning and of other consequences of external causes

197

1613

1.23

2.07

1.1

1.73

2.05

u/ml

0.23

400

Crowding of teeth, including avohilmo

199

1346

1.23

2.07

1.1

3.95

3.50

u/ml

0.15

416

Unspecified kidney failure

206

0.44

2.06

1.0

—

3.12

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

756

5994

0.90

2.06

1.1

3.11

2.13

u/ml

0.69

194

1497

Other bursopathies

515

1.40

2.05

1.1

4.39

2.51

u/ml

0.23

111

Abnormal involuntary movements

729

1.34

2.04

1.1

3.29

2.63

u/ml

0.19

181

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

436

0.61

2.04

1.1

0.87

2.30

u/ml

—

Polyarthrosis

551

1.38

2.02

1.1

1.0

0.49

1.19

u/ml

0.97

115

Fissure and fistula of anal and rectal regions

181

1473

1.23

2.02

1.1

1.59

1.80

u/ml

0.11

360

Other skin changes

713

1.34

2.02

1.1

7.23

2.11

u/ml

0.69

173

Malignant neoplasm of breast, HER-positive

115

1460

0.77

2.01

1.1

1.14

1.08

u/ml

0.05

295

Sicca syndrome [Sjögren]

384

1.47

2.01

1.0

1.1

0.21

2.35

u/ml

2.48

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

265

3126

0.84

2.01

1.1

1.58

2.25

u/ml

0.83

795

Endometriosis ASRM stages 1,2

197

1621

1.22

2.00

1.1

0.64

1.68

u/ml

2.11

393

Congenital malformations, deformations and chromosomal abnormalities

729

6315

1.11

2.00

1.1

2.51

2.55

u/ml

0.03

202

1649

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

351

0.54

2.00

1.2

1.1

7.02

2.39

u/ml

—

Other and unspecified injuries of ankle and foot

386

1.47

1.99

1.1

1.36

2.92

u/ml

1.01

102

Poisoning by drugs, medicaments and biological substances

196

2372

0.82

1.98

1.1

2.10

2.17

u/ml

0.04

609

Infections with a predominantly sexual mode of transmission

398

3473

1.15

1.98

1.1

3.26

2.18

u/ml

0.42

905

Other shoulder lesions

587

1.37

1.98

1.1

1.70

2.15

u/ml

0.19

130

Nonorganic sleeping disorders, excluding more controls

201

1659

1.22

1.98

1.1

1.24

2.28

u/ml

1.07

429

Other predominantly sexually transmitted diseases, not elsewhere classified

228

1906

1.20

1.97

1.1

3.88

2.09

u/ml

0.48

491

Rash and other nonspecific skin eruption

562

1.38

1.97

1.1

1.55

2.46

u/ml

0.69

146

Implicit bacterial Sepsis

108

1282

0.77

1.97

1.0

1.1

1.35

1.89

u/ml

0.48

289

Other and unspecified erythematous conditions

134

1.81

1.96

1.1

0.67

3.59

u/ml

—

Viral pneumonia (unknown virus, not influenza)

420

1.44

1.95

1.1

6.57

2.35

u/ml

0.53

106

Fracture of femur

633

0.68

1.94

1.0

1.1

2.26

2.59

u/ml

—

162

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

474

4187

1.13

1.94

1.1

3.42

2.55

u/ml

0.49

133

1103

Disorders of vitreous body

220

1795

1.20

1.93

1.0

1.1

2.08

1.41

u/ml

0.17

376

Unspecified event, undetermined intent

165

1.72

1.93

1.1

0.71

4.14

u/ml

—

Benign neoplasm: Transverse colon

234

1.59

1.92

1.1

1.0

0.02

2.37

u/ml

—

Hallux rigidus

455

1.41

1.91

1.1

1.0

1.53

1.45

u/ml

0.03

Carpal tunnel syndrome

439

3490

1.14

1.90

1.1

2.05

1.55

u/ml

0.29

800

Asymmetry of jaw

136

1.80

1.90

1.1

1.20

3.87

u/ml

—

Hypertensive diseases (excluding secondary)

538

3507

0.89

1.88

1.1

1.81

2.02

u/ml

0.18

135

849

Malignant neoplasm of digestive organs

907

0.73

1.88

1.0

1.89

1.81

u/ml

0.02

208

Disorders of orbit

236

1.58

1.88

1.1

1.19

2.58

u/ml

0.51

Oral leukoplakia and related diseases, including avohilmo

316

1.49

1.88

1.1

7.91

1.85

u/ml

—

Viral infections characterized by skin and mucous membrane lesions

378

3302

1.15

1.87

1.1

3.53

2.15

u/ml

0.71

106

888

Cellulitis

179

1470

1.22

1.87

1.1

2.25

2.18

u/ml

0.03

372

Hypothyroidism, strict autoimmune, 3 medication purchases required

803

4986

1.10

1.86

1.1

1.46

2.16

u/ml

1.11

179

1244

Systemic connective tissue disorders

227

1908

1.19

1.85

1.1

0.93

1.95

u/ml

1.44

452

Presence of other devices

671

1.33

1.85

1.1

0.21

2.35

u/ml

3.47

162

Noninfectious colitis NAS

119

935

1.28

1.85

1.2

1.1

1.42

2.14

u/ml

0.43

245

Melanocytic naevi

263

2241

1.18

1.84

1.1

2.63

2.02

u/ml

0.34

569

Glaucoma suspect

151

1220

1.24

1.83

1.1

2.58

1.82

u/ml

0.14

278

Primary_lymphoid and hematopoietic malignant neoplasms

927

0.73

1.83

1.1

3.60

2.54

u/ml

0.21

230

Disorders of vitreous body and globe

227

1862

1.19

1.83

1.0

1.1

1.96

1.47

u/ml

0.13

395

Persons encountering health services in circumstances related to reproduction

724

4451

1.10

1.82

1.1

2.52

2.76

u/ml

0.17

205

1183

Diseases of salivary glands

147

1186

1.24

1.82

1.1

0.69

2.58

u/ml

3.41

270

Benign neoplasm: Transverse colon

238

1.56

1.81

1.1

1.0

0.02

2.26

u/ml

—

Other and unspecified acute skin changes due to ultraviolet radiation

2.28

1.81

1.1

1.0

0.44

2.60

u/ml

—

Other and unspecified hypertrophic disorders of skin

2.82

1.81

1.0

—

2.10

—

Delivery, wide proxy

290

1798

0.86

1.81

1.1

1.40

3.00

u/ml

2.30

474

Benign neoplasm of mouth and pharynx

469

1.39

1.80

1.1

6.21

2.04

u/ml

—

116

Wide developmental disorders

581

0.66

1.80

1.1

1.2

0.99

3.73

u/ml

2.16

188

Open wound of wrist and hand

422

3690

1.13

1.80

1.1

3.93

1.99

u/ml

1.06

100

956

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

397

3490

1.14

1.80

1.1

1.83

1.93

u/ml

0.07

103

835

Sequelae of cerebrovascular disease

782

0.73

1.79

1.0

1.1

0.55

1.72

u/ml

1.37

178

Dental caries 1 and operation codes

832

3893

1.10

1.79

1.1

1.39

2.43

u/ml

2.08

210

950

Use of hypnotics and sedatives

854

5392

0.91

1.78

1.1

1.33

2.14

u/ml

1.63

207

1297

Dislocation, sprain and strain of joint and ligaments of hip

109

1.85

1.77

1.2

1.1

0.25

5.12

u/ml

—

Other disorders of cornea

437

1.40

1.77

1.1

5.97

2.57

u/ml

0.75

105

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

335

0.60

1.77

1.0

1.1

0.99

2.39

u/ml

—

Congenital malformations of the urinary system

545

0.66

1.77

1.1

3.62

3.45

u/ml

0.02

159

Myocardial infarction

129

1158

0.80

1.76

1.1

1.0

2.59

1.74

u/ml

0.37

254

Severe mental retardation

0.00

1.76

0.0

1.1

—

3.32

—

Viral pneumonia (known virus, not influenza)

117

1.82

1.75

1.1

7.64

4.00

u/ml

—

Atrial fibrillation and flutter with reimbursement

783

0.77

1.75

1.0

2.87

1.77

u/ml

0.27

168

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

458

0.71

1.74

1.0

1.1

1.28

1.59

u/ml

—

Cholelithiasis, broad definition with cholecystitis

543

4144

0.90

1.73

1.1

1.10

1.73

u/ml

1.47

113

947

Status post-ami

0.00

1.73

0.0

1.0

—

0.04

—

Other bursitis of knee

2.16

1.73

1.1

1.0

—

4.33

u/ml

—

Testicular dysfunction

194

1.61

1.72

1.1

0.45

3.66

u/ml

—

Superficial injury of lower leg

234

1988

1.18

1.72

1.1

2.66

2.49

u/ml

0.07

525

Other congenital malformations of skin

365

1.44

1.72

1.1

0.93

3.24

u/ml

2.23

106

154

1261

1.23

1.71

1.1

1.34

1.50

u/ml

0.12

299

Antenatal screening

303

1970

0.86

1.71

1.1

1.57

3.28

u/ml

2.25

505

Myocardial infarction, strict

114

1050

0.79

1.71

1.1

1.0

1.77

1.82

u/ml

0.02

236

Disorders of ocular muscles, binocular movement, accommodation and refraction

523

4659

1.12

1.69

1.1

2.71

2.52

u/ml

0.10

136

1236

Cholelithiasis

519

4056

0.90

1.69

1.1

1.03

1.72

u/ml

1.73

108

928

Use of pramipexole

100

778

1.29

1.69

1.1

0.61

1.83

u/ml

2.11

182

severe traumatic brain injury, does not include concussion

764

0.72

1.69

1.1

1.82

2.04

u/ml

—

184

Neuralgia and neuritis, unspecified

243

1.53

1.68

1.1

0.44

3.67

u/ml

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

101

902

0.78

1.68

1.0

1.1

1.26

1.75

u/ml

0.33

195

Haemorrhage in early pregnancy

315

2679

1.15

1.67

1.1

1.27

2.04

u/ml

0.73

648

Rheumatoid arthritis

146

1622

0.82

1.67

1.1

0.74

1.20

u/ml

0.64

350

Retinal detachments and breaks

144

1172

1.23

1.67

1.1

1.78

1.74

u/ml

0.01

255

Examination and encounter for administrative purposes

134

1.73

1.66

1.1

1.0

1.00

2.35

u/ml

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

142

1.70

1.65

1.1

0.18

4.51

u/ml

—

Nontoxic goitre/thyroid nodule

156

1283

1.22

1.64

1.1

0.19

1.49

u/ml

5.36

292

Mental and behavioural disorders due to sedatives or hypnotics

512

0.66

1.64

1.1

1.23

2.42

u/ml

0.92

127

Hypothyroidism and >3 levothyroxin purchases

444

2270

1.13

1.63

1.1

1.64

2.70

u/ml

0.99

109

597

Hypothyroidism, levothyroxine purchases

444

2270

1.13

1.63

1.1

1.64

2.70

u/ml

0.99

109

597

Hypothyroidism (congenital or acquired)

449

2295

1.13

1.63

1.1

1.63

2.69

u/ml

1.00

110

605

Synovial cyst of popliteal space [Baker]

229

1.53

1.62

1.1

7.70

3.34

u/ml

—

Second line medication for Crohn's disease

413

4637

0.89

1.62

1.1

2.37

2.36

u/ml

0.00

102

1188

Postpartum hemorraghe, parous women as controls

328

2515

1.15

1.62

1.1

0.98

2.02

u/ml

2.80

619

Testicular hypofunction

174

1.62

1.1

0.55

3.70

u/ml

—

Unspecified fall

402

3540

1.13

1.61

1.1

3.03

2.47

u/ml

0.17

122

947

Concussion

546

4265

1.11

1.61

1.1

2.23

2.50

u/ml

0.19

157

1104

Other gastritis (incl. Duodenitis)

111

882

1.26

1.60

1.1

1.49

1.89

u/ml

0.26

204

Congenital absence, atresia and stenosis of large intestine

0.00

1.60

0.0

1.3

—

7.65

—

Pedestrian injured in collision with pedal cycle

159

1.65

1.60

1.1

0.31

2.68

u/ml

1.82

Foreign body in alimentary tract

312

1.45

1.59

1.1

1.34

2.92

u/ml

0.79

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

680

1.30

1.59

1.0

1.1

0.92

2.02

u/ml

1.33

161

Poisoning by medicine

181

2153

0.84

1.59

1.1

2.16

2.29

u/ml

0.06

563

Budesonide

109

866

1.26

1.59

1.1

2.94

1.48

u/ml

0.42

182

Other noninflammatory disorders of vulva and perineum

637

1.31

1.59

1.1

2.63

1.82

u/ml

0.18

159

Liposarcoma, excluding all cancers (controls excluding all cancers)

3.03

1.59

1.0

1.1

—

3.26

—

Other disorders of veins

258

2224

1.16

1.58

1.1

0.95

1.44

u/ml

0.79

508

Other/unspecified rheumatoid arthritis

400

0.62

1.58

1.2

1.1

1.27

2.27

u/ml

—

Other diseases of anus and rectum

165

1369

1.21

1.58

1.1

2.01

1.92

u/ml

0.03

325

Open wound of abdomen, lower back and pelvis

223

1.54

1.58

1.2

1.1

0.84

3.32

u/ml

1.42

Skin changes due to chronic exposure to nonionizing radiation

618

1.30

1.58

1.0

1.68

1.30

u/ml

0.09

143

Focal epilepsy, mode (most common among epilepsy diagnosis)

101

1273

0.79

1.57

1.1

2.12

2.35

u/ml

0.07

344

Other infective otitis externa

313

1.45

1.57

1.1

2.91

3.11

u/ml

0.04

Other disorders of conjunctiva

439

1.37

1.57

1.1

2.64

1.69

u/ml

0.29

110

Medicines for HER+ breast cancer

142

1681

0.82

1.56

1.1

0.93

1.36

u/ml

0.56

356

Other retinal disorders

253

2354

0.86

1.56

1.0

1.1

0.91

1.75

u/ml

1.58

570

Endometriosis of ovary

155

1279

1.21

1.56

1.1

0.89

1.97

u/ml

1.41

303

Varicose veins

275

2393

0.87

1.56

1.0

1.1

0.56

1.56

u/ml

2.89

527

Other diseases of intestines

1203

6526

1.07

1.55

1.1

2.16

2.47

u/ml

0.28

279

1709

Polyarteritis nodosa and related conditions

2.06

1.55

1.3

1.0

0.26

1.07

u/ml

—

Benign lipomatous neoplasm

182

1529

1.19

1.55

1.0

1.1

1.07

1.76

u/ml

0.95

351

Benign neoplasm: Skin of eyelid, including canthus

552

1.33

1.55

1.1

5.15

2.47

u/ml

0.52

132

Other diseases of peritoneum

184

1.59

1.54

1.0

2.00

1.11

u/ml

—

Hypertensive heart and/or renal disease

476

0.70

1.54

1.0

0.11

1.87

u/ml

—

Uterine polyps

475

1.35

1.54

1.0

1.1

2.65

1.38

u/ml

0.30

113

Actinic keratosis

565

1.31

1.54

1.0

1.76

1.37

u/ml

0.09

131

Primary_lymphoid and hematopoietic malignant neoplasms

899

0.75

1.53

1.1

3.60

2.56

u/ml

0.21

226

Hypertensive Heart Disease

414

0.67

1.53

1.0

0.12

1.35

u/ml

—

Fracture at wrist and hand level

318

2793

1.14

1.52

1.1

3.67

2.31

u/ml

0.76

100

729

Malignant neoplasm of breast, HER-negative

771

0.74

1.52

1.1

0.54

1.44

u/ml

1.21

166

Panniculitis affecting regions of neck and back

185

1.58

1.52

1.2

1.1

2.55

u/ml

—

Contraceptive management

490

3100

1.11

1.52

1.1

1.75

2.52

u/ml

0.73

116

762

Open wound of hip and thigh

242

1.50

1.51

1.1

0.99

3.58

u/ml

—

Other maternal disorders predominantly related to pregnancy

676

3885

1.10

1.50

1.1

1.49

2.29

u/ml

1.66

159

958

Mixed specific developmental disorders

518

0.69

1.50

1.1

1.2

2.98

4.23

u/ml

0.30

166

Spirochaetal infections, other/unspecified

375

1.39

1.50

1.1

1.99

3.05

u/ml

0.28

Benign neoplasm of mouth and pharynx

486

1.34

1.50

1.1

6.21

2.42

u/ml

—

118

Bruxism

139

1.68

1.50

1.1

0.59

1.51

u/ml

—

Other and unspecified follicular disorders

226

1.52

1.50

1.1

1.0

0.98

2.47

u/ml

—

Melanocytic naevi of other and unspecified parts of face

367

1.40

1.49

1.1

2.85

2.87

u/ml

0.00

Angina pectoris

166

1340

0.84

1.49

1.1

1.0

2.13

1.42

u/ml

0.31

291

Gonarthrosis [arthrosis of knee](FG)

429

2823

0.89

1.49

1.1

1.17

1.62

u/ml

0.74

105

635

Muscle strain

194

1.56

1.49

1.1

0.68

2.72

u/ml

—

Polyp of the female genital tract

263

1323

1.16

1.49

1.1

2.37

1.96

u/ml

0.15

301

False labour

479

2707

1.11

1.49

1.1

1.79

2.66

u/ml

1.18

121

669

Pulmonary heart disease, diseases of pulmonary circulation

137

1125

1.22

1.49

1.1

1.25

1.88

u/ml

0.47

259

Inflammatory disease of cervix uteri

267

1.47

1.49

1.1

1.0

0.73

0.95

u/ml

—

Oxycodone

103

1244

0.80

1.48

1.1

1.0

1.28

1.76

u/ml

0.32

291

Syncope and collapse

296

2296

1.14

1.48

1.1

2.53

2.18

u/ml

0.18

609

Retained placenta and membranes, without haemorrhage

110

884

1.25

1.48

1.1

1.14

1.64

u/ml

0.35

188

Superficial injury of wrist and hand

227

1954

1.17

1.47

1.1

2.31

2.46

u/ml

0.04

526

LeFortI or BSSRO operation

360

1.40

1.47

1.1

0.62

2.72

u/ml

2.20

Care involving dialysis

355

0.62

1.47

1.0

1.1

0.48

2.96

u/ml

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

142

1178

0.83

1.46

1.1

0.78

1.45

u/ml

0.74

260

Other symptoms and signs involving the digestive system and abdomen

115

930

1.24

1.46

1.1

0.85

2.37

u/ml

2.23

241

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

426

3014

0.89

1.46

1.1

0.75

1.86

u/ml

4.11

702

L04AX Other immunosuppressants

396

4424

0.89

1.46

1.1

2.40

2.26

u/ml

0.06

101

1130

Other acquired deformities of ankle and foot

2.53

1.46

1.0

—

8.83

—

Persistent delusional disorders

366

0.63

1.45

1.0

1.1

0.47

1.97

u/ml

—

Bacterial intestinal infections, IBD co-morbidities

104

832

1.25

1.45

1.1

1.00

2.13

u/ml

1.05

200

Dental caries 1, only avohilmo

743

3489

1.09

1.45

1.1

1.75

2.40

u/ml

0.82

190

844

Hypopituitarism

648

0.72

1.44

1.0

1.1

0.65

3.62

u/ml

4.45

180

Supervision of high-risk pregnancy

257

1787

0.87

1.44

1.1

1.08

2.87

u/ml

3.87

447

Exposure to other and unspecified animate mechanical forces

278

1.46

1.44

1.1

0.45

2.90

u/ml

2.37

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

118

1.73

1.44

1.2

1.1

8.77

2.70

u/ml

—

Complications of procedures, not elsewhere classified

671

5319

1.09

1.44

1.1

1.68

2.14

u/ml

0.55

162

1273

Pregnancy, childbirth and the puerperium

259

1560

0.87

1.44

1.1

1.50

3.22

u/ml

2.12

412

Adhesive capsulitis of shoulder

691

1.28

1.44

1.1

0.20

2.02

u/ml

3.43

147

Other arthrosis

338

2137

1.13

1.43

1.1

1.14

1.38

u/ml

0.22

469

Other and/or unspecified nontoxic goitre

311

1.42

1.43

1.0

0.12

2.45

u/ml

—

Hyperplasia of prostate

136

635

1.22

1.42

1.0

0.54

1.77

u/ml

2.20

151

Obesity, other/unspecified

317

2801

1.13

1.42

1.1

2.37

1.95

u/ml

0.19

691

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

657

4664

0.92

1.42

1.1

1.03

1.89

u/ml

2.48

149

1089

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

1.88

1.41

1.1

5.77

5.49

u/ml

—

Hypertension, essential

611

3815

0.91

1.41

1.1

1.97

1.90

u/ml

0.06

150

869

Other disorders of the musculoskeletal system and connective tissue

596

1.30

1.41

1.1

1.22

2.47

u/ml

0.87

136

Malignant neoplasm of prostate

491

0.74

1.41

1.0

1.1

1.03

1.46

u/ml

0.24

112

Personal history of risk-factors, not elsewhere classified

1.80

1.40

1.3

1.1

0.17

2.83

u/ml

—

Focal epilepsy

124

1505

0.82

1.40

1.1

3.44

2.42

u/ml

0.23

410

Biological medication for rheuma

120

1461

0.82

1.40

1.0

1.1

2.56

2.39

u/ml

0.04

363

Unknown and unspecified causes of morbidity

406

1.36

1.40

1.1

2.57

2.05

u/ml

—

104

Streptococcal septicaemia

362

0.63

1.39

1.0

1.1

3.70

2.58

u/ml

—

101

Non-selective monoamine reuptake inhibitors

223

1868

1.16

1.39

1.1

0.64

1.37

u/ml

1.77

399

Other diseases of jaws

381

1.37

1.39

1.0

1.1

0.67

2.59

u/ml

—

Symptoms and signs involving emotional state

239

1.48

1.38

1.1

0.39

4.00

u/ml

2.85

Tramadol

665

3923

1.09

1.38

1.1

1.06

2.10

u/ml

2.88

168

909

Sarcoidosis

660

1.28

1.38

1.1

6.66

2.05

u/ml

0.55

149

Mixed conductive and sensorineural hearing loss

407

1.36

1.37

1.1

1.0

2.13

2.03

u/ml

—

Seropositive rheumatoid arthritis, strict definition

712

0.74

1.37

1.1

0.15

2.00

u/ml

4.13

158

Explicit bacterial Sepsis

514

0.70

1.36

1.0

1.1

3.31

2.39

u/ml

—

134

Other bacterial intestinal infections

103

831

1.24

1.36

1.1

0.99

1.98

u/ml

0.78

212

594

0.72

1.35

1.2

5.23

4.00

u/ml

0.12

207

Melanocytic naevi

263

2305

1.14

1.35

1.1

2.63

2.15

u/ml

0.25

576

DVT of lower extremities and pulmonary embolism

186

1583

1.17

1.35

1.1

1.48

1.73

u/ml

0.16

369

671

0.74

1.35

1.2

4.90

3.86

u/ml

0.11

227

Long labour

321

2488

1.13

1.34

1.1

1.24

2.51

u/ml

2.02

587

Other acquired deformities of musculoskeletal system and connective tissue

232

1.47

1.34

1.1

1.83

2.41

u/ml

—

Habitual aborter

233

1.48

1.33

1.1

2.84

1.65

u/ml

—

Perineal laceration during delivery

198

2047

0.86

1.33

1.1

1.16

2.90

u/ml

2.10

502

Pilonidal cyst

888

0.77

1.33

1.1

1.43

2.17

u/ml

0.51

216

Other or ill-defined heart diseases

249

1.45

1.33

1.1

1.0

2.02

3.63

u/ml

—

Dental caries 3 and operation codes

888

4233

1.08

1.33

1.1

1.13

2.36

u/ml

3.26

223

1045

Melanocytic naevi of other and unspecified parts of face

376

1.36

1.32

1.1

2.85

2.88

u/ml

0.00

malignant neoplasm of female genital organs

441

0.68

1.32

1.0

1.1

2.87

1.53

u/ml

—

100

Rheumatoid arthritis, including avohilmo

167

1963

0.85

1.32

1.1

0.72

1.38

u/ml

1.15

443

Dystonia

300

1.41

1.31

1.1

2.71

2.98

u/ml

—

Monoamine oxidase A inhibitors

550

1.29

1.31

1.0

1.28

1.87

u/ml

0.25

133

Hernia of abdominal wall

278

2451

1.14

1.31

1.1

2.60

1.65

u/ml

0.44

587

Disorders of other endocrine glands

406

3601

1.11

1.31

1.1

1.65

2.45

u/ml

0.56

104

971

Localized skin eruption due to drugs and medicaments

2.12

1.31

1.0

—

2.73

—

Other disorders of fluid, electrolyte and acid-base balance

1080

0.80

1.30

1.2

1.1

0.52

2.02

u/ml

3.19

243

Female infertility, tubal origin

395

1.35

1.29

1.1

1.63

1.39

u/ml

—

Cardiac murmurs and other cardiac sounds

104

836

1.24

1.29

1.1

3.61

2.70

u/ml

0.20

250

Dislocation, sprain and strain of joints and ligaments of thorax

177

1.54

1.29

1.0

1.1

0.76

3.10

u/ml

—

Pain associated with micturition

640

1.27

1.29

1.1

2.95

2.89

u/ml

0.02

171

Ovarian hyperstimulation (induction)

194

1.52

1.29

1.0

1.1

4.62

1.20

u/ml

—

Other disorders of breast and lactation associated with childbirth

194

1.52

1.29

1.1

0.07

1.31

u/ml

—

Generalized epilepsy, strict definition

235

1.46

1.29

1.2

1.31

4.43

u/ml

—

Septal defects

841

0.77

1.29

1.1

1.2

4.26

3.67

u/ml

0.11

262

Benign neoplasm of colon, rectum, anus and anal canal

256

2027

1.14

1.28

1.1

1.31

1.29

u/ml

0.01

459

Focal epilepsy, strict definition

110

1337

0.82

1.28

1.1

2.06

2.68

u/ml

0.23

363

Puerperal sepsis

766

1.24

1.28

1.1

1.05

1.26

u/ml

0.14

162

Congenital malformations of cardiac septa

874

0.78

1.28

1.1

4.26

3.64

u/ml

0.12

275

Pervasive developmental disorders excl. Autism + Asperger

288

0.61

1.27

1.0

1.2

1.31

3.59

u/ml

—

104

Medial epicondylitis

186

1.51

1.27

1.2

1.0

0.23

3.01

u/ml

—

Deep bite that required surgery

1.84

1.26

1.0

1.1

0.88

2.75

u/ml

—

Poor fetal growth

132

1572

0.84

1.26

1.1

1.04

1.63

u/ml

0.96

381

Insomnia

161

1370

1.18

1.25

1.1

1.30

2.06

u/ml

0.61

344

Wide developmental disorders, excluding more controls

532

0.72

1.25

1.1

1.2

0.99

3.46

u/ml

1.84

174

Certain conditions originating in the perinatal period

189

1445

1.17

1.25

1.2

1.1

3.94

3.57

u/ml

0.10

471

Fracture of shoulder and upper arm

196

2261

0.86

1.25

1.1

1.28

2.53

u/ml

2.33

602

Fall on same level involving ice and snow

448

4073

1.10

1.24

1.1

2.91

2.12

u/ml

0.42

116

1016

Viral agents as the cause of diseases classified to other chapters

155

1.57

1.24

1.0

1.1

1.78

3.77

u/ml

—

Benign neoplasm: Skin of eyelid, including canthus

573

1.28

1.23

1.1

5.15

2.42

u/ml

0.53

137

Hypothyroidism, autoimmune, DX-based

2.23

1.23

1.0

1.1

—

1.66

—

Bilateral sagittal split ramus osteotomy operation

296

1.40

1.23

1.1

0.73

2.95

u/ml

1.79

Major anomalies of jaw size

204

1.48

1.23

1.2

1.1

0.74

4.26

u/ml

—

Acute pancreatitis

867

0.78

1.23

1.1

1.53

2.43

u/ml

0.44

197

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

419

3785

1.10

1.22

1.1

1.79

2.04

u/ml

0.18

106

895

COPD, hospital admissions 3, with asthma pneumonia sepsis

434

1.29

1.22

1.1

1.0

1.29

1.71

u/ml

0.21

Lesion of femoral nerve

2.66

1.22

1.0

—

0.27

—

Convergent concomitant strabismus

605

0.74

1.22

1.0

1.1

4.43

2.57

u/ml

—

160

Carcinoma in situ of colon

2.65

1.22

1.0

1.1

—

0.12

—

Acute pancreatitis (for exclusion)

865

0.78

1.21

1.1

1.53

2.40

u/ml

0.42

199

Any mental disorder

1182

5574

1.06

1.21

1.1

2.15

2.40

u/ml

0.27

335

1383

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

131

1077

0.84

1.20

1.1

1.0

0.35

1.43

u/ml

2.75

232

Maternal care for other conditions predominantly related to pregnancy

284

2492

1.13

1.20

1.1

1.52

2.21

u/ml

0.41

614

Alcohol abuse, main dg

1140

0.81

1.20

1.1

3.84

2.44

u/ml

0.40

285

Oral lichen ruber planus

1.84

1.20

1.0

0.17

0.69

u/ml

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

710

1.24

1.20

1.0

1.1

0.91

1.96

u/ml

1.23

163

Diagnoses used for exclusion with ILD

132

1109

1.19

1.1

3.74

1.88

u/ml

0.40

258

Other epidermal thickening

197

1.48

1.19

1.1

1.56

2.82

u/ml

—

Other appendicitis

497

1.29

1.19

1.1

5.15

2.22

u/ml

0.59

119

Supervision of normal pregnancy

298

1911

0.89

1.19

1.1

1.55

3.36

u/ml

2.31

488

Complications following infusion, transfusion and therapeutic injection

1.89

1.19

1.1

0.66

1.16

u/ml

—

Influenza and pneumonia

1105

6842

1.06

1.18

1.1

2.62

2.33

u/ml

0.26

309

1729

Bullous disorders

181

1.50

1.18

1.0

2.78

3.00

u/ml

—

Oesophageal obstruction

1.88

1.18

1.3

1.0

3.28

4.13

u/ml

—

Speech and linguistic disorders, excluding more controls

148

1187

1.18

1.17

1.2

1.1

1.90

3.32

u/ml

0.95

363

Achilles tendinitis

498

1.29

1.17

1.1

4.58

2.41

u/ml

0.39

107

Impacted maxillary canine

134

1.61

1.17

1.0

1.1

4.10

5.79

u/ml

—

Myocarditis

290

1.39

1.17

1.1

2.09

3.05

u/ml

0.38

Postprocedural disorders of nervous system

714

0.77

1.17

1.1

0.76

1.88

u/ml

1.60

177

Alopecia areata

190

1.49

1.17

1.0

1.1

3.41

3.40

u/ml

—

Behavioural syndromes associated with physiological disturbances and physical factors

391

3544

1.11

1.17

1.1

1.59

2.68

u/ml

1.40

105

946

Drug-induced cataract

102

1.68

1.17

1.2

1.0

1.36

3.88

u/ml

—

Fall involving playground equipment

159

1.56

1.17

1.4

1.2

3.19

5.11

u/ml

—

Oral lichen ruber planus, including avohilmo

223

1.44

1.16

1.0

1.1

0.11

2.11

u/ml

2.15

Psoriatic and enteropathic arthropathies

759

0.77

1.16

1.1

0.31

1.73

u/ml

—

176

Other congenital malformations

123

1031

1.20

1.16

1.1

1.61

3.27

u/ml

1.07

300

Intentional self-harm by jumping from a high place

0.00

1.16

0.0

1.0

—

0.28

—

Algoneurodystrophy

232

1.43

1.16

1.1

0.36

3.14

u/ml

—

Persons encountering health services for specific procedures, not carried out

526

1.28

1.16

1.1

0.82

2.48

u/ml

2.01

130

Coxarthrosis [arthrosis of hip](FG)

200

1660

0.87

1.16

1.1

1.79

1.40

u/ml

0.10

379

Invasive ventilation

392

0.69

1.16

1.1

0.49

2.61

u/ml

—

119

Congenital malformations of great arteries

428

0.70

1.15

1.1

1.2

3.27

4.47

u/ml

0.27

145

Carcinoma in situ of colon

2.52

1.15

1.0

1.1

—

0.04

—

Other deformities of toe(s)

118

1.62

1.15

1.1

1.0

1.51

3.18

u/ml

—

Disorders of refraction and accommodation

307

2742

1.12

1.15

1.1

2.83

2.59

u/ml

0.09

758

Benign neoplasm: Conjunctiva

134

1.58

1.15

1.0

1.1

0.52

3.33

u/ml

—

Meniscus derangement

411

2553

1.10

1.14

1.1

1.42

1.60

u/ml

0.19

110

569

Intracranial injury

498

4416

1.09

1.14

1.1

2.44

2.38

u/ml

0.03

137

1161

Colonic or urogenital fistula

184

1596

1.16

1.14

1.1

1.57

1.73

u/ml

0.08

381

Malignant neoplasm of skin

159

1395

0.86

1.14

1.1

1.0

0.71

1.40

u/ml

0.87

300

Acute generalized exanthematous pustulosis

258

1.40

1.14

1.1

5.29

3.08

u/ml

0.32

Dental pulpitis 4

1084

5973

0.94

1.14

1.1

1.98

2.51

u/ml

0.62

284

1522

Dental pulpitis 1

1084

5974

0.94

1.14

1.1

1.98

2.51

u/ml

0.62

284

1522

Corns and callosities

283

0.63

1.13

1.1

2.03

2.73

u/ml

—

Fall on and from stairs and steps

174

1505

1.16

1.13

1.1

3.39

2.37

u/ml

0.31

388

Unstable angina pectoris

720

0.79

1.12

1.1

1.0

0.45

1.72

u/ml

1.88

159

Burn and corrosion confined to eye and adnexa

151

1.54

1.12

1.0

1.1

2.46

2.94

u/ml

—

Keratoconus

151

1.54

1.12

1.0

1.1

10.53

4.01

u/ml

0.66

Chronic iridocyclitis

294

0.64

1.12

1.0

1.1

0.62

3.20

u/ml

—

Personal history of other diseases and conditions

169

1455

1.16

1.12

1.1

2.90

2.81

u/ml

0.03

428

Injuries to the hip and thigh

269

2192

1.12

1.1

1.27

2.14

u/ml

1.50

543

Benign neoplasm: Conjunctiva

135

1.57

1.12

1.0

1.1

0.52

3.33

u/ml

—

Cardiomyopathy (excluding other)

436

0.71

1.12

1.2

1.1

2.52

2.91

u/ml

—

103

Cardiac arrhythmias

638

4543

0.93

1.11

1.1

2.66

2.15

u/ml

0.35

155

1111

Measles

1.75

1.10

1.1

1.0

5.86

4.60

u/ml

—

Other disorders of gingiva or/and edentulous alveolar ridge

352

0.68

1.10

1.0

1.1

5.22

3.43

u/ml

—

109

Benign neoplasm of bone and articular cartilage

566

1.26

1.10

1.0

1.1

2.72

2.40

u/ml

0.07

136

Other hammer toe(s) (acquired)

430

1.29

1.09

1.1

1.0

0.67

1.28

u/ml

0.65

Other and unspecified iridocyclitis

235

1.41

1.09

1.1

1.82

2.87

u/ml

—

Nonorganic sleeping disorders

201

1763

1.14

1.09

1.1

1.24

2.28

u/ml

1.14

472

Dental caries 1

723

3440

1.08

1.09

1.1

1.96

2.44

u/ml

0.48

182

833

Sequelae of external causes of morbidity and mortality

143

1223

1.17

1.08

1.1

1.40

1.79

u/ml

0.23

301

Disease of hard tissues of teeth, NOS

1.89

1.08

1.4

1.1

1.85

5.96

u/ml

—

Other and unspecified visual disturbances

487

1.28

1.08

1.2

1.1

0.74

2.38

u/ml

1.53

114

Diseases of pulp and periapical tissues, including avohilmo

1085

5967

0.94

1.08

1.1

1.97

2.51

u/ml

0.64

285

1521

Benign paroxysmal vertigo

143

1224

1.17

1.07

1.1

2.09

1.70

u/ml

0.13

283

Secondary and unspecified malignant neoplasm of lymph nodes

279

0.64

1.07

1.2

1.1

0.12

2.39

u/ml

—

Obesity due to excess calories

432

3957

1.09

1.07

1.1

1.72

2.25

u/ml

0.64

106

986

Transient ischemic attack

142

1373

0.86

1.07

1.1

0.47

1.55

u/ml

2.90

313

Bitten or struck by other mammals

116

977

1.19

1.06

1.1

1.75

2.40

u/ml

0.49

242

Dental caries, including avohilmo

722

3439

1.07

1.06

1.1

1.96

2.44

u/ml

0.48

182

833

Contusion of toe(s) without damage to nail

203

1.44

1.06

1.1

2.65

2.76

u/ml

—

Viral hepatitis, IBD co-morbidity

465

0.73

1.06

1.1

0.66

2.24

u/ml

—

113

Retinal vascular occlusion

211

1.42

1.05

1.0

0.82

1.81

u/ml

—

Other specified and unspecified disorders of eye and adnexa

178

1.47

1.05

1.1

1.0

0.40

4.14

u/ml

—

Gonarthrosis,primary

415

2856

0.91

1.05

1.1

1.08

1.50

u/ml

0.66

626

Glomerular diseases

1001

0.82

1.05

1.0

1.1

2.59

2.22

u/ml

0.08

251

Other disorders starting during childhood or adolecense, excluding more controls

111

901

1.20

1.05

1.1

4.13

3.18

u/ml

0.24

280

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

476

0.73

1.04

1.1

0.13

2.15

u/ml

—

115

Other diseases of arteries and capillaries

340

1.33

1.04

1.0

1.1

8.15

2.12

u/ml

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

473

0.73

1.04

1.1

1.2

3.40

4.07

u/ml

0.09

152

Carbimazole or st.post thyroidectomy, condition for graves disease

157

1359

1.16

1.03

1.0

1.1

1.42

1.66

u/ml

0.11

329

Mixed disorders of conduct and emotions

404

0.71

1.03

1.0

1.1

2.69

2.59

u/ml

—

110

Sleep disorders

219

1940

1.13

1.03

1.1

1.17

2.32

u/ml

1.41

511

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

140

1123

0.86

1.03

1.1

0.33

1.45

u/ml

3.22

247

Hypoplasia of dental enamel, including avohilmo

295

0.65

1.03

1.0

1.2

0.38

5.32

u/ml

—

101

Cardiomyopathies, Primary/intrinsic

417

0.72

1.03

1.2

1.1

2.52

2.82

u/ml

—

100

Symptoms and signs involving cognition, perception, emotional state and behaviour

760

5682

0.94

1.03

1.1

1.16

2.35

u/ml

4.02

202

1399

Presence of other functional implants

173

1405

0.87

1.02

1.1

1.28

1.74

u/ml

0.37

314

Calculus of kidney and ureter

156

1351

1.16

1.02

1.1

3.72

1.77

u/ml

0.51

317

Cerebral cysts

421

1.29

1.02

1.1

2.55

2.65

u/ml

0.02

107

Ulcer of vagina/vulva

155

1.50

1.02

1.2

1.0

1.23

1.79

u/ml

—

Other protozoal intestinal diseases

1.67

1.01

1.1

5.33

3.95

u/ml

—

L04AC Interleukin inhibitors

357

0.70

1.01

1.0

1.1

0.50

2.67

u/ml

—

Chronic periodontitis, complicated

334

0.69

1.01

1.1

0.29

1.93

u/ml

—

Contact with machinery

492

1.26

1.01

1.1

1.07

2.60

u/ml

1.64

117

Arthropathic psoriasis

631

0.77

1.01

1.1

0.31

1.92

u/ml

—

148

Benign neoplasm: Sigmoid colon

474

1.27

1.01

1.0

1.1

2.79

1.75

u/ml

0.17

110

Tumor necrosis factor alpha inhibitors

114

1343

0.85

1.01

1.1

2.65

2.29

u/ml

0.08

343

Other and unspecified epidermal thickening

139

1.52

1.00

1.1

1.95

2.38

u/ml

—

Osteomyelitis

256

1.37

1.00

1.1

0.54

3.03

u/ml

—

Pedal cyclist injured in noncollision transport accidents

863

0.81

1.00

1.1

0.62

2.38

u/ml

3.93

212

Other complications of labour and delivery, not elsewhere classified

143

1592

0.86

1.00

1.1

2.39

2.35

u/ml

0.01

390

164

1.47

1.00

1.1

1.0

9.78

2.47

u/ml

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1158

0.84

0.99

1.1

0.22

1.79

u/ml

5.73

260

Fracture of neck

188

0.58

0.99

1.0

1.1

—

2.49

—

Aplastic and other anaemias

151

1649

0.87

0.99

1.1

2.09

2.00

u/ml

0.04

416

Tic and related disorders

190

1.44

0.99

1.2

0.77

4.25

u/ml

1.69

Other and unspecified corneal deformities and disorders

156

1.48

0.99

1.0

1.1

2.78

2.61

u/ml

—

Melanocytic naevi of lower limb, including hip

283

1.35

0.99

1.0

1.1

1.01

2.19

u/ml

—

Autoimmune diseases

1166

6271

0.95

0.98

1.1

1.75

2.57

u/ml

1.35

293

1664

Lesion of plantar nerve

223

1.40

0.98

1.1

1.0

0.14

1.99

u/ml

1.97

Erythema nodosum

148

1.50

0.98

1.0

1.1

0.03

2.63

u/ml

—

Xanthelasma of eyelid

2.19

0.98

1.0

—

0.19

—

Bicipital tendinitis

181

1.44

0.98

1.0

0.29

3.86

u/ml

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

265

2943

0.90

0.98

1.1

1.58

2.30

u/ml

0.81

729

5-aminosalicylic acid

186

1637

1.14

0.98

1.1

2.85

2.02

u/ml

0.29

378

Progressive vascular leukoencephalopathy

2.18

0.98

1.0

—

0.18

—

Tic disorders

182

1.45

0.98

1.2

1.1

0.32

5.13

u/ml

—

Malignant neoplasm of eye and adnexa

0.00

0.98

0.0

1.1

—

0.16

—

Benign neoplasm: Tonsil

1.96

0.97

1.0

1.1

—

0.19

—

Caught, crushed, jammed or pinched in or between objects

380

1.30

0.97

1.1

1.35

2.81

u/ml

1.10

Nontoxic multinodular goitre

748

1.21

0.97

1.0

1.1

0.19

1.83

u/ml

3.47

166

Disorders of parathyroid gland

613

1.23

0.96

1.1

0.34

2.44

u/ml

3.03

143

Alcohol abuse, main dg, excluding more controls

1110

0.84

0.96

1.1

3.84

2.18

u/ml

0.49

266

Ulcerative colitis (strict definition, all Crohn cases excluded)

103

1218

0.84

0.96

1.1

0.87

1.97

u/ml

2.59

306

Contact with other hot fluids

259

1.36

0.96

1.0

1.1

13.20

3.49

u/ml

—

Burns and corrosions confined to eye and internal organs

174

1.45

0.96

1.1

1.76

2.62

u/ml

—

Juvenile arthritis (FINNGEN)

624

0.78

0.95

1.1

0.73

3.67

u/ml

3.64

175

Delayed milestone in childhood

511

0.76

0.95

1.1

1.2

4.67

4.37

u/ml

0.04

182

Seropositive rheumatoid arthritis

102

1203

0.84

0.95

1.0

1.1

0.22

1.47

u/ml

6.53

275

Retinal vascular disorders

216

1.39

0.95

1.0

0.82

2.00

u/ml

—

Nontraumatic intracranial haemmorrhage

524

0.76

0.95

1.1

1.57

2.31

u/ml

—

131

Coxarthrosis

194

1488

0.88

0.95

1.1

1.89

1.41

u/ml

0.12

324

Other symptoms and signs involving the circulatory and respiratory systems

285

1.34

0.94

1.1

1.0

0.35

2.83

u/ml

—

Other keratitis

769

1.20

0.94

1.1

3.42

2.02

u/ml

0.40

187

Spondylosis

286

2217

1.11

0.94

1.1

2.47

1.60

u/ml

0.32

480

Emotional disorders starting during childhood or adolecense, excluding more controls

817

1.20

0.94

1.1

0.96

2.88

u/ml

2.85

252

Abnormal findings on diagnostic imaging of other body structures

533

1.24

0.94

1.1

1.30

1.97

u/ml

0.32

126

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

222

1982

1.12

0.94

1.1

0.66

2.28

u/ml

5.45

489

Mixed hyperlipidaemia

116

0.52

0.94

1.0

1.1

—

2.37

—

Carcinoma in situ of uteri, other/unspecified

2.25

0.94

1.0

—

0.30

—

Viral conjunctivitis

150

1.48

0.93

1.1

1.28

3.74

u/ml

—

Benign neoplasm of bone and articular cartilage

579

1.23

0.93

1.0

1.1

2.72

2.28

u/ml

0.10

142

Deep endometriosis

688

1.21

0.93

1.1

0.52

1.13

u/ml

1.27

164

Seborrhoeic keratosis

651

1.22

0.93

1.1

1.0

0.13

1.71

u/ml

3.00

146

Juvenile osteochondrosis

330

1.31

0.93

1.0

1.1

1.17

3.53

u/ml

1.72

Anogenital herpesviral [herpes simplex] infection

634

1.22

0.93

1.1

0.32

1.73

u/ml

4.74

154

Hyperparathyroidism

492

1.25

0.93

1.0

0.11

2.02

u/ml

2.78

116

Gingival hyperplasia

268

0.67

0.92

1.1

0.35

3.66

u/ml

—

Tic and related disorders

193

1.42

0.92

1.2

1.1

0.77

3.41

u/ml

1.72

Other benign neoplasms of connective and other soft tissue

521

0.77

0.92

1.1

0.43

2.27

u/ml

—

126

Ptosis of eyelid

304

1.32

0.92

1.1

1.15

2.64

u/ml

—

Fibroblastic disorders

836

1.19

0.91

1.1

0.34

2.21

u/ml

3.89

181

Bulimia nervosa (incl. atypical)

438

1.27

0.91

1.2

1.1

0.55

2.00

u/ml

—

105

Injury of muscle and tendon at ankle and foot level

151

1.47

0.91

1.0

1.1

0.21

3.33

u/ml

—

Mesial bite

102

0.48

0.91

1.0

1.1

—

5.17

—

Residual foreign body in soft tissue

305

1.32

0.90

1.1

3.44

3.47

u/ml

—

Valvular operations

486

0.76

0.90

1.0

1.1

2.11

2.34

u/ml

—

118

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

340

1.30

0.90

1.1

1.25

2.30

u/ml

—

Other diseases of intestine

384

1.28

0.90

1.1

0.69

2.43

u/ml

1.65

Ulcerative colitis (strict definition, require KELA)

124

1435

0.86

0.90

1.1

0.71

2.23

u/ml

4.34

363

Problems related to lifestyle

851

0.82

0.90

1.1

2.36

2.59

u/ml

0.06

215

Undescended testicle

240

0.65

0.90

1.1

1.2

0.76

3.11

u/ml

—

Other/unspecified seropositive rheumatoid arthritis

1166

0.85

0.89

1.1

0.22

1.77

u/ml

5.75

263

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

102

0.49

0.89

1.0

—

0.39

—

Secondary hypertension

480

0.76

0.89

1.1

2.13

3.13

u/ml

—

115

Other and unspecified acne

119

1.53

0.89

1.1

0.08

4.01

u/ml

—

conjunctival haemorrhage

202

1.39

0.89

1.0

5.03

1.82

u/ml

—

Non-invasive ventilation

177

1470

1.13

0.89

1.1

1.78

2.25

u/ml

0.20

347

Dental caries 3, only avohilmo

803

3871

1.06

0.88

1.1

1.33

2.44

u/ml

2.22

206

952

Cluster headache, wide,, including avohilmo

386

1.28

0.88

1.1

0.57

2.30

u/ml

2.71

Mucosal proctocolitis

1066

0.84

0.88

1.1

2.67

2.10

u/ml

0.11

269

Anorexia (incl.atypical)

705

0.80

0.88

1.1

3.67

2.74

u/ml

0.17

186

Disorders of vestibular function (Vertigo)

242

2167

1.11

0.87

1.1

2.03

1.49

u/ml

0.34

493

Crushed, pushed or stepped on by crowd or human stampede

795

1.19

0.87

1.1

0.85

2.82

u/ml

2.28

222

Carcinoma in situ of uteri, other/unspecified

2.03

0.87

1.0

—

0.32

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

342

1.29

0.87

1.1

1.25

1.59

u/ml

—

Nail disorders

539

1.23

0.87

1.1

2.06

2.49

u/ml

0.09

138

Hydronephrosis

494

0.77

0.87

1.1

2.12

2.43

u/ml

—

121

Collagenous colitis

440

1.25

0.87

1.1

0.93

2.90

u/ml

1.68

105

Other benign neoplasms of connective and other soft tissue

516

0.77

0.87

1.1

0.43

1.76

u/ml

—

128

Fracture of lumbar spine and pelvis

759

0.81

0.87

1.1

0.57

1.83

u/ml

1.35

179

Sacroiliitis, not elsewhere classified

414

1.26

0.86

1.0

1.1

3.33

1.94

u/ml

0.17

105

Biomechanical lesions, not elsewhere classified

178

1.41

0.86

1.2

1.0

1.16

4.01

u/ml

—

Personal history of malignant neoplasm

204

0.63

0.86

1.2

1.1

0.60

2.60

u/ml

—

Ulcer of lower limb, not elsewhere classified

345

0.72

0.85

1.2

1.0

1.65

2.59

u/ml

—

Other/unspecified disorders of vestibular function

120

1.51

0.85

1.2

1.0

1.07

3.97

u/ml

—

Unspecified lump in breast

100

852

1.18

0.85

1.2

1.1

2.66

1.48

u/ml

0.29

204

Sexual dysfunction

1.61

0.85

1.0

1.1

2.46

3.61

u/ml

—

Enlarged lymph nodes

121

1047

1.16

0.85

1.1

4.74

2.56

u/ml

0.68

274

Parapsoriasis

1.57

0.85

1.1

1.56

5.74

u/ml

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

121

1394

0.87

0.84

1.1

0.71

2.13

u/ml

4.14

351

Other benign neoplasms of skin

204

1827

1.12

0.84

1.1

2.57

1.83

u/ml

0.37

434

Generalized skin eruption due to drugs and medicaments

239

1.35

0.84

1.1

5.29

2.96

u/ml

0.34

Glaucoma-related operations

1.60

0.84

1.0

0.49

0.31

u/ml

—

Glomerulonephritis

580

0.79

0.84

1.0

1.1

0.56

2.64

u/ml

3.43

155

Other sleep disorders

642

1.20

0.84

1.1

1.64

2.59

u/ml

0.54

159

Convulsions, not elsewhere classified

195

2150

0.89

0.84

1.1

2.81

2.83

u/ml

0.01

627

Persistent mood disorders

151

1329

1.14

0.84

1.1

2.04

1.85

u/ml

0.08

325

Varicose veins of other sites

336

1.28

0.83

1.1

0.98

2.32

u/ml

1.10

Psychiatric diseases

1166

5572

1.05

0.83

1.1

2.08

2.38

u/ml

0.34

328

1383

Other congenital malformations of ear

189

1.40

0.82

1.1

1.69

3.05

u/ml

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

763

1.18

0.82

1.1

1.74

1.51

u/ml

0.08

195

Contact with heat and hot substances

417

1.25

0.82

1.0

1.1

11.15

2.62

u/ml

0.86

113

Hirsprung

0.00

0.82

0.0

1.1

—

2.15

—

Other secondary gonarthrosis

163

1.42

0.82

1.0

1.1

1.02

2.78

u/ml

—

Melanocytic naevi of lower limb, including hip

293

1.30

0.82

1.0

1.1

1.01

2.02

u/ml

—

Superficial injury of shoulder and upper arm

736

1.19

0.81

1.1

6.88

2.23

u/ml

0.71

180

Other female pelvic inflammatory diseases

117

1014

1.16

0.81

1.1

1.18

1.37

u/ml

0.11

244

Other disorders of teeth and supporting structures

132

1154

1.15

0.81

1.2

1.1

1.21

2.38

u/ml

1.45

265

Crohn disease (strict definition, all UC cases excluded)

427

1.25

0.81

1.0

1.1

7.50

3.04

u/ml

—

110

Dental caries 3

792

3828

1.06

0.81

1.1

1.32

2.46

u/ml

2.27

203

940

Psoriatic arthropathies

588

0.80

0.81

1.1

0.31

1.59

u/ml

—

133

Graves disease, strict definition

746

1.18

0.81

1.0

1.1

1.60

1.69

u/ml

0.02

175

Misadventures to patients during surgical and medical care

709

1.19

0.81

1.2

1.1

0.41

1.98

u/ml

2.87

174

Marasmic kwashiorkor

0.00

0.80

0.0

1.1

—

3.57

—

Abrasion of teeth

234

1555

1.11

0.80

1.1

0.72

2.03

u/ml

3.36

362

Benzodiazepine use

830

6223

0.95

0.80

1.1

1.20

2.29

u/ml

2.83

205

1537

Macular pucker

241

1.33

0.80

1.0

1.1

0.67

1.26

u/ml

—

Dizziness and giddiness

547

4161

1.07

0.80

1.1

0.76

2.04

u/ml

6.65

138

996

Myopia

148

1307

1.14

0.80

1.1

2.19

2.31

u/ml

0.03

349

Cholecystectomy

467

3850

1.07

0.80

1.1

1.08

1.69

u/ml

1.43

108

864

Myocardial infarction, with ST-elevation

340

0.73

0.79

1.0

1.1

0.08

1.73

u/ml

—

Osteoporosis

654

0.82

0.79

1.1

1.97

2.24

u/ml

0.07

153

Benign lipomatous neoplasm of other sites/unspecified

268

1.31

0.79

1.0

0.99

2.20

u/ml

—

Other and unspecified immunodeficiencies with predominantly antibody defects

1.64

0.79

1.2

1.1

0.45

0.26

u/ml

—

Blood alcohol or alcohol intoxication level

187

0.64

0.79

1.0

1.1

5.80

3.43

u/ml

—

Ulcer of oesophagus

156

1.41

0.78

1.1

0.18

2.21

u/ml

—

Chronic myeloproliferative disease

0.00

0.78

0.0

1.0

—

3.23

—

Hordeolum and other deep inflammation of eyelid

393

1.25

0.78

1.1

4.45

2.83

u/ml

0.23

101

Other and unspecified vasculitis limited to skin

1.57

0.78

1.3

1.1

—

4.12

u/ml

—

Psoriatic arthropathies, ICD10

574

0.80

0.78

1.1

0.31

1.88

u/ml

—

140

Non-ischemic cardiomyopathy

697

0.84

0.78

1.0

1.1

0.94

2.35

u/ml

0.79

159

Other and unspecified diseases of blood and blood-forming organs

1.59

0.78

1.1

0.08

2.27

u/ml

—

Heart failure and bmi 25plus

631

0.84

0.78

1.0

1.42

1.61

u/ml

0.07

146

Car occupant injured in other and unspecified transport accidents

191

1716

1.12

0.77

1.1

2.31

2.17

u/ml

0.05

447

Convergence insufficiency and excess

115

1.49

0.77

1.4

1.1

0.06

1.83

u/ml

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

262

2392

1.10

0.77

1.1

1.95

2.40

u/ml

0.36

626

Other specified/unspecified hearing loss

269

1.30

0.77

1.1

0.32

2.71

u/ml

2.11

Cluster headache, strict, including avohilmo

376

1.26

0.77

1.1

0.57

2.36

u/ml

2.74

Other arrhythmias

525

3767

1.07

0.77

1.1

2.08

1.91

u/ml

0.12

125

890

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

155

1686

0.89

0.77

1.1

3.22

3.03

u/ml

0.06

500

Gout

603

0.82

0.77

1.1

1.0

1.17

1.54

u/ml

—

136

Sequelae of injuries of lower limb

585

1.20

0.76

1.1

2.27

2.37

u/ml

0.03

140

KRA_PSY_EATING, excluding more controls

132

1158

1.14

0.76

1.1

1.43

2.75

u/ml

0.77

310

Acute nasopharyngitis (common cold)

101

866

1.16

0.76

1.1

3.13

2.01

u/ml

0.39

222

Adult respiratory distress syndrome

0.00

0.76

0.0

1.1

—

0.13

—

Heart failure and hypertrophic cardiomyopathy

0.00

0.76

0.0

1.0

—

6.33

—

Acute peritonitis

233

0.68

0.76

1.0

1.1

0.13

4.06

u/ml

—

Seropositive rheumatoid arthritis, wide

102

1178

0.86

0.76

1.0

1.1

0.22

1.78

u/ml

5.84

264

Congenital malformations of the respiratory system

175

1.39

0.75

1.2

3.04

4.19

u/ml

—

Toxic effects of substances chiefly nonmedicinal as to source

103

891

1.16

0.75

1.0

1.1

3.10

2.60

u/ml

0.16

232

Congenital malformations of heart and great arteries

124

1366

0.88

0.75

1.1

3.54

3.25

u/ml

0.08

407

Impacted cerumen

413

1.24

0.75

1.2

1.1

0.29

2.86

u/ml

4.18

118

Ulcerative colitis

180

2003

0.90

0.75

1.1

2.55

2.30

u/ml

0.07

507

Benign neoplasm: Larynx

1.54

0.75

1.1

0.17

5.28

u/ml

—

Other heart diseases

535

3762

0.94

0.75

1.1

2.76

2.41

u/ml

0.19

130

948

Mixed disorders of conduct and emotions, excluding more controls

380

0.76

0.75

1.0

1.1

2.69

3.66

u/ml

—

102

Benign neoplasm: Sigmoid colon

495

1.21

0.74

1.0

1.1

2.79

1.80

u/ml

0.17

109

Heterophoria

744

1.17

0.74

1.1

1.35

2.84

u/ml

0.93

207

Gout, FINNGEN

658

0.82

0.74

1.1

1.0

1.17

1.52

u/ml

—

150

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

726

1.18

0.74

1.1

1.83

1.30

u/ml

0.20

184

Persons with potential health hazards related to communicable diseases

524

4886

1.07

0.74

1.1

2.84

2.68

u/ml

0.08

161

1323

Volume depletion

312

0.74

0.73

1.1

6.38

3.93

u/ml

—

Drug-induced neutropenia

266

0.71

0.73

1.1

1.0

1.14

2.44

u/ml

—

Infections of genitourinary tract in pregnancy

840

0.84

0.73

1.1

3.65

1.67

u/ml

0.38

209

Postmenopausal bleeding

120

575

1.15

0.73

1.0

1.59

1.76

u/ml

0.06

123

Follicular cysts of skin and subcutaneous tissue

123

1081

1.14

0.73

1.1

1.89

2.05

u/ml

0.05

253

Other viral diseases, not elsewhere classified

214

1938

1.10

0.73

1.1

2.67

2.98

u/ml

0.13

547

Tibial collateral bursitis [Pellegrini-Stieda]

1.81

0.73

1.0

—

2.19

—

Benign neoplasm of colon, rectum, anus and anal canal

248

1939

0.91

0.73

1.1

1.37

1.36

u/ml

0.00

429

Vitiligo

1.68

0.72

1.0

1.1

0.28

3.47

u/ml

—

Familial hypercholesterolemia

379

1.24

0.72

1.0

1.1

0.65

1.89

u/ml

1.38

Benign neoplasm: Larynx

1.53

0.72

1.1

0.17

5.97

u/ml

—

Retinal haemorrhage

1.67

0.72

1.0

—

1.67

—

Early lumbar disc prolapse, operated

116

1017

1.14

0.72

1.1

2.38

1.80

u/ml

0.24

245

Intestinal stricture

102

1172

0.87

0.72

1.1

2.41

2.05

u/ml

0.07

279

Open wound of ankle and foot

728

1.17

0.72

1.1

2.35

2.68

u/ml

0.10

183

Inguinal hernia, unilateral

1.62

0.72

1.0

4.48

0.44

u/ml

—

Inguinal of femoral hernia, unilateral

1.62

0.72

1.0

4.48

0.44

u/ml

—

Femoral hernia, unilateral

1.62

0.72

1.0

4.48

0.44

u/ml

—

Haemorrhoids and perianal venous thrombosis

127

1119

1.14

0.71

1.0

1.1

2.22

1.64

u/ml

0.11

272

Other diseases of blood and blood-forming organs

264

1.29

0.71

1.0

2.18

2.11

u/ml

0.01

Chronic suppurative otitis media

471

1.21

0.71

1.1

2.22

3.94

u/ml

0.61

127

Oligomenorrhoea

327

1.26

0.71

1.0

1.1

1.28

1.57

u/ml

—

Inguinal hernia

389

2815

0.93

0.71

1.1

3.05

2.11

u/ml

0.61

735

Diseases of the digestive system

278

2552

1.09

0.71

1.1

4.61

2.15

u/ml

0.48

656

Stomatitis and related lesions

591

1.19

0.70

1.1

2.21

2.98

u/ml

0.25

151

Benign neoplasms

1101

5891

1.04

0.70

1.1

1.91

2.57

u/ml

1.03

275

1532

Retinal detachment with retinal break

381

1.24

0.70

1.1

4.04

1.74

u/ml

0.36

Superficial injury of thorax

860

1.15

0.70

1.1

0.95

1.98

u/ml

1.30

203

Astigmatism

628

1.18

0.70

1.0

1.1

2.95

3.18

u/ml

0.03

191

Acute gastritis

265

1.29

0.70

1.1

1.14

1.85

u/ml

0.43

Other, unspecified and serous retinal detachments

1.51

0.69

1.1

6.42

2.39

u/ml

—

Chronic suppurative otitis media, including avohilmo

592

1.19

0.69

1.1

1.67

2.82

u/ml

0.55

168

Lesion of radial nerve

152

1.39

0.69

1.0

1.10

3.32

u/ml

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

137

1538

0.89

0.69

1.1

1.92

2.31

u/ml

0.12

392

Other heart diseases, wide

916

5943

0.96

0.69

1.1

2.39

2.21

u/ml

0.13

227

1495

Exposure to other and unspecified inanimate mechanical forces

538

1.19

0.68

1.2

1.1

2.63

2.54

u/ml

0.02

138

Effects of other external causes

231

1.31

0.68

1.0

1.1

0.14

3.26

u/ml

—

Missing teeth due to accident, extraction or parodontitis

475

0.80

0.68

1.1

0.32

3.01

u/ml

—

105

Other disorders of binocular vision

102

1.48

0.68

1.2

1.0

1.28

2.97

u/ml

—

Benign neoplasm: Parotid gland

275

1.28

0.68

1.0

1.1

0.08

2.40

u/ml

—

Chalazion

695

1.17

0.68

1.1

1.37

1.91

u/ml

0.31

178

Benign neoplasm: Cerebral meninges

284

1.27

0.68

1.1

0.99

2.36

u/ml

—

Hodgkin lymphoma

156

0.64

0.67

1.4

1.1

1.67

3.21

u/ml

—

Autism

373

0.77

0.67

1.1

1.25

3.16

u/ml

0.94

110

Psoriasis

155

1725

0.90

0.67

1.1

0.61

1.89

u/ml

3.74

406

Injury of nerves at shoulder and upper arm level

1.64

0.67

1.1

—

2.30

—

Serous carcinoma of ovary

0.55

0.67

1.0

—

0.45

—

Cramp and spasm

267

1.28

0.67

1.1

3.42

2.56

u/ml

0.20

Gout, idiopatic and unspecified

540

0.81

0.67

1.0

0.13

1.73

u/ml

—

123

Used for control exclusion in common control thyroid runs

1144

6036

0.96

0.67

1.1

1.84

2.63

u/ml

1.18

278

1625

Other hereditary haemolytic anaemias

1.80

0.66

1.2

1.0

—

3.00

u/ml

—

Venous thromboembolism

259

2315

1.09

0.66

1.1

1.15

1.46

u/ml

0.34

535

Benign neoplasm: Tongue

1.52

0.66

1.1

1.0

—

4.01

—

Benign neoplasm of major salivary glands

339

1.24

0.66

1.0

1.1

0.07

2.00

u/ml

—

Scissor bite

475

1.21

0.66

1.1

2.14

3.82

u/ml

0.64

143

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

283

0.74

0.66

1.0

1.1

2.05

2.03

u/ml

—

Other and unspecified nerve root and plexus disorders, also in other diseases

127

1128

1.13

0.66

1.0

1.1

2.40

1.82

u/ml

0.16

265

Viral meningitis

286

1.27

0.65

1.1

2.97

3.24

u/ml

0.06

Other functional intestinal disorders

332

2942

1.08

0.65

1.1

1.56

2.29

u/ml

0.79

783

Postpartum haemorrhage

328

2656

1.08

0.65

1.1

0.98

2.68

u/ml

5.19

629

Pyogenic arthritis

277

1.27

0.65

1.2

1.1

0.08

2.11

u/ml

—

Conotruncal defects

269

0.73

0.65

1.1

1.2

4.35

3.39

u/ml

—

Superficial injury of ankle and foot

142

1272

1.12

0.65

1.1

3.79

2.54

u/ml

0.30

349

Benign neoplasm: Cerebral meninges

286

1.26

0.65

1.1

0.99

1.62

u/ml

—

Other and unspecified disorders of psychological development

275

0.74

0.65

1.2

0.50

4.02

u/ml

—

Antihypertensive medication - note that there are other indications

980

5139

1.04

0.64

1.1

2.37

2.59

u/ml

0.19

271

1351

Tooth agenesis EXCLUDE clefts and syndromes

579

1.18

0.64

1.1

1.55

3.84

u/ml

1.58

159

Superficial injury of forearm

858

1.15

0.64

1.1

3.38

2.74

u/ml

0.15

237

Fatigue fracture of vertebra

1.75

0.64

1.0

1.1

—

5.85

—

Obstructed labour due to maternal pelvic abnormality

104

914

1.14

0.64

1.0

1.1

0.32

1.42

u/ml

2.55

191

Other diseases of blood and blood-forming organs, wide

132

1178

1.12

0.64

1.1

3.97

1.75

u/ml

0.55

296

Abnormal findings on antenatal screening of mother

129

1151

1.13

0.64

1.1

3.76

2.08

u/ml

0.36

290

Other psoriatic arthropathies

558

0.82

0.64

1.1

0.31

1.93

u/ml

—

132

Digeorge syndrome

0.00

0.64

0.0

1.3

—

11.84

—

Endometriosis diagnosis and infertility diagnosis occurring together

1052

0.87

0.64

1.1

1.18

u/ml

0.00

252

Abnormal blood-pressure reading, without diagnosis

207

1.31

0.63

1.0

1.1

3.45

2.35

u/ml

—

Conduction disorders

132

978

1.12

0.63

1.1

1.40

2.49

u/ml

0.63

220

Other and unspecified injuries of lower leg

570

1.18

0.63

1.1

1.32

2.87

u/ml

1.18

148

Other juvenile arthritis

535

0.82

0.63

1.1

0.73

3.72

u/ml

3.23

145

Benign lipomatous neoplasm of other sites/unspecified

278

1.26

0.63

1.0

1.1

0.99

2.07

u/ml

—

Thoracic aortic aneurysm

350

1.23

0.63

1.0

1.1

1.48

1.59

u/ml

0.05

Other disorders of male genital organs

225

1.29

0.63

1.0

1.1

0.25

3.19

u/ml

—

Erosion and ectropion of cervix uteri

104

1.45

0.62

1.1

0.42

2.25

u/ml

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

360

1.23

0.62

1.2

1.1

0.80

1.89

u/ml

—

Anxious personality disorder

176

0.68

0.62

1.0

1.1

0.36

3.84

u/ml

—

Femoral hernia

104

1.45

0.62

1.0

3.21

1.38

u/ml

—

Other and unspecified iron deficiency

198

1808

1.10

0.62

1.1

3.66

2.09

u/ml

0.53

458

Medical abortion

669

3458

1.05

0.62

1.1

1.72

2.41

u/ml

0.96

179

829

Adjustment and management of implanted device

433

1.20

0.62

1.1

2.20

2.42

u/ml

0.04

107

Cholecystitis

433

1.20

0.62

1.1

1.93

1.97

u/ml

0.01

102

307

1.25

0.62

1.1

2.76

4.43

u/ml

—

Other (seronegative) rheumatoid arthritis, wide

826

0.86

0.62

1.2

1.1

1.21

1.89

u/ml

0.44

188

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

1.55

0.62

1.1

0.20

0.28

u/ml

—

Conductive and sensorineural hearing loss

414

3051

0.94

0.62

1.1

1.34

1.70

u/ml

0.27

716

Glomerular disorders in diseases classified elsewhere

545

0.82

0.62

1.0

1.1

5.70

1.94

u/ml

—

135

Delayed puberty

139

1.39

0.62

1.1

13.71

4.06

u/ml

—

Spinal stenosis

192

1371

1.10

0.62

1.1

1.0

0.34

1.45

u/ml

3.43

290

Disorders of myoneural junction and muscle in diseases classified elsewhere

1.68

0.61

1.0

—

0.24

—

Benign neoplasm: Rectum

461

1.19

0.61

1.1

1.0

0.63

2.23

u/ml

—

111

Benign neoplasm: Descending colon

147

1.36

0.61

1.2

1.0

4.68

1.96

u/ml

—

Rhabdomyosarcoma, excluding all cancers (controls excluding all cancers)

0.00

0.61

0.0

1.1

—

2.82

—

Gastroduodenal ulcer

673

0.84

0.61

1.1

1.0

1.04

2.21

u/ml

0.89

158

Hodgkin lymphoma, hilmo

152

0.65

0.61

1.4

1.1

1.67

3.40

u/ml

—

Nonischemic cardiomyopathy

210

0.71

0.60

1.3

1.1

4.45

3.53

u/ml

—

Benign neoplasm: Endocrine pancreas

0.00

0.60

0.0

1.1

—

0.13

—

Hypotension

316

1.24

0.60

1.0

1.1

0.67

1.80

u/ml

—

Dislocation of lens

0.00

0.60

0.0

1.1

—

0.70

—

Corneal ulcer

145

1308

1.11

0.60

1.1

5.72

1.93

u/ml

1.05

325

Congenital malformations of the nervous system

288

0.76

0.60

1.1

1.2

1.06

4.05

u/ml

—

Benign neoplasm: Endocrine pancreas

0.00

0.59

0.0

1.0

—

0.16

—

Herpesviral keratitis and keratoconjunctivitis

183

1.32

0.59

1.0

1.1

2.90

2.84

u/ml

—

Crohn's disease (strict) with PSC

0.00

0.59

0.0

1.1

—

5.79

—

Amblyopia ex anopsia

427

1.20

0.59

1.0

1.1

3.07

4.42

u/ml

0.37

127

Meralgia paraesthetica

157

1.34

0.59

1.1

1.0

1.23

2.62

u/ml

—

Benign neoplasm of thyroid gland

131

1.38

0.59

1.2

1.1

0.64

1.16

u/ml

—

Effects of foreign body entering through natural orifice

208

1911

1.09

0.59

1.1

1.64

2.76

u/ml

1.00

522

Labour and delivery complicated by umbilical cord complications

432

0.81

0.59

1.0

1.1

0.41

1.37

u/ml

—

Acne vulgaris

130

1168

1.12

0.59

1.2

1.1

3.44

2.60

u/ml

0.23

337

Speech disturbances, not elsewhere classified

288

0.76

0.59

1.0

1.1

5.26

2.58

u/ml

—

Diseases of inner ear

290

2644

1.07

0.58

1.1

1.78

1.40

u/ml

0.27

609

Anomalies of pupillary function

149

1.35

0.58

1.2

1.1

6.03

3.56

u/ml

—

Benign neoplasm of meninges

318

1.23

0.58

1.1

0.99

1.58

u/ml

—

Benign neoplasm: Tongue

1.47

0.58

1.1

1.0

—

3.87

—

Benign neoplasm: Stomach

291

1.24

0.58

1.1

1.0

1.42

1.93

u/ml

0.19

Autism spe, excluding more controls

353

0.79

0.58

1.1

1.25

3.50

u/ml

1.04

105

Early complications of trauma

219

0.73

0.57

1.1

5.56

3.22

u/ml

—

!Aliquae complicationes praecoces traumatis

219

0.73

0.57

1.1

5.56

3.22

u/ml

—

Precocious puberty

0.56

0.57

1.0

1.1

—

8.27

—

Use of teriflunomide

1.50

0.57

1.1

1.0

0.42

2.58

u/ml

—

Congenital malformations of eye, ear, face and neck

773

1.14

0.57

1.1

2.91

3.44

u/ml

0.13

228

Scar conditions and fibrosis of skin

264

0.75

0.57

1.0

1.1

3.14

3.40

u/ml

—

Abnormal weight loss

401

1.20

0.57

1.1

0.95

2.89

u/ml

1.38

109

Contact with other sharp object(s)

593

0.84

0.57

1.1

6.81

2.54

u/ml

0.35

150

Abnormal findings on diagnostic imaging of central nervous system

274

1.25

0.57

1.1

2.03

3.21

u/ml

—

Amyloidosis

1.67

0.56

1.2

1.0

—

0.52

—

Dronedarone medication

1.67

0.56

1.0

—

1.02

—

Venous complications and haemorrhoids in the puerperium

1.46

0.56

1.1

1.0

—

0.25

—

Toxic effect of other and unspecified substances

0.56

1.0

1.1

—

5.70

—

Benign mammary dysplasia

624

1.16

0.56

1.1

0.98

1.48

u/ml

0.30

143

Maxillary retrognathism

212

1.28

0.56

1.1

0.59

3.86

u/ml

—

Type of accident

237

2196

1.08

0.56

1.1

1.71

2.43

u/ml

0.73

573

Methotrexate

732

0.86

0.56

1.0

0.11

1.78

u/ml

4.10

144

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

203

1.29

0.56

1.1

3.68

2.99

u/ml

—

Dental pulpitis 4, only avohilmo

1111

6010

0.96

0.56

1.1

1.91

2.48

u/ml

0.74

291

1528

Other injuries of lower limb, level unspecified

1.63

0.56

1.0

1.1

—

0.15

—

Malignant melanoma of skin

330

0.79

0.56

1.0

1.1

0.06

1.66

u/ml

—

Additional codes for the location of defect, injury or illness

320

1.22

0.56

1.1

0.18

2.99

u/ml

—

Colorectal cancer, excluding all cancers (controls excluding all cancers)

687

0.86

0.55

1.0

4.61

1.88

u/ml

0.43

143

Benign neoplasm: Long bones of lower limb

221

1.27

0.55

1.0

1.1

8.68

3.39

u/ml

—

Varicella [chickenpox]

403

1.20

0.55

1.1

1.66

3.51

u/ml

0.62

103

Weight loss

495

1.17

0.55

1.1

0.95

2.68

u/ml

1.28

139

Scleritis and episcleritis

357

1.21

0.55

1.0

1.1

3.40

2.38

u/ml

0.24

Phobic anxiety disorders

172

1574

1.09

0.55

1.1

4.21

2.22

u/ml

0.71

439

Endometriosis ASRM stages 3,4

192

1766

1.09

0.55

1.1

0.74

1.51

u/ml

1.48

422

Nontoxic single thyroid nodule

339

1.21

0.55

1.1

0.18

2.56

u/ml

—

Osteopathies and chondropathies

370

3305

1.06

0.54

1.1

1.88

2.11

u/ml

0.17

837

Emotional disorders and disorders of social functioning with onset specific to childhood

110

972

1.12

0.54

1.1

0.95

3.25

u/ml

4.03

301

Benign neoplasm of meninges

321

1.22

0.54

1.1

0.99

2.32

u/ml

—

Other abnormal uterine and vaginal bleeding

151

978

1.10

0.54

1.1

0.90

1.86

u/ml

1.31

229

Speech and linguistic disorders

159

1393

1.10

0.54

1.2

1.1

1.93

3.39

u/ml

1.07

442

Vasculitis limited to skin, not elsewhere classified

1.42

0.54

1.3

1.1

—

4.95

u/ml

—

Benign neoplasm: salivary glands, exclude unknown (D119)

312

1.22

0.54

1.0

1.1

0.08

2.22

u/ml

—

Prepatellar bursitis

195

1.29

0.54

1.0

0.93

2.87

u/ml

—

Azathioprine

106

1185

0.89

0.54

1.1

3.74

1.89

u/ml

0.51

286

Benign neoplasm: Long bones of lower limb

222

1.27

0.54

1.0

1.1

8.68

3.27

u/ml

—

Pneumonitis due to solids and liquids

205

0.73

0.54

1.1

0.75

2.86

u/ml

—

Chromosomal abnormalities, not elsewhere classified

359

0.80

0.54

1.1

1.2

4.09

3.61

u/ml

—

124

Prolonged pregnancy

197

1948

0.92

0.54

1.0

1.1

1.16

2.62

u/ml

3.36

481

Urolithiasis

156

1423

1.10

0.53

1.1

3.72

1.70

u/ml

0.54

334

Injury of other and unspecified intrathoracic organs

272

0.77

0.53

1.1

0.67

3.20

u/ml

—

Need for immunization against other single viral diseases

108

1.40

0.53

1.0

1.1

2.95

3.18

u/ml

—

Constipation

603

4521

0.95

0.53

1.1

1.16

2.25

u/ml

2.20

149

1132

Use of glatiramer acetate

158

0.69

0.53

1.1

0.48

1.66

u/ml

—

Oral leukoplakia

1.54

0.53

1.2

1.1

—

0.43

—

Chronic periodontitis

610

0.85

0.53

1.1

1.01

2.27

u/ml

0.88

137

Mandibular retrognathia AND surgery (BSSRO)

214

1.27

0.53

1.1

0.92

2.01

u/ml

0.77

Maternal care for known or suspected fetal abnormality and damage

196

1887

0.92

0.52

1.1

0.72

2.48

u/ml

5.21

457

Eustachian salpingitis and obstruction

855

1.13

0.52

1.1

1.28

2.62

u/ml

0.75

216

Event of undetermined intent

489

1.17

0.52

1.1

2.45

2.61

u/ml

0.03

121

Agranulocytosis

555

0.85

0.52

1.1

5.37

2.94

u/ml

—

137

Inguinal hernia, bilateral

296

1.22

0.51

1.0

1.1

7.38

2.01

u/ml

—

Benign neoplasm: Parotid gland

287

1.22

0.51

1.0

1.1

0.08

2.19

u/ml

—

Pneumonia due to Streptococcus pneumoniae

179

1.29

0.51

1.0

1.1

5.08

2.83

u/ml

—

Congenital malformations of aortic and mitral valves

347

0.80

0.51

1.0

1.1

7.24

3.83

u/ml

—

Sequelae with surgical and medical care as external cause

856

1.12

0.51

1.1

1.88

2.23

u/ml

0.13

203

Abnormal results of function studies

490

1.17

0.51

1.1

0.30

2.91

u/ml

2.79

118

Disorder of lipoprotein metabolism, unspecified

333

1.20

0.51

1.1

1.45

1.59

u/ml

0.05

Other diseases of pleura

163

1324

1.09

0.50

1.1

2.03

1.96

u/ml

0.03

311

Infections, IBD-co-morbidities

129

851

1.11

0.50

1.1

0.96

2.57

u/ml

1.73

221

Impacted maxillary molar

787

0.87

0.50

1.1

0.81

2.81

u/ml

3.17

224

Pedestrian injured in transport accident

398

1.18

0.50

1.2

1.1

0.36

2.59

u/ml

3.25

106

Infectious mononucleosis

127

1153

1.10

0.50

1.1

1.04

2.52

u/ml

2.78

314

Infections of breast associated with childbirth

371

1.19

0.50

1.2

1.1

0.33

1.61

u/ml

3.17

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

334

1.20

0.50

1.1

0.15

2.13

u/ml

—

Carcinoma in situ of breast, intraductal

313

0.80

0.49

1.0

2.13

1.61

u/ml

—

Acute alcohol intoxication ICD-9

101

1.39

0.49

1.0

1.1

2.03

2.66

u/ml

—

Other specified/unspecified systemic involvement of connective tissue

307

1.21

0.49

1.1

0.57

2.48

u/ml

1.91

Maternal care for known or suspected abnormality of pelvic organs

341

2219

1.06

0.49

1.1

1.45

2.37

u/ml

0.96

528

Diseases of pulp and periapical tissues

260

2434

1.07

0.49

1.1

1.49

2.62

u/ml

1.15

578

Benign neoplasm of major salivary glands

353

1.19

0.49

1.0

1.1

0.07

1.91

u/ml

—

Cholangitis (primary sclerosing, PSC)

268

0.78

0.49

1.0

1.1

0.67

2.80

u/ml

—

Benign neoplasm of brain and other parts of central nervous system

334

0.81

0.49

1.1

0.31

2.62

u/ml

—

Other congenital malformations, not elsewhere classified

128

1.35

0.49

1.1

1.39

2.25

u/ml

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

803

1.12

0.48

1.1

1.74

1.42

u/ml

0.11

188

Symptoms and signs concerning food and fluid intake

651

1.14

0.48

1.1

0.92

3.50

u/ml

2.39

202

Congenital malformations of breast

181

1.28

0.48

1.2

1.1

0.21

2.12

u/ml

—

Bacterial pneumonia (organism specified)

252

2146

1.07

0.48

1.1

2.74

2.16

u/ml

0.35

520

Twin gestation

964

0.89

0.48

1.1

0.13

1.47

u/ml

5.79

220

Diabetic retinopathy, strict definition

506

1.15

0.48

1.0

1.1

1.26

1.85

u/ml

0.33

143

Disturbances of smell and taste

163

1.29

0.48

1.1

1.0

1.08

3.76

u/ml

—

Myositis

1.40

0.48

1.0

0.35

5.88

u/ml

—

Certolizumab pegol

143

0.69

0.48

1.0

1.1

7.71

1.94

u/ml

—

Papulosquamous disorders

246

2301

1.07

0.48

1.1

1.21

1.78

u/ml

0.44

545

Other neurotic disorders

190

1.27

0.48

1.4

1.1

0.19

2.51

u/ml

—

Benign neoplasms

1009

5521

1.03

0.48

1.1

1.98

2.64

u/ml

0.93

256

1456

Special screening examination for other diseases and disorders

587

1.14

0.47

1.1

4.74

2.06

u/ml

0.42

153

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

233

0.77

0.47

1.1

1.2

6.35

3.66

u/ml

—

Scabies

336

1.19

0.47

1.1

0.62

2.49

u/ml

—

Polycystic ovarian syndrome

730

0.87

0.47

1.0

1.1

0.77

1.70

u/ml

1.23

180

Family history of malignant neoplasm

794

0.88

0.47

1.1

2.30

2.06

u/ml

0.04

187

Other and unspecified coagulation defects

355

1.19

0.47

1.1

0.23

3.07

u/ml

—

Ménière disease

318

1.20

0.47

1.1

2.03

1.93

u/ml

—

Cerebral palsy

210

0.76

0.47

1.1

1.2

0.11

3.60

u/ml

—

Vertical strabismus

191

1.26

0.46

1.1

3.56

3.82

u/ml

—

Benign neoplasm: Rectum

476

1.16

0.46

1.1

0.63

2.26

u/ml

—

110

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

118

1297

0.91

0.46

1.1

0.95

1.60

u/ml

0.79

297

Dental pulpitis 1, only avohilmo

1117

6015

0.97

0.46

1.1

1.88

2.48

u/ml

0.78

292

1532

Open wound of lower leg

102

920

1.11

0.46

1.1

0.96

2.43

u/ml

1.40

243

Other peripheral vascular diseases

402

1.17

0.46

1.1

2.01

1.78

u/ml

0.05

Viral infections of central nervous system, not elsewhere classified/unspecified

1.44

0.46

1.0

—

2.40

u/ml

—

Myocardial infarction, unclassifiable

296

0.81

0.46

1.1

3.43

1.99

u/ml

—

Fracture of foot, except ankle

222

2074

1.07

0.46

1.1

1.17

2.35

u/ml

1.39

534

Primary biliary cholangitis (PBC)

0.61

0.46

1.0

—

1.89

—

Convalescence

264

1.22

0.46

1.2

1.0

1.81

2.58

u/ml

0.19

Thyrotoxicosis

165

1524

1.08

0.46

1.1

1.71

1.58

u/ml

0.07

376

Injury of eye and orbit

126

1150

1.10

0.46

1.1

3.58

2.35

u/ml

0.23

292

Crohn's disease of small intestine

571

1.14

0.45

1.1

5.04

2.58

u/ml

0.40

134

Encephalitis

164

0.73

0.45

1.1

3.10

4.28

u/ml

—

GI-bleeding

115

1263

0.91

0.45

1.1

6.57

2.09

u/ml

0.48

315

Adalimumab

790

0.88

0.45

1.1

2.05

2.45

u/ml

0.08

192

Polyarthritis, unspecified

174

1.27

0.45

1.1

0.44

3.41

u/ml

—

Oral leukoplakia and related diseases

165

1.28

0.45

1.1

0.31

2.53

u/ml

—

Thyrotoxicosis, other and/or unspecified

139

1276

1.09

0.45

1.1

2.04

1.67

u/ml

0.16

320

Benign neoplasm of brain and other parts of central nervous system

330

0.82

0.45

1.1

0.31

2.66

u/ml

—

Fall on and from ladder

274

1.21

0.44

1.1

0.09

3.16

u/ml

—

Other diseases of the digestive system

115

1262

0.91

0.44

1.1

5.93

2.11

u/ml

0.41

309

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

297

0.81

0.44

1.1

6.04

2.78

u/ml

—

Injuries to the thorax

263

2474

1.06

0.44

1.1

1.08

2.13

u/ml

2.56

607

Dental pulpitis 3

264

2019

0.94

0.44

1.1

4.15

3.47

u/ml

0.23

611

Fracture of skull and facial bones

143

1553

0.92

0.44

1.1

1.63

2.17

u/ml

0.30

391

Guillain-Barre syndrome

1.38

0.44

1.0

1.1

—

4.81

u/ml

—

Mandibular prognathia

166

1.27

0.44

1.1

1.2

8.77

2.26

u/ml

—

Benign neoplasm of thyroid gland

139

1.30

0.43

1.2

1.1

0.64

1.06

u/ml

—

Autism spe

339

0.82

0.43

1.1

1.25

3.14

u/ml

0.96

100

Postpartum hemorraghe, all women as controls

328

3096

1.06

0.43

1.1

0.98

2.07

u/ml

3.43

769

Mandibular retrognathia

770

1.12

0.43

1.1

2.83

2.81

u/ml

0.00

212

Reactive arthropathies, FINNGEN

470

1.15

0.43

1.1

0.40

2.56

u/ml

3.36

115

Etanercept

501

0.86

0.43

1.0

1.1

0.19

2.62

u/ml

4.43

120

Intrahepatic Cholestasis of Pregnancy (ICP)

763

1.12

0.43

1.1

1.82

1.18

u/ml

0.25

177

Procreative management

400

3214

1.05

0.43

1.1

2.78

2.90

u/ml

0.05

135

861

Later onset COPD

208

1.21

0.43

1.0

0.54

0.56

u/ml

—

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

252

0.79

0.43

1.1

2.05

2.15

u/ml

—

Ingrowing nail

377

1.17

0.43

1.2

1.1

2.33

2.91

u/ml

0.11

Spermatocele

193

1.25

0.43

1.0

1.1

0.75

3.41

u/ml

—

Precocious central puberty

0.64

0.43

1.2

1.1

—

5.34

—

Chronic periapical parodontitis

103

1134

0.91

0.43

1.1

1.09

2.76

u/ml

1.73

255

Glucosamine medication

137

1004

1.09

0.43

1.0

0.47

1.16

u/ml

1.29

210

Lichen sclerosus et atrophicus

405

1.16

0.43

1.1

0.76

2.23

u/ml

—

Benign neoplasm: Stomach

303

1.19

0.43

1.1

1.42

2.56

u/ml

0.43

Lactose intolerance

239

1.22

0.43

1.1

1.38

2.50

u/ml

—

Inguinal or femoral hernia, bilateral

303

1.19

0.43

1.0

1.1

7.37

1.98

u/ml

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

322

1.19

0.43

1.2

1.1

6.07

3.21

u/ml

0.23

Exclusion endpoint for supernumerary teeth

173

0.74

0.43

1.2

1.1

1.49

2.30

u/ml

—

Outcome of delivery

241

1589

0.94

0.42

1.1

0.58

2.99

u/ml

6.90

401

Retinoblastoma, excluding all cancers (controls excluding all cancers)

0.00

0.42

0.0

1.1

—

0.05

—

Disorders of lens

306

2040

0.95

0.42

1.0

1.1

1.78

1.50

u/ml

0.19

447

Left ventricular outflow tract obstruction, narrow definition

435

0.85

0.42

1.0

1.1

6.04

3.95

u/ml

—

125

Reactive arthropathies

556

1.14

0.42

1.0

1.1

0.59

2.17

u/ml

2.31

121

Other/unspecified reactive arthropathies

406

1.16

0.42

1.0

1.1

0.22

2.93

u/ml

3.90

Retinoblastoma

0.00

0.42

0.0

1.1

—

0.05

—

Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism

0.00

0.42

0.0

1.1

—

7.49

—

Other and unspecified injuries of shoulder and upper arm

149

1.28

0.42

1.3

1.1

1.43

3.87

u/ml

—

Other congenital malformations of respiratory system

0.00

0.42

0.0

1.2

—

9.37

—

Hidradenitis suppurativa

305

0.82

0.42

1.2

1.1

8.90

2.79

u/ml

—

Polyglandular dysfunction

0.00

0.41

0.0

1.0

—

3.24

—

Benign neoplasm: Bone and articular cartilage, unspecified

1.52

0.41

1.0

—

6.24

—

ILD medications: azathioprine

106

1162

0.91

0.41

1.1

3.74

1.96

u/ml

0.48

285

Restrictive cardiomyopathy

0.00

0.41

0.0

1.2

—

0.38

—

In situ neoplasms

179

1668

1.07

0.41

1.1

1.27

1.51

u/ml

0.20

402

Spondylopathies

507

3211

0.96

0.41

1.1

2.12

1.84

u/ml

0.14

112

738

Crohn disease (strict definition, require KELA)

586

1.13

0.41

1.0

1.1

4.94

2.54

u/ml

0.41

141

Diseases of tongue

277

1.19

0.41

1.0

1.1

4.17

2.89

u/ml

—

Thyrotoxicosis with diffuse goitre

107

976

1.10

0.41

1.0

1.1

1.28

1.87

u/ml

0.27

231

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

624

1.12

0.41

1.1

4.45

2.44

u/ml

0.39

152

Blindness or visual impairment, binocular

0.00

0.41

0.0

1.0

—

0.04

—

Foreign body entering into or through eye or natural orifice

605

1.13

0.41

1.1

3.46

2.33

u/ml

0.15

155

Other misadventures during surgical and medical care

1.40

0.41

1.3

1.1

0.04

2.29

u/ml

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

0.00

0.41

0.0

1.0

—

0.24

—

Other drug-induced secondary parkinsonism

0.00

0.41

0.0

1.1

—

3.28

—

Other aneurysm

114

1.32

0.40

1.1

1.0

0.44

1.40

u/ml

—

Malignant neoplasm of other connective and soft tissue

1.34

0.40

1.1

1.0

—

2.38

—

Contact with nonpowered hand tool

241

1.21

0.40

1.1

1.01

2.30

u/ml

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

0.00

0.40

0.0

1.1

—

0.29

—

Benign neoplasm: Descending colon

159

1.26

0.40

1.2

1.1

4.68

1.90

u/ml

—

Pneumonia, organism unspecified

810

5672

1.03

0.40

1.1

2.49

2.26

u/ml

0.18

233

1422

Other embolism and thrombosis

521

1.13

0.40

1.1

0.24

2.41

u/ml

4.16

127

Carcinoma in situ of breast, intraductal

303

0.82

0.39

1.0

2.13

1.66

u/ml

—

Benign neoplasm: Bone and articular cartilage, unspecified

1.44

0.39

1.0

—

6.23

—

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

400

0.85

0.39

1.0

1.1

2.44

2.19

u/ml

—

Palmar fascial fibromatosis [Dupuytren]

334

1.17

0.39

1.0

1.1

0.22

2.63

u/ml

—

Other symptoms and signs involving general sensations and perceptions

193

0.77

0.39

1.3

1.1

0.46

2.74

u/ml

—

Cluster headache, wide

251

1.20

0.39

1.1

0.67

3.02

u/ml

—

Neoplasms

1035

5705

0.97

0.39

1.1

2.11

2.62

u/ml

0.69

274

1528

Gout, strict definition

324

0.83

0.39

1.1

0.08

1.89

u/ml

—

Ulcerative rectosigmoiditis

580

0.88

0.38

1.1

0.60

2.11

u/ml

—

138

Cirrhosis of liver, NAS

133

1.28

0.38

1.1

0.10

2.40

u/ml

—

Pedal cyclist injured in collision with motor vehicle

224

1.21

0.38

1.1

0.97

3.50

u/ml

—

Aneurysms, operations, SAH

601

0.88

0.38

1.1

1.85

2.23

u/ml

—

146

Benign neoplasm: Rectum, anus and anal canal

551

1.13

0.38

1.1

0.57

1.91

u/ml

—

135

Left ventricular outflow tract obstruction (LVOTO), broad definition

706

0.89

0.38

1.0

1.1

1.52

2.81

u/ml

0.60

192

Nephrotic syndrome

225

0.80

0.38

1.0

1.2

0.03

3.81

u/ml

—

Diplopia

618

1.12

0.38

1.2

1.1

2.08

2.32

u/ml

0.05

151

Hypoglycaemia, other or unspecified

462

0.86

0.38

1.2

1.1

1.24

3.71

u/ml

1.19

133

Single delivery by forceps and vacuum extractor

224

1447

0.94

0.38

1.1

1.63

2.45

u/ml

0.53

376

Glaucoma

207

1709

1.06

0.37

1.0

1.1

2.32

1.65

u/ml

0.16

387

Vitamin deficiency, wide

234

1.20

0.37

1.1

3.46

3.21

u/ml

—

Vitamin deficiency

234

1.20

0.37

1.1

3.46

3.21

u/ml

—

Other disorders of bladder

364

1.16

0.37

1.2

1.1

2.50

1.69

u/ml

0.19

Melanocytic naevi, other sites/unspecified

496

1.13

0.37

1.0

1.1

2.26

2.42

u/ml

0.03

112

Other vitreous opacities

116

1.30

0.37

1.1

0.63

1.20

u/ml

—

Contusion of other and unspecified parts of foot

487

1.13

0.37

1.1

2.74

3.59

u/ml

0.29

132

Other facial nerve disorders

125

1.28

0.37

1.4

1.0

0.22

2.56

u/ml

—

Paralytic ileus and intestinal obstruction

945

0.91

0.37

1.1

3.81

2.04

u/ml

0.31

223

Alcohol-induced chronic pancreatitis

246

0.81

0.37

1.0

1.1

2.38

2.32

u/ml

—

Epilepsy

213

2252

0.94

0.37

1.1

2.49

2.54

u/ml

0.01

603

Unspecified misadventure during surgical and medical care

216

1.21

0.37

1.1

0.27

2.56

u/ml

—

Elevated blood glucose level

450

0.87

0.36

1.2

1.1

0.25

2.66

u/ml

—

113

Abscess of anal and rectal regions

556

0.88

0.36

1.0

1.1

0.65

2.33

u/ml

—

137

Foreign body in respiratory tract

365

1.15

0.36

1.1

0.73

3.16

u/ml

2.24

101

Gout, unspecified

418

0.86

0.36

1.1

1.0

0.13

1.68

u/ml

—

Other and unspecified myopathies

278

0.83

0.36

1.0

1.1

0.39

2.63

u/ml

—

Other disorders of kidney and ureter

460

0.87

0.36

1.2

1.1

4.48

1.85

u/ml

0.40

122

Disorders of calcium metabolism

245

0.81

0.36

1.1

3.77

2.70

u/ml

—

Embedded teeth, including avohilmo

129

1197

1.08

0.36

1.1

1.85

2.71

u/ml

0.50

338

Multiple delivery

723

0.90

0.35

1.1

0.97

1.16

u/ml

—

161

Viral infections of the central nervous system

479

1.13

0.35

1.1

2.40

2.80

u/ml

0.13

118

Radial styloid tenosynovitis [de Quervain]

366

1.15

0.35

1.1

2.20

2.22

u/ml

—

Other follicular disorders

536

1.12

0.35

1.1

3.62

2.01

u/ml

0.36

126

Other orthopaedic follow-up care

254

1.18

0.35

1.1

1.46

2.36

u/ml

—

Lack of expected normal physiological development

491

0.88

0.35

1.1

1.2

7.12

4.10

u/ml

0.43

173

Psychotic depression

395

0.86

0.35

1.0

2.67

1.56

u/ml

—

100

Motorcycle rider injured in other and unspecified transport accidents

546

1.12

0.35

1.2

1.1

0.74

2.70

u/ml

2.19

148

Psoriasis vulgaris

101

1098

0.92

0.35

1.1

0.71

2.22

u/ml

2.58

255

Colorectal adenocarcinoma

395

0.86

0.35

1.0

1.1

2.44

1.54

u/ml

—

Crohn disease (strict definition, require KELA, min 2 HDR)

575

1.12

0.35

1.0

1.1

4.94

2.57

u/ml

0.40

137

Burns and corrosions

125

1160

1.08

0.35

1.1

6.85

2.63

u/ml

0.97

300

Other disorders of optic disc

1.38

0.35

1.4

1.1

9.96

2.29

u/ml

—

Nonspecific lymphadenitis

395

1.14

0.34

1.1

0.78

2.43

u/ml

1.69

Hypermetropia

700

0.90

0.34

1.1

3.75

3.64

u/ml

0.02

207

Other noninflammatory disorders of cervix uteri

181

1.22

0.34

1.0

1.1

1.22

1.61

u/ml

—

Benign neoplasm: Rectum, anus and anal canal

556

1.12

0.34

1.1

0.57

1.96

u/ml

—

131

Acute appendicitis, with complications

103

1117

0.92

0.34

1.1

2.40

1.72

u/ml

0.23

256

Disorders of synovium and tendon in diseases classified elsewhere

1.35

0.34

1.1

1.0

1.14

4.51

u/ml

—

Other articular cartilage disorders

1.35

0.34

1.2

1.0

—

3.34

—

Papilloedema, unspecified

145

1.25

0.34

1.1

3.30

3.24

u/ml

—

Sequelae of infectious and parasitic diseases

396

1.14

0.33

1.2

1.1

0.92

2.06

u/ml

0.88

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

181

1.21

0.33

1.0

1.1

2.33

2.31

u/ml

—

Tooth eruption problems

234

2199

1.06

0.33

1.1

2.34

3.09

u/ml

0.46

635

Viral Sepsis

105

969

1.08

0.33

1.1

3.77

2.39

u/ml

0.52

252

Personality disorders, excluding more controls

276

2631

1.05

0.33

1.1

1.30

1.84

u/ml

0.79

638

Multiple gestation

1001

0.92

0.33

1.1

0.12

1.41

u/ml

6.04

234

Congenital malformations of gallbladder, bile ducts and liver

0.68

0.33

1.0

1.1

—

1.75

—

Malignant neoplasm of kidney, except renal pelvis

210

0.81

0.33

1.1

2.43

2.25

u/ml

—

Antepartum haemorrhage, not elsewhere classified

1021

0.92

0.33

1.1

2.86

2.27

u/ml

0.18

230

Cysts of oral region, not elsewhere classified

219

1.19

0.33

1.0

1.1

0.97

3.54

u/ml

—

Open wound of forearm

614

0.89

0.33

1.1

1.32

2.82

u/ml

0.99

153

Bipolar affective disorders

190

1794

1.06

0.33

1.0

1.1

0.94

1.87

u/ml

1.26

448

Use of rivastigmine

0.69

0.33

1.2

1.0

—

0.13

—

Other ulcerative colitis

445

0.87

0.33

1.2

1.1

0.62

2.42

u/ml

—

115

Other anaemias

145

1494

0.94

0.33

1.1

2.15

1.97

u/ml

0.07

373

Pedal cyclist injured in transport accident

172

1826

0.94

0.32

1.1

1.13

2.57

u/ml

2.92

471

Spontaneous abortion

477

3129

1.04

0.32

1.1

1.38

2.26

u/ml

1.83

113

735

All pneumoniae

977

6575

1.03

0.32

1.1

2.69

2.32

u/ml

0.32

282

1647

Melanocytic naevi of trunk

812

0.91

0.32

1.1

1.21

1.72

u/ml

0.38

204

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

128

1.26

0.32

1.1

0.73

4.00

u/ml

—

Benign neoplasm: Vagina

1.28

0.32

1.2

1.0

—

0.22

—

112

1039

1.08

0.32

1.1

1.93

2.56

u/ml

0.22

263

Other maltreatment syndromes

263

0.83

0.32

1.0

1.1

0.46

2.40

u/ml

—

Ascites

198

0.81

0.32

1.1

2.34

2.10

u/ml

—

Preterm labour and delivery

204

2152

0.95

0.32

1.1

0.55

1.93

u/ml

4.19

479

Emotional disorders starting during childhood or adolescence

101

927

1.08

0.32

1.1

0.96

3.39

u/ml

4.18

286

HSIL lesion of the cervix uteri

209

1982

1.06

0.32

1.1

1.58

1.69

u/ml

0.05

489

Other and unspecified disease of Bartholin gland

119

1.26

0.32

1.3

1.0

4.85

1.00

u/ml

—

Gestational diabetes (for exclusion)

521

3565

1.03

0.31

1.1

1.25

2.29

u/ml

2.33

113

892

Malignant neoplasm of urinary organs

219

0.82

0.31

1.1

2.43

2.27

u/ml

—

Duodenal ulcer

219

0.82

0.31

1.2

1.1

1.54

2.48

u/ml

—

Other Crohn's disease

618

1.10

0.31

1.0

1.1

5.44

2.52

u/ml

0.40

149

Congenital deformities of hip

258

1.17

0.31

1.2

1.1

2.13

6.16

u/ml

—

Abnormal serum enzyme levels

984

0.92

0.31

1.1

0.61

1.80

u/ml

2.07

240

Other and unspecified injuries of wrist and hand

305

1.15

0.31

1.2

1.1

0.87

3.45

u/ml

1.66

Recurring oral aphthae

305

1.15

0.31

1.1

0.62

2.02

u/ml

1.58

Ectopic pregnancy

147

1381

1.07

0.30

1.1

2.00

1.11

u/ml

0.60

310

Direct fill therapy

105

1130

0.93

0.30

1.2

1.1

3.05

2.95

u/ml

0.02

305

Other symptoms and signs involving cognitive functions and awareness

175

1737

0.94

0.30

1.1

1.63

1.79

u/ml

0.08

407

Ventral hernia

109

1013

1.08

0.30

1.0

1.1

1.74

1.84

u/ml

0.04

240

Iron deficiency anaemia secondary to blood loss (chronic)

600

0.90

0.30

1.1

0.68

2.56

u/ml

1.75

145

Iridocyclitis

149

1401

1.06

0.30

1.1

0.80

1.90

u/ml

1.49

333

Manic episode

207

0.82

0.30

1.0

1.1

3.79

2.41

u/ml

—

Pyoderma

1.31

0.30

1.2

1.0

0.61

5.69

u/ml

—

Artificial joint re-operation

120

1.25

0.30

1.1

1.0

0.23

1.20

u/ml

—

Myocardial infarction, without ST-elevation

757

1.08

0.30

1.1

1.0

2.54

1.64

u/ml

0.36

164

Other obstructive and reflux uropathy

306

1.15

0.30

1.1

4.95

2.96

u/ml

—

Other and unspecified anaemias

144

1481

0.94

0.29

1.1

2.15

1.98

u/ml

0.07

372

Other and unspecified vascular occlusions

166

1.21

0.29

1.1

1.0

0.82

2.05

u/ml

—

Nonpyogenic thrombosis of intracranial venous system

1.26

0.29

1.6

1.0

—

1.75

—

Diabetic neuropathy

239

1.17

0.29

1.1

1.28

2.01

u/ml

—

Excessive vomiting in pregnancy

813

1.08

0.29

1.1

1.23

1.33

u/ml

0.05

201

Iron deficiency anaemia

238

2250

1.05

0.29

1.1

3.29

2.09

u/ml

0.43

558

Implicit viral Sepsis

104

968

1.08

0.29

1.1

2.93

2.40

u/ml

0.21

251

Bacterial, viral and other infectious agents

679

1.09

0.29

1.1

1.12

2.42

u/ml

1.68

169

Congenital malformations and deformations of the musculoskeletal system

131

1224

1.07

0.28

1.1

2.19

3.31

u/ml

0.62

372

Lung cancer and mesothelioma

182

1.18

0.28

1.0

0.99

1.02

u/ml

—

Pneumococcal septicemia

173

0.81

0.28

1.1

4.94

4.02

u/ml

—

Specific development disorders of speech and language

868

1.08

0.28

1.2

2.57

3.54

u/ml

0.33

274

Superficial injury of head

174

1649

1.06

0.28

1.1

1.66

2.88

u/ml

1.05

446

Other specific arthropathies, wide

1.28

0.28

1.0

0.31

4.07

u/ml

—

HSIL lesion of the cervix uteri, vagina or vulva

217

2070

1.05

0.28

1.1

1.55

1.66

u/ml

0.06

507

Dental pulpitis 3, only avohilmo

247

1885

0.96

0.28

1.1

4.04

3.52

u/ml

0.16

579

Hypo-osmolality and hyponatraemia

469

0.89

0.28

1.2

1.1

0.25

2.55

u/ml

—

108

Burn and corrosion of trunk

186

1.19

0.28

1.0

1.1

18.70

3.92

u/ml

—

Disorders in reading

233

1.17

0.28

1.1

1.76

3.16

u/ml

—

Intentional self-harm by sharp object

261

1.15

0.28

1.1

0.84

3.97

u/ml

2.12

Other endocrine disorders

785

1.08

0.27

1.1

1.2

4.13

3.73

u/ml

0.06

251

Artificial opening status

237

0.84

0.27

1.1

1.74

3.79

u/ml

—

205

1.18

0.27

1.1

1.86

1.79

u/ml

—

Plantar fascial fibromatosis

508

1.10

0.27

1.1

0.54

2.61

u/ml

—

110

Fall on same level

1209

6886

0.98

0.27

1.1

2.25

2.41

u/ml

0.15

333

1766

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

375

1.12

0.27

1.1

0.15

1.96

u/ml

—

Burns and corrosions of external body surface, specified by site

894

1.08

0.27

1.1

9.40

2.70

u/ml

1.11

223

Haemorrhagic and haematological disorders of fetus and newborn

546

0.90

0.27

1.2

6.65

4.17

u/ml

0.23

186

Melanocytic naevi, other sites/unspecified

509

1.10

0.27

1.0

1.1

2.26

u/ml

0.00

121

Hypertrophic disorders of skin

490

1.10

0.27

1.1

2.08

2.26

u/ml

0.07

118

Unspecified haematuria

177

1440

1.05

0.27

1.1

2.35

2.09

u/ml

0.09

351

Liveborn infants according to place of birth

199

1.17

0.26

1.1

1.20

5.32

u/ml

—

Dental caries 3 and operation codes, only avohilmo

384

1862

1.04

0.26

1.1

1.66

2.81

u/ml

0.98

490

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

416

0.89

0.26

1.0

1.1

0.05

1.72

u/ml

—

Endocrine, nutritional and metabolic diseases

1101

5489

1.02

0.26

1.1

2.19

2.69

u/ml

0.58

277

1462

Dissociative [conversion] disorders

363

0.88

0.26

1.1

2.64

3.12

u/ml

—

Need for other prophylactic measures

357

1.12

0.26

1.1

0.66

2.98

u/ml

1.68

Postpartum haemorrhage due to retained placenta

136

1284

1.06

0.26

1.0

1.1

1.49

1.28

u/ml

0.20

315

Arthropod-borne viral fevers and viral haemorrhagic fevers

478

0.90

0.26

1.1

0.52

1.91

u/ml

2.34

115

Hernia

737

5119

0.98

0.26

1.1

2.61

2.05

u/ml

0.45

191

1263

Dental caries

201

2084

0.95

0.26

1.2

1.1

1.17

3.15

u/ml

2.79

548

Disorders of mineral metabolism

348

1.12

0.26

1.0

1.1

5.05

2.48

u/ml

0.48

Cluster headache, strict

244

1.15

0.26

1.1

0.67

3.09

u/ml

—

Other peripheral vertigo

329

1.13

0.26

1.1

1.74

u/ml

—

Hypertrophic scar

463

1.10

0.25

1.1

2.08

2.37

u/ml

0.12

108

Overexertion and strenuous or repetitive movements

684

1.08

0.25

1.1

2.35

2.17

u/ml

0.05

163

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

301

1.13

0.25

1.0

1.1

6.23

2.45

u/ml

—

Leisure time condition

134

1266

1.06

0.25

1.1

1.45

2.81

u/ml

1.14

335

Ulcerative colitis, NAS

104

1109

0.94

0.25

1.1

1.84

2.19

u/ml

0.12

276

Artificial joint operation, meniscal resection

533

3645

0.97

0.25

1.1

1.03

1.66

u/ml

1.06

125

838

Pregnancy hypertension

422

3921

0.97

0.25

1.1

1.55

1.99

u/ml

0.40

931

Pneumonias (Asthma/COPD co-morbidities)

964

6542

1.02

0.25

1.1

2.69

2.34

u/ml

0.30

281

1631

Aortic aneurysm

474

1.10

0.25

1.0

1.26

1.56

u/ml

0.16

108

Other and unspecified injuries of thorax

1.20

0.25

1.0

—

3.11

—

Dental caries 1 and operation codes, only avohilmo

312

1511

1.04

0.25

1.1

2.35

2.89

u/ml

0.26

391

Other benign neoplasms of skin

204

1914

1.05

0.24

1.1

2.57

1.74

u/ml

0.43

453

Divergent concomitant strabismus

580

0.91

0.24

1.1

2.02

2.28

u/ml

0.05

144

Primary gonarthrosis, bilateral

170

1416

1.05

0.24

1.0

0.53

1.21

u/ml

1.42

290

Other problems related to primary support group, including family circumstances

156

1598

0.95

0.24

1.1

1.22

2.88

u/ml

2.53

465

Lesion of ulnar nerve

725

1.08

0.24

1.1

0.42

2.01

u/ml

3.65

170

Other CVD

455

1.10

0.24

1.0

1.1

0.57

1.78

u/ml

1.70

114

Female genital prolapse

187

1030

1.05

0.24

1.1

1.26

1.68

u/ml

0.31

224

Bacterial pneumonia, not elsewhere classified

221

1876

1.04

0.23

1.1

2.86

2.08

u/ml

0.47

455

Superficial injury of ankle and foot, unspecified

1.36

0.23

1.0

—

3.31

—

Other specified congenital malformation syndromes affecting multiple systems

264

0.87

0.23

1.1

1.2

5.21

2.95

u/ml

—

Exclusions for E4_PCOS_BROAD

145

1524

0.95

0.23

1.1

0.53

2.64

u/ml

6.05

408

Erosion of teeth

179

0.83

0.23

1.1

0.18

6.39

u/ml

—

Hypoplasia of dental enamel , including avohilmo

621

0.92

0.23

1.1

1.2

8.51

4.02

u/ml

0.25

196

Other and unspecified disorders of skin and subcutaneous tissue

275

1.13

0.23

1.1

0.30

2.13

u/ml

—

Respiratory and cardiovascular disorders specific to the perinatal period

606

1.08

0.23

1.2

5.09

4.22

u/ml

0.12

205

Atrophic disorders of skin

785

1.07

0.23

1.1

1.22

2.37

u/ml

0.79

184

Injury of muscle and tendon at forearm level

1.24

0.23

1.1

—

3.97

u/ml

—

Congenital malformations of uterus and cervix

228

1.14

0.23

1.0

1.1

1.84

1.95

u/ml

—

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

1.28

0.23

1.0

—

1.01

—

Motor neuron disease

1.28

0.23

1.0

—

8.85

—

Diabetic nephropathy

394

1.10

0.23

1.0

1.1

4.82

1.71

u/ml

0.58

102

Molar incisor enamel hypoplasia, with caries

251

0.86

0.22

1.0

1.2

0.46

4.48

u/ml

—

Diseases of peritoneum

409

1.10

0.22

1.0

1.1

1.15

2.87

u/ml

1.27

Ankylosing spondylitis

563

1.08

0.22

1.0

1.1

3.07

2.45

u/ml

0.08

135

Degeneration of macula and posterior pole

751

1.07

0.22

1.0

0.49

1.38

u/ml

1.23

163

Other neonatal haemorrhages

0.00

0.22

0.0

1.1

—

Phlebitis and thrombophlebitis (not including DVT)

116

1097

1.06

0.22

1.1

0.61

1.90

u/ml

2.89

257

Chronic hepatitis NAS

1.25

0.22

1.4

1.0

—

2.48

u/ml

—

Intracranial trauma

583

4460

0.98

0.22

1.1

2.21

2.53

u/ml

0.24

162

1161

Hyperlipidaemia, other/unspecified

112

1121

0.95

0.22

1.1

1.0

0.89

1.51

u/ml

0.51

250

Bell's palsy

641

1.08

0.22

1.0

1.1

2.45

1.95

u/ml

0.10

164

Senile cataract

239

1426

1.04

0.22

1.0

1.14

1.50

u/ml

0.29

297

Contact with and exposure to communicable diseases

450

4365

1.03

0.22

1.1

3.16

2.74

u/ml

0.21

135

1198

Neuromuscular dysfunction of bladder

362

1.11

0.22

1.1

2.69

2.68

u/ml

0.00

Torsion of ovary, ovarian pedicle and fallopian tube

191

1.16

0.22

1.1

0.52

2.07

u/ml

—

Hallux valgus (acquired)

181

1368

0.96

0.22

1.1

0.57

1.13

u/ml

1.18

281

Disorder of amino-acid metabolism, other/unspecified

0.00

0.21

0.0

1.0

—

2.73

—

ILD medications: immunosuppressive drugs

487

4553

1.03

0.21

1.1

3.23

2.16

u/ml

0.69

126

1058

Autoimmune polyglandular failure

0.00

0.21

0.0

1.0

—

3.24

—

Thrombocytopenia, unspecified

336

0.89

0.21

1.1

0.79

2.78

u/ml

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

0.00

0.21

0.0

1.1

—

Sudden idiopathic hearing loss

353

1.11

0.21

1.1

1.0

7.16

2.52

u/ml

0.47

Diverticular disease of intestine

338

2315

0.97

0.21

1.0

1.1

0.53

1.62

u/ml

3.27

520

Other infestations

0.00

0.21

0.0

1.2

—

5.01

—

Ovarian dysfunction

915

0.94

0.21

1.0

1.1

0.77

1.72

u/ml

1.46

228

Coxarthrosis, primary

186

1548

1.04

0.21

1.1

1.0

1.94

1.18

u/ml

0.18

346

Cardiodefibrillation

893

0.94

0.21

1.0

1.1

1.13

2.12

u/ml

0.58

203

Other encephalitis

145

0.83

0.21

1.1

3.10

4.23

u/ml

—

Amenorrhoea

832

0.94

0.21

1.1

2.65

1.95

u/ml

—

223

Other arthritis (FG)

214

2222

0.96

0.21

1.1

0.63

1.90

u/ml

5.64

555

Other metabolic disorders

925

1.06

0.21

1.1

1.82

1.95

u/ml

0.05

221

Cutaneous abscess, furuncle and carbuncle

194

2018

0.96

0.21

1.1

2.89

2.35

u/ml

0.20

524

Convulsions of newborn

0.00

0.21

0.0

1.3

—

0.28

—

Anisometropia and aniseikonia

211

1.14

0.20

1.0

1.1

0.35

4.60

u/ml

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

838

1.06

0.20

1.1

1.59

1.77

u/ml

0.07

196

Overjet

439

1.09

0.20

1.1

1.2

2.77

3.44

u/ml

0.16

127

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

615

0.93

0.20

1.1

0.50

1.52

u/ml

1.13

141

Tobacco use

316

1.11

0.20

1.0

1.1

1.08

2.40

u/ml

—

Abscess of mediastinum

0.00

0.20

0.0

1.2

—

0.46

—

Benign neoplasm: Vagina

1.25

0.20

1.2

1.0

—

0.22

—

Other eating disorders

738

0.93

0.20

1.1

0.69

3.23

u/ml

3.78

208

Degeneration of nervous system due to alcohol

1.25

0.20

1.0

1.1

—

4.79

—

Degeneration of the brain due to alcohol

1.25

0.20

1.0

1.1

—

4.79

—

Recurrent dislocation and subluxation of joint

645

0.93

0.20

1.0

1.1

0.43

2.14

u/ml

3.48

158

Family history of certain disabilities and chronic diseases leading to disablement

461

1.09

0.20

1.1

3.21

2.44

u/ml

0.15

112

Smoking dependency

438

0.91

0.20

1.1

6.62

2.02

u/ml

—

106

Nutritional anaemias

265

2495

1.03

0.20

1.1

2.96

2.04

u/ml

0.35

615

Assault by unspecified means

174

1.15

0.20

1.1

3.98

3.59

u/ml

—

Superficial injury of abdomen, lower back and pelvis

121

1152

1.05

0.19

1.1

1.86

2.42

u/ml

0.35

302

Benign neoplasm of other and unspecified endocrine glands

587

1.07

0.19

1.0

1.1

0.71

1.85

u/ml

1.65

135

Congenital malformations of eyelid, lacrimal apparatus and orbit

146

1.17

0.19

1.2

1.32

4.51

u/ml

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

453

4059

0.98

0.19

1.1

1.49

2.01

u/ml

0.55

963

Dentinal caries

171

1771

0.96

0.19

1.2

1.1

0.78

3.22

u/ml

6.60

483

Cardiomyopathy

665

0.93

0.19

1.1

1.44

2.83

u/ml

0.83

159

Benign neoplasm: Pituitary gland, craniopharyngeal duct

298

1.11

0.19

1.0

1.1

0.55

2.46

u/ml

—

Mental and behavioural disorders due to tobacco

437

0.91

0.19

1.1

6.62

2.04

u/ml

—

106

Contact with sharp object, undetermined intent

154

0.84

0.19

1.0

1.1

0.49

3.90

u/ml

—

Viral warts

802

1.06

0.19

1.1

2.36

2.49

u/ml

0.03

210

Injury of nerves at wrist and hand level

228

0.88

0.19

1.0

1.1

0.28

3.07

u/ml

—

Injuries involving multiple body regions

249

0.88

0.19

1.0

1.1

0.34

3.31

u/ml

—

Hereditary corneal dystrophies

1.24

0.18

1.4

1.0

3.95

1.82

u/ml

—

Carcinoma in situ of cervix uteri

910

1.06

0.18

1.1

1.72

1.38

u/ml

0.15

226

Burn and corrosion of hip and lower limb, except ankle and foot

143

0.84

0.18

1.0

1.1

—

4.83

—

Perioral dermatitis

156

1.16

0.18

1.1

1.0

3.38

1.49

u/ml

—

Injury of unspecified body region

453

1.08

0.18

1.0

1.1

5.03

3.12

u/ml

0.30

117

Viral and other specified intestinal infections

296

2809

1.03

0.18

1.1

4.20

2.98

u/ml

0.29

823

Sulfasalazine

184

1773

1.04

0.18

1.1

1.73

1.58

u/ml

0.06

382

Other congenital malformations of male genital organs

174

0.85

0.18

1.1

1.2

0.62

3.73

u/ml

—

Optic neuritis

342

0.90

0.18

1.0

1.1

0.31

2.28

u/ml

—

Disorders of tooth development and eruption

773

1.06

0.18

1.1

0.40

3.73

u/ml

5.68

227

Other disorders starting during childhood or adolescence

111

1050

1.05

0.18

1.1

4.13

3.13

u/ml

0.26

339

Other disorders of glucose regulation and pancreatic internal secretion

559

0.93

0.18

1.1

0.94

3.60

u/ml

1.81

152

Melanocytic naevi of trunk

785

0.94

0.18

1.1

1.21

1.83

u/ml

0.48

193

Other disorders of skin and subcutaneous tissue

405

3798

0.98

0.17

1.1

1.18

1.90

u/ml

1.54

105

923

Cerebral palsy and other paralytic syndromes

723

0.94

0.17

1.0

1.1

1.10

2.76

u/ml

0.82

189

Other diseases of pancreas

237

0.89

0.17

1.0

0.36

2.77

u/ml

—

Basal cell carcinoma

134

1114

0.96

0.17

1.1

1.0

0.34

1.40

u/ml

2.72

235

Hyperfunction of pituitary gland

455

0.92

0.17

1.1

0.40

2.87

u/ml

—

111

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

157

1.15

0.17

1.1

0.20

3.27

u/ml

—

Chronic pancreatitis

465

0.92

0.17

1.0

1.56

2.07

u/ml

—

107

Retention of urine

102

905

0.95

0.17

1.2

1.1

1.66

1.85

u/ml

0.06

221

Other and unspecified injuries of head

382

0.91

0.17

1.1

0.63

2.39

u/ml

1.99

Sequelae of other and unspecified infectious and parasitic diseases

378

1.09

0.17

1.2

1.1

0.99

2.14

u/ml

0.82

Benign neoplasm of breast

679

1.06

0.17

1.1

2.37

1.45

u/ml

0.19

154

Malignant melanoma, excluding all cancers (controls excluding all cancers)

506

0.93

0.17

1.0

1.1

0.06

2.07

u/ml

—

114

Other disorders of pigmentation

205

1.12

0.17

1.2

1.1

1.40

3.04

u/ml

—

Early lumbar disc prolapse operation

119

1139

1.05

0.17

1.1

2.31

1.83

u/ml

0.20

282

Motor neuron disease (with DMD)

0.73

0.17

1.0

1.1

—

7.68

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

301

1.10

0.17

1.0

1.1

0.54

2.68

u/ml

—

Conductive hearing loss, unspecified

485

0.93

0.17

1.1

0.81

2.46

u/ml

1.83

123

Acute and subacute iridocyclitis

125

1198

1.04

0.16

1.1

0.45

2.08

u/ml

4.66

272

Other congenital malformations of tongue, mouth and pharynx

300

1.10

0.16

1.2

6.65

3.37

u/ml

0.41

101

Disorders of optic nerve and visual pathways

711

0.94

0.16

1.1

3.48

2.21

u/ml

0.22

186

Abnormal findings on examination of blood, without diagnosis

212

2047

0.97

0.16

1.1

1.88

1.97

u/ml

0.04

506

Gastric ulcer

417

1.08

0.16

1.1

0.68

2.37

u/ml

—

102

Neonatal jaundice from other and unspecified causes

438

0.92

0.16

1.2

8.19

4.47

u/ml

0.29

151

Abnormalities of forces of labour

103

983

1.05

0.16

1.1

2.72

1.50

u/ml

0.59

209

Benign leiomyoma with endometriosis

721

0.94

0.16

1.1

1.09

1.38

u/ml

0.14

158

Other and unspecified mood [affective] disorders

768

1.06

0.16

1.0

1.1

3.35

2.07

u/ml

0.31

197

Cardiomyopathy, other and unspecified

263

1.10

0.16

1.1

0.72

2.97

u/ml

—

Diseases of liver

183

1769

1.03

0.16

1.1

0.44

1.81

u/ml

5.00

425

Gonarthrosis

397

2330

0.98

0.16

1.1

1.26

1.48

u/ml

0.28

506

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

112

1057

1.05

0.16

1.1

4.13

3.36

u/ml

0.19

338

Pregnancy examination and test

265

1608

1.03

0.16

1.1

1.69

3.14

u/ml

1.57

414

Crohn disease

116

1111

1.05

0.16

1.1

3.96

2.05

u/ml

0.53

278

Sensorineural hearing loss

366

2622

0.98

0.16

1.1

1.40

1.64

u/ml

0.14

601

Benign neoplasm of ovary

788

1.05

0.16

1.1

0.27

1.59

u/ml

3.14

175

Fourth [trochlear] nerve palsy

1.10

0.15

1.1

1.0

—

3.48

—

Melanocytic naevi of upper limb, including shoulder

130

1.16

0.15

1.1

0.95

4.16

u/ml

—

Other congenital malformations of limb(s)

119

0.83

0.15

1.1

0.09

5.20

u/ml

—

Diabetic retinopathy

105

633

1.05

0.15

1.0

1.1

2.82

1.66

u/ml

0.43

168

Nerve, nerve root and plexus disorders

874

5410

1.01

0.15

1.1

1.90

2.00

u/ml

0.08

199

1309

Benign neoplasm: Skin of trunk

216

1.11

0.15

1.2

1.1

1.93

3.54

u/ml

—

Benign neoplasm: Skin of trunk

216

1.11

0.15

1.2

1.1

1.93

3.54

u/ml

—

Other noninflammatory disorders of uterus, except cervix

618

1.05

0.15

1.1

1.0

0.82

1.15

u/ml

0.20

129

Spondyloarthritis

120

1249

0.96

0.15

1.1

2.34

1.99

u/ml

0.10

303

Gestational [pregnancy-induced] hypertension

278

2845

0.97

0.15

1.1

1.45

1.90

u/ml

0.52

692

Other hearing loss

747

1.05

0.15

1.1

3.27

2.02

u/ml

0.25

183

Cyst of Bartholin Gland

274

1.10

0.15

1.1

1.0

0.21

1.51

u/ml

—

Hyperhidrosis

226

1.11

0.15

1.1

1.30

4.98

u/ml

—

Feeding problems of newborn

150

1.15

0.15

1.2

0.62

4.42

u/ml

—

Foreign body in ear

121

1.16

0.15

1.1

2.49

3.76

u/ml

—

Molar incisor enamel hypoplasia

673

0.94

0.15

1.1

1.2

8.12

4.25

u/ml

0.24

213

Diabetes mellitus in pregnancy

486

3092

1.02

0.15

1.1

1.83

2.33

u/ml

0.59

118

782

Burn and corrosion of ankle and foot

1.10

0.15

1.0

1.1

—

4.03

u/ml

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

1.10

0.15

1.1

1.0

—

2.45

—

Colorectal cancer

523

0.94

0.15

1.1

1.0

2.24

1.74

u/ml

—

123

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

574

0.94

0.14

1.1

0.77

2.81

u/ml

2.40

152

Other condition

103

987

1.04

0.14

1.1

1.96

2.40

u/ml

0.23

245

Inflammatory diseases of the central nervous system

502

0.94

0.14

1.1

4.51

2.37

u/ml

0.41

126

Maltreatment syndromes

543

0.94

0.14

1.1

4.88

2.05

u/ml

0.30

135

Coxarthrosis, primary, with hip surgery

107

1057

0.96

0.14

1.1

1.0

0.31

1.18

u/ml

2.78

225

Follicular lymphoma, hilmo

0.80

0.14

1.0

—

2.68

u/ml

—

Other congenital malformations of face and neck

246

1.10

0.14

1.0

1.1

0.63

2.77

u/ml

—

Symptoms and signs involving the urinary system

478

3762

0.98

0.14

1.1

1.56

2.09

u/ml

0.53

101

960

Hyperprolactinaemia

314

1.08

0.14

1.1

0.40

2.55

u/ml

—

Unspecified urinary incontinence

343

1.08

0.14

1.1

0.66

2.83

u/ml

—

Constitutional tall stature

122

1.16

0.14

1.1

1.2

5.62

5.11

u/ml

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

261

2529

1.03

0.14

1.1

1.51

2.37

u/ml

1.23

656

Deposits [accretions] on teeth

701

0.95

0.14

1.1

1.2

5.69

3.72

u/ml

0.24

213

LSIL lesion of the cervix uteri, vagina or vulva

130

1347

0.96

0.14

1.1

0.52

1.46

u/ml

1.77

326

Generalized epilepsy

451

1.07

0.13

1.1

5.16

3.57

u/ml

0.14

124

Inflammatory bowel disease, strict (require KELA)

206

2116

0.97

0.13

1.1

2.89

2.37

u/ml

0.18

543

Paroxysmal tachycardia

184

1511

1.03

0.13

1.1

1.25

2.26

u/ml

1.05

360

Parodontitis, under 40 years, or operation codes

135

1396

0.97

0.13

1.1

3.15

2.36

u/ml

0.23

378

Chronic tubulo-interstitial nephritis

151

1.13

0.13

1.2

1.0

3.23

4.26

u/ml

—

Disorder of external ear, unspecified

132

1.14

0.13

1.1

1.0

1.35

2.95

u/ml

—

Assault by bodily force

775

0.95

0.13

1.1

4.05

2.06

u/ml

0.36

193

Other obstetric trauma

579

1.06

0.13

1.0

1.1

1.78

1.23

u/ml

0.17

133

Pneumothorax

242

0.91

0.13

1.2

1.1

1.54

1.60

u/ml

—

Golimumab

277

1.09

0.13

1.1

0.21

2.66

u/ml

3.34

All dysplastic lesions of the cervix uteri

297

2902

1.02

0.12

1.1

1.28

1.90

u/ml

0.58

705

Torticollis

142

1.13

0.12

1.2

1.1

0.57

3.97

u/ml

—

Pustulosis palmaris et plantaris

190

1.11

0.12

1.0

0.54

2.60

u/ml

—

IBD patients in KELA-register

206

2113

0.97

0.12

1.1

2.89

2.41

u/ml

0.16

535

Viral haemorrhagic fevers, not elsewhere classified/unspecified

396

0.93

0.12

1.1

0.57

2.08

u/ml

2.04

Dental pulpitis 2

623

3144

1.01

0.12

1.1

1.83

2.49

u/ml

0.72

159

756

Disorders of continuity of bone

629

1.05

0.12

1.0

1.1

2.08

2.42

u/ml

0.09

145

Maternal care related to the fetus and amniotic cavity and possible delivery problems

554

3212

1.02

0.12

1.1

1.25

2.80

u/ml

3.73

132

789

Impotence

158

0.89

0.12

1.0

1.1

0.21

2.80

u/ml

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

239

1.09

0.12

1.1

1.0

1.15

2.42

u/ml

—

Female infertility, associated with anovulation

1017

0.96

0.12

1.1

3.03

2.14

u/ml

0.26

268

Parodontitis, under 40 years

135

1392

0.97

0.12

1.1

3.15

2.36

u/ml

0.23

377

Disorders of speech understanding and production

608

0.95

0.12

1.2

4.64

3.66

u/ml

0.13

198

Episcleritis

317

1.07

0.12

1.0

1.1

4.37

2.39

u/ml

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

807

1.04

0.11

1.2

1.1

0.60

1.22

u/ml

1.15

186

Other blood glucose lowering drugs, excl. Insulins

446

0.94

0.11

1.1

1.18

2.08

u/ml

0.45

100

Visual impairment including blindness (binocular or monocular)

292

0.92

0.11

1.0

1.1

1.60

3.80

u/ml

—

Motor disorders

423

0.94

0.11

1.1

1.2

3.86

4.24

u/ml

0.05

144

Gonococcal infection

172

1.11

0.11

1.1

0.47

2.24

u/ml

—

Dislocation, sprain and strain of joints and ligaments of head

394

0.94

0.11

1.1

6.94

3.21

u/ml

—

Other specified/unspecified inflammatory spondylopathies

347

1.07

0.11

1.1

0.30

2.16

u/ml

—

Hypertrichosis

211

1.09

0.11

1.0

0.97

1.85

u/ml

—

Spondylopathies (FG)

112

1157

0.97

0.11

1.1

1.72

1.98

u/ml

0.07

280

Intentional self-harm by unspecified means

105

1.15

0.11

1.3

1.1

0.80

4.22

u/ml

—

Fracture of forearm

428

3946

1.02

0.11

1.1

1.68

2.37

u/ml

0.84

112

992

Calcific aortic valvular stenosis, including rheumatic fever

465

0.95

0.11

1.0

1.1

1.63

2.26

u/ml

0.24

109

Congenital malformations of the circulatory system

148

1473

0.97

0.11

1.1

2.82

3.16

u/ml

0.11

433

Strabismus

241

2456

0.98

0.11

1.1

3.23

2.56

u/ml

0.29

678

Hydrocele

414

0.94

0.11

1.1

1.62

2.67

u/ml

—

110

Maternal care for known or suspected disproportion

465

1.06

0.11

1.1

3.36

1.28

u/ml

0.54

Melanocytic naevi of upper limb, including shoulder

134

1.12

0.11

1.1

0.95

3.66

u/ml

—

Contusion of ankle

338

1.07

0.11

1.1

5.83

2.76

u/ml

0.24

Mental disorders, not otherwise specified

770

0.96

0.10

1.1

0.41

1.88

u/ml

4.49

197

Other disorders of binocular movement

202

1.09

0.10

1.4

1.1

2.13

2.34

u/ml

—

Social phobias

1023

0.97

0.10

1.0

1.1

4.48

2.40

u/ml

0.46

276

Sleep disorders, other/unspecified

290

1.07

0.10

1.1

0.21

3.91

u/ml

—

Primary open-angle glaucoma, strict

465

1.05

0.10

1.0

0.83

1.74

u/ml

0.63

115

Failed induction of labour

728

0.96

0.10

1.1

0.96

1.44

u/ml

0.45

167

Respiratory distress of newborn

448

0.95

0.10

1.2

3.56

4.29

u/ml

0.09

157

Other disorders of optic [2nd] nerve and visual pathways

398

1.06

0.10

1.1

5.20

2.84

u/ml

0.28

110

Toxic liver disease

1.11

0.10

1.0

—

6.50

u/ml

—

Injuries to the shoulder and upper arm

639

5296

1.01

0.09

1.1

1.68

2.16

u/ml

0.50

154

1343

Benign neoplasm of breast

693

1.04

0.09

1.1

2.37

1.64

u/ml

0.15

162

Basal cell carcinoma, including avohilmo

144

1163

0.97

0.09

1.1

1.0

0.31

1.40

u/ml

3.12

249

Inflammatory bowel disease

264

2687

0.98

0.09

1.1

2.92

2.30

u/ml

0.23

677

Myeloproliferative diseases (CML excluded)

203

1.08

0.09

1.0

5.14

1.76

u/ml

—

Foreign body in genitourinary tract

1.06

0.09

1.2

1.0

—

0.22

—

Aortic valve malfunction, age under 60 years

544

0.96

0.09

1.0

1.1

1.82

2.38

u/ml

—

138

Specific personality disorders

238

2424

0.98

0.09

1.1

1.44

2.35

u/ml

1.31

621

Other sexually transmitted chlamydial diseases

921

1.03

0.09

1.1

4.02

2.36

u/ml

0.36

246

Dental pulpitis 2, only avohilmo

629

3183

1.01

0.09

1.1

1.81

2.48

u/ml

0.74

160

764

Carcinoma in situ of cervix uteri

931

1.03

0.09

1.1

1.72

1.42

u/ml

0.13

241

Seronegative rheumatoid arthritis

513

0.95

0.09

1.1

0.51

1.84

u/ml

1.91

113

Other surgical follow-up care

223

1.08

0.09

1.1

4.90

3.99

u/ml

—

Purpura and other haemorrhagic conditions

783

1.03

0.09

1.1

0.39

2.19

u/ml

4.88

210

Foreign body on external eye

107

1040

1.03

0.09

1.0

1.1

2.13

2.22

u/ml

0.03

267

Brachial plexus disorders

734

1.04

0.09

1.0

1.1

1.02

1.75

u/ml

0.75

179

Disorders of psychological development

190

1796

0.98

0.09

1.1

2.37

3.24

u/ml

0.54

551

Benign neoplasm: Colon

212

1593

1.02

0.09

1.1

1.45

1.42

u/ml

0.01

362

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

415

0.95

0.08

1.2

0.39

4.45

u/ml

4.71

140

Injury of muscle and tendon at wrist and hand level

857

0.97

0.08

1.1

1.17

2.13

u/ml

0.89

202

Medical treatment for female infertility

267

2621

1.02

0.08

1.1

2.30

1.68

u/ml

0.39

627

Poisoning by medicine, drug-induced

1.05

0.08

1.0

—

1.86

—

Malignant neoplasm of endocrine gland

349

0.94

0.08

1.0

1.1

0.15

2.32

u/ml

—

Injuries to the head

1070

7021

0.99

0.08

1.1

2.45

2.36

u/ml

0.07

287

1797

Specific developmental disorder of motor function

412

0.95

0.08

1.1

1.2

3.86

4.42

u/ml

0.07

134

Intestinal adhesions without obstruction

257

0.93

0.08

1.0

1.1

3.97

2.36

u/ml

—

Calcific aortic valvular stenosis, diagnosis (helper)

461

0.95

0.08

1.0

1.1

1.63

2.26

u/ml

0.24

109

Operations 2 for CAVS

461

0.95

0.08

1.0

1.1

1.62

2.26

u/ml

0.24

109

Benign neoplasm of other and unspecified endocrine glands

607

1.04

0.08

1.0

1.1

0.71

2.22

u/ml

1.89

139

Other arterial embolism and thrombosis

0.83

0.08

1.0

—

3.54

—

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

0.79

0.08

1.0

1.1

—

3.21

—

Gonarthrosis, primary, with knee surgery

162

1351

0.98

0.08

1.0

0.43

1.24

u/ml

1.99

274

Other CVD (FINNGEN)

284

1.05

0.08

1.0

0.67

2.02

u/ml

—

Other disorders of ear

668

4492

0.99

0.08

1.1

2.32

2.13

u/ml

0.11

165

1123

Mixed connective tissue disease

342

1.05

0.08

1.1

0.26

2.03

u/ml

3.04

Calcific aortic valvular stenosis, operated

470

0.96

0.08

1.0

1.1

1.50

2.49

u/ml

0.43

112

Calcific aortic valvular stenosis

470

0.96

0.08

1.0

1.1

1.50

2.50

u/ml

0.43

112

LSIL lesion of the cervix uteri

117

1142

1.03

0.08

1.1

0.53

1.30

u/ml

1.31

278

Fracture of rib(s), sternum and thoracic spine

123

1259

0.98

0.08

1.1

1.35

1.93

u/ml

0.57

287

Autoimmune hyperthyroidism

421

1.05

0.07

1.1

0.24

1.89

u/ml

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

628

1.04

0.07

1.1

0.37

2.68

u/ml

3.55

152

Enteropathic arthropathies

143

0.91

0.07

1.1

—

2.44

u/ml

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

550

0.96

0.07

1.3

1.1

6.94

2.68

u/ml

0.43

174

Anaemias

315

2122

0.99

0.07

1.1

3.03

2.63

u/ml

0.14

583

Congenital musculoskeletal deformities of head, face, spine and chest

147

1.09

0.07

1.1

1.2

0.90

4.00

u/ml

—

Other disorders of amniotic fluid and membranes

173

1745

0.98

0.07

1.1

1.31

2.47

u/ml

1.48

422

Injuries to the elbow and forearm

615

5508

1.01

0.07

1.1

1.89

2.52

u/ml

0.75

163

1421

Other cataract

158

1247

0.98

0.07

1.0

1.1

1.91

1.89

u/ml

0.01

281

Other osteochondropathies

489

0.96

0.07

1.0

1.1

3.59

2.56

u/ml

0.19

117

Primary coxarthrosis, bilateral

639

1.03

0.07

1.1

1.0

3.84

1.14

u/ml

0.32

135

Anterior Iridocyclitis

128

1253

1.02

0.07

1.1

0.45

2.01

u/ml

4.72

291

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

389

0.95

0.07

1.2

2.15

4.65

u/ml

0.65

137

Follicular lymphoma

0.83

0.07

1.0

—

2.48

u/ml

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

133

1072

0.98

0.07

1.1

1.0

0.82

1.51

u/ml

0.68

226

Polyhydramnios

509

0.96

0.07

1.0

1.1

1.38

1.22

u/ml

0.09

117

AV-block

383

1.04

0.07

1.1

0.24

2.75

u/ml

2.71

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

1.07

0.07

1.1

1.0

—

2.60

—

Diabetic nephropathy, excluding more controls

374

0.96

0.07

1.0

1.1

4.82

1.71

u/ml

0.58

Other mental disorders due to brain damage and dysfunction and to physical disease

265

0.94

0.07

1.0

1.1

0.35

2.08

u/ml

—

Exclusion endpoint for clefts

295

0.95

0.06

1.1

1.2

5.21

2.87

u/ml

—

100

Pregnancy with abortive outcome

685

3553

1.01

0.06

1.1

1.53

2.59

u/ml

2.06

178

862

Normotensive glaucoma

128

1.09

0.06

1.0

0.21

1.07

u/ml

—

Squamous cell neoplasms and carcinomas of the skin

128

1.09

0.06

1.1

1.0

0.86

1.89

u/ml

—

Tubulo-interstitial nephritis, not specified as acute or chronic

344

1.05

0.06

1.0

1.1

0.92

3.21

u/ml

—

Hirsutism in women

187

1.07

0.06

1.1

1.0

1.10

2.05

u/ml

—

Hypokalaemia

437

0.96

0.06

1.2

1.1

0.63

2.24

u/ml

1.85

111

Ankyloglossia

363

1.05

0.06

1.2

5.02

3.06

u/ml

0.30

118

Other assisted single delivery

193

0.93

0.06

1.0

1.1

0.10

1.17

u/ml

—

Anankastic personality disorder

305

1.05

0.06

1.1

0.99

2.40

u/ml

—

Myeloproliferative diseases

244

0.94

0.06

1.0

5.14

1.82

u/ml

—

Unspecified abortion

315

1.05

0.06

1.0

1.1

0.20

2.17

u/ml

—

Arthrosis

544

3016

0.99

0.06

1.1

1.49

1.70

u/ml

0.17

144

671

Congenital malformations of pulmonary and tricuspid valves

162

0.92

0.06

1.0

1.2

3.58

5.04

u/ml

—

Emotionally unstable personality disorder

140

1425

0.98

0.06

1.1

1.14

2.15

u/ml

1.75

369

All dysplastic lesions of the cervix uteri, vagina or vulva

313

3144

0.99

0.06

1.1

1.24

1.89

u/ml

0.65

748

Polycystic ovarian syndrome, broad definition

144

1465

0.98

0.06

1.1

2.35

1.92

u/ml

0.18

375

Other fall from one level to another

201

2037

0.99

0.06

1.1

3.09

2.82

u/ml

0.07

581

Otosclerosis

286

1.05

0.06

1.0

1.1

0.64

1.68

u/ml

—

Right hemicolectomy

121

0.91

0.06

1.0

—

1.55

u/ml

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

240

2430

0.99

0.06

1.0

1.1

0.88

2.10

u/ml

2.35

619

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

446

0.96

0.06

1.2

1.1

0.58

1.93

u/ml

—

110

Short stature, not elsewhere classified

583

1.03

0.05

1.1

1.2

4.48

4.17

u/ml

0.04

188

Disorders of puberty, all

316

1.05

0.05

1.1

1.2

13.71

3.29

u/ml

—

Assault

131

1333

0.98

0.05

1.1

4.14

2.29

u/ml

0.59

340

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

247

1.05

0.05

1.1

1.15

2.30

u/ml

—

Eating disorder

132

1296

1.02

0.05

1.1

1.43

2.81

u/ml

1.01

367

DVT of lower extremities

698

0.97

0.05

1.0

1.1

2.10

2.08

u/ml

0.01

156

Complications of internal orthopaedic prosthetic devices, implants and grafts

593

1.03

0.05

1.1

1.0

0.89

1.92

u/ml

0.61

141

Other infectious diseases

334

0.96

0.05

1.1

1.51

2.30

u/ml

—

Bacterial pneumoniae

236

2064

1.01

0.05

1.1

2.80

2.14

u/ml

0.39

508

Benign neoplasm: Skin of other and unspecified parts of face

425

0.96

0.05

1.1

1.82

2.85

u/ml

—

103

Ankylosing spondylitis, strict definition

344

0.96

0.05

1.0

1.1

0.60

2.30

u/ml

—

Enterocolitis due to Clostridium difficile

344

0.96

0.05

1.1

0.42

1.88

u/ml

—

Scoliosis

748

0.98

0.05

1.0

1.1

2.12

2.53

u/ml

0.09

213

Car occupant injured in noncollision transport accident

283

0.95

0.05

1.1

3.88

2.64

u/ml

—

Fracture of lower leg, including ankle

387

3887

0.99

0.05

1.1

1.96

2.37

u/ml

0.21

969

Infections specific to the perinatal period

313

0.95

0.05

1.3

1.2

3.00

3.04

u/ml

0.01

102

Pneumonia derived septicemia

161

0.93

0.05

1.1

4.56

4.24

u/ml

—

Primary open-angle glaucoma

569

1.03

0.05

1.0

0.80

1.55

u/ml

0.56

133

Benign neoplasm: Adrenal gland

228

1.05

0.05

1.0

1.1

0.81

1.95

u/ml

—

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

446

1.03

0.04

1.1

0.15

2.05

u/ml

—

114

L02BA Anti-estrogens

786

0.98

0.04

1.1

1.28

1.46

u/ml

0.10

168

Autoimmune diseases related-to ILD

742

6558

0.99

0.04

1.1

1.85

2.21

u/ml

0.33

178

1622

Crohn's disease of large intestine

417

1.03

0.04

1.1

4.80

2.74

u/ml

0.29

103

Complications of labour and delivery

626

3510

0.99

0.04

1.1

0.96

2.61

u/ml

6.52

158

839

Artrosis, including avohilmo

698

3809

1.01

0.04

1.1

1.81

1.78

u/ml

0.02

182

881

Carrier of infectious disease

160

1.06

0.04

1.1

0.30

2.34

u/ml

—

Dermatophytosis

574

0.98

0.04

1.1

1.45

2.13

u/ml

0.29

142

Agoraphobia

342

0.96

0.04

1.1

1.0

0.06

2.83

u/ml

—

Motorcycle rider injured in noncollision transport accidents

261

0.96

0.04

1.0

1.1

0.71

3.21

u/ml

—

Other pulmonary heart/vessel disease

119

0.92

0.04

1.2

1.1

0.24

1.67

u/ml

—

Open bite

724

0.98

0.03

1.1

1.03

3.24

u/ml

3.01

206

Behavioural disorders, excluding more controls

269

1.04

0.03

1.1

6.27

2.81

u/ml

—

Premature separation of placenta [abruptio placentae]

210

0.95

0.03

1.0

1.1

0.64

1.51

u/ml

—

Other obstructed labour

583

0.98

0.03

1.1

0.25

1.81

u/ml

2.62

130

Fentanyl

220

0.95

0.03

1.1

1.0

0.46

2.35

u/ml

—

Eating disorders

141

1392

1.01

0.03

1.1

2.19

2.64

u/ml

0.16

397

Zoster [herpes zoster]

663

0.98

0.03

1.1

0.95

2.48

u/ml

1.60

157

Other infections specific to the perinatal period

141

1.07

0.03

1.4

1.2

4.01

3.04

u/ml

—

Hernia of abdominal wall, postoperative

866

1.02

0.03

1.0

1.1

1.58

1.97

u/ml

0.12

194

Polycystic ovarian syndrome, consortium definition

748

4493

1.00

0.03

1.1

2.04

2.27

u/ml

0.15

161

1121

Lung diseases due to external agents

389

1.03

0.03

1.2

1.1

0.70

2.19

u/ml

1.51

101

Dislocation, sprain and strain of joints and ligaments of elbow

582

0.98

0.03

1.1

1.62

3.53

u/ml

1.27

165

Salpingitis and oophoritis

102

1006

1.01

0.03

1.1

1.0

1.54

1.39

u/ml

0.06

226

Complications of the puerperium, not elsewhere classified

429

1.03

0.03

1.1

0.36

1.39

u/ml

—

Hypothyroidism, drug reimbursement

158

1141

0.99

0.03

1.1

1.67

2.01

u/ml

0.19

277

Left bundle-branch block

171

1.05

0.03

1.1

1.0

1.31

2.44

u/ml

—

Parodontitis, under 40 years and operation codes

130

1315

0.99

0.03

1.1

3.15

2.38

u/ml

0.22

355

Parodontitis, operation under 40 years and operation codes

130

1315

0.99

0.03

1.1

3.15

2.38

u/ml

0.22

355

Transient global amnesia

191

1.05

0.03

1.2

1.0

0.41

1.71

u/ml

—

In situ neoplasms

179

1722

0.99

0.03

1.1

1.27

1.49

u/ml

0.17

407

Labour and delivery complicated by fetal stress [distress]

363

2408

1.01

0.03

1.1

1.29

2.62

u/ml

2.28

578

Obstructed labour due to malposition and malpresentation of fetus

266

2522

0.99

0.02

1.1

0.88

2.39

u/ml

2.90

581

Ankylosing spondylitis, ICD10

599

1.02

0.02

1.0

1.1

3.07

2.39

u/ml

0.09

142

Open wound of head

366

3586

1.01

0.02

1.1

2.92

2.41

u/ml

0.27

103

936

Specific development disorders of scholastic skills

752

0.99

0.02

1.2

1.1

0.94

3.28

u/ml

2.95

222

Other strabismus

223

2238

0.99

0.02

1.1

3.33

2.64

u/ml

0.30

621

Motor disorders, excluding more controls

373

1.02

0.02

1.1

1.2

3.86

4.66

u/ml

0.11

125

Vestibular neuronitis

361

1.03

0.02

1.1

1.77

2.12

u/ml

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

400

0.98

0.02

1.2

2.15

4.56

u/ml

0.63

142

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

710

0.99

0.02

1.0

1.1

0.45

1.99

u/ml

3.36

172

Other disorders of the genitourinary system

401

1.02

0.02

1.1

1.0

1.74

1.97

u/ml

—

Pediculosis, acariasis and other infestations

421

1.02

0.02

1.0

1.1

0.58

2.55

u/ml

—

112

Congenital malformations of genital organs

121

1214

0.99

0.02

1.1

2.89

2.11

u/ml

0.24

348

Abnormal findings on examination of urine, without diagnosis

222

1.04

0.02

1.0

1.1

0.03

3.32

u/ml

—

Diabetic retinopathy, excluding more controls

530

0.99

0.02

1.1

2.61

1.66

u/ml

0.30

145

Other coagulation defects

501

1.02

0.02

1.1

0.20

2.64

u/ml

—

127

Meningitis

298

0.97

0.02

1.1

1.87

2.85

u/ml

—

Cardiovascular diseases (excluding rheumatic etc)

945

5468

1.00

0.02

1.1

2.10

2.42

u/ml

0.31

246

1417

Hyperkinetic disorders (excl. ADHD)

329

1.03

0.01

1.2

2.61

3.70

u/ml

0.33

104

Exposure to smoke, fire and flames

123

1.06

0.01

1.0

1.1

4.65

2.36

u/ml

—

Coagulation defects, purpura and other haemorrhagic conditions

129

1280

1.01

0.01

1.1

0.34

2.00

u/ml

6.04

341

Other congenital malformations of the digestive system

558

1.02

0.01

1.2

5.06

3.47

u/ml

0.27

178

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

133

1.05

0.01

1.1

1.0

0.86

1.82

u/ml

—

Other symptoms and signs involving the urinary system

432

1.02

0.01

1.0

1.1

0.20

2.50

u/ml

3.67

111

Foreign body or object entering through skin

442

1.02

0.01

1.1

3.30

2.73

u/ml

0.07

115

Cyst of kidney

163

1.04

0.01

1.3

1.0

0.03

3.08

u/ml

—

Postprocedural musculoskeletal disorders, not elsewhere classified

207

0.97

0.01

1.1

1.0

0.67

2.21

u/ml

—

Benign leiomyoma with endometriosis

688

0.99

0.01

1.1

1.09

1.43

u/ml

0.16

151

Pacemaker

653

1.01

0.01

1.0

1.1

6.13

1.94

u/ml

0.68

154

Mixed and other personality disorders

698

0.99

0.01

1.1

0.50

1.66

u/ml

2.78

172

Conduct disorder

287

0.97

0.01

1.1

6.27

3.22

u/ml

—

Ulcerative ileocolitis

297

0.98

0.01

1.1

1.27

2.24

u/ml

—

Personality disorders

276

2770

1.00

0.01

1.1

1.30

2.24

u/ml

1.64

697

Disorders of adult personality and behaviour

300

3010

1.00

0.01

1.1

1.27

2.16

u/ml

1.64

764

Maternal care for known or suspected malpresentation of fetus

265

1968

1.00

0.01

1.1

1.53

2.36

u/ml

0.89

462

295

1.02

0.01

1.1

1.0

0.06

0.81

u/ml

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

543

1.01

0.01

1.1

2.16

1.29

u/ml

0.37

130

Other specified and unspecified personality disorders

783

1.01

0.01

1.2

1.1

2.26

1.59

u/ml

0.29

193

Pustular psoriasis

204

1.03

0.00

1.0

0.54

2.98

u/ml

—

Memory loss

204

1.03

0.00

1.1

1.47

3.08

u/ml

—

Abnormal spermatozoa

224

1.03

0.00

1.0

1.1

2.20

1.93

u/ml

—

Benign neoplasm: Adrenal gland

234

1.03

0.00

1.0

1.1

0.81

1.95

u/ml

—

Other disorders originating in the perinatal period

276

0.98

0.00

1.1

1.2

0.59

3.62

u/ml

2.47

100

Behavioural disorders

286

0.98

0.00

1.1

6.27

3.09

u/ml

—

Complications of surgical and medical care, not elsewhere classified

802

5744

1.00

0.00

1.1

1.53

2.16

u/ml

1.08

200

1397

Burn and corrosion of wrist and hand

324

1.02

0.00

1.1

7.18

3.16

u/ml

0.52

Abnormalities of gait and mobility

456

0.99

0.00

1.1

3.12

3.07

u/ml

—

120

Injuries to unspecified part of trunk, limb or body region

624

1.01

0.00

1.0

1.1

4.52

2.58

u/ml

0.37

154

Benign neoplasm of ovary

824

1.01

0.00

1.1

0.27

1.51

u/ml

3.12

186

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

903

6348

1.00

0.00

1.1

2.47

2.26

u/ml

0.18

263

1581

Premature rupture of membranes

296

2180

1.00

0.00

1.1

2.05

2.53

u/ml

0.30

531

Other specified/unspecified arthritis

186

1854

1.00

0.00

1.1

0.64

1.77

u/ml

4.28

456

Presbycusis

109

1.00

0.00

1.0

0.03

0.23

u/ml

—

Visual field defects

332

0.99

0.00

1.0

1.1

2.78

2.44

u/ml

—

Malignant melanoma

402

0.99

0.00

1.0

1.1

0.07

1.56

u/ml

—

Hemiplegia

232

0.99

0.00

1.1

4.23

2.35

u/ml

—

Use of antiglaucoma preparations and miotics

131

0.99

0.00

1.0

0.51

2.05

u/ml

—

Other and unspecified psoriasis

285

0.98

0.00

1.2

1.1

0.30

2.21

u/ml

—

Calcific tendinitis of shoulder

271

1.00

0.00

1.1

1.71

3.38

u/ml

—

Diseases of the myoneural junction and muscle

505

1.01

0.00

1.1

0.94

2.35

u/ml

1.38

126

Recurrent dislocation of patella

615

1.01

0.00

1.1

4.18

2.24

u/ml

0.48

152

Other or unspecified ileus, impaction or obstruction

570

1.00

0.00

1.1

4.23

2.12

u/ml

0.23

138

Distal bite

634

1.00

0.00

1.1

4.27

3.38

u/ml

0.14

193

Isolated proteinuria

146

1.03

0.00

1.0

1.1

0.05

3.41

u/ml

—

Disorders of puberty

275

0.98

0.00

1.0

1.2

13.71

3.93

u/ml

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

194

0.98

0.00

1.2

1.1

1.45

3.65

u/ml

—

Fibrosis and cirrhosis of liver

244

0.98

0.00

1.0

0.45

3.04

u/ml

—

Malignant neoplasm of thyroid gland

314

0.99

0.00

1.0

1.1

0.15

2.38

u/ml

—

Benign neoplasm: Skin of other and unspecified parts of face

406

1.01

0.00

1.1

1.82

2.31

u/ml

—

104

Torsion of testis

227

1.01

0.00

1.1

1.27

4.12

u/ml

—

Ulcerative proctitis

466

1.01

0.00

1.1

0.76

2.74

u/ml

—

105

Dipeptidyl peptidase 4 (DPP-4) inhibitors

283

0.99

0.00

1.0

1.1

1.83

1.73

u/ml

—

Juvenile rheumatoid arthirtis

222

0.99

0.00

1.1

0.78

3.40

u/ml

—

Colectomy operation

538

1.00

0.00

1.1

0.87

2.03

u/ml

—

139

Pedal cyclist injured in other and unspecified transport accidents

793

1.00

0.00

1.1

1.63

1.82

u/ml

0.10

194

Opening and dilatation of root channel of tooth

482

1.00

0.00

1.2

1.1

1.07

2.02

u/ml

—

119

Orchitis and epididymitis

407

1.01

0.00

1.0

1.1

0.24

3.20

u/ml

—

117

Palatinal maxillary operation

149

1.01

0.00

1.0

1.1

2.94

5.71

u/ml

—

Toxic effect of ethanol

321

1.00

0.00

1.1

3.22

2.88

u/ml

—

Male infertility

412

1.00

0.00

1.1

0.66

2.83

u/ml

—

117

Vitamin B12 deficiency anaemia

258

1.01

0.00

1.1

0.18

2.39

u/ml

—

Chronic ulcer of skin, not elsewhere classified

185

0.97

0.00

1.2

1.1

0.71

1.94

u/ml

—

Crohn's disease NAS

527

1.01

0.00

1.1

4.73

2.71

u/ml

0.36

127

Sequelae of injuries of head

297

1.01

0.00

1.1

1.48

2.83

u/ml

—

Placenta praevia

507

1.01

0.00

1.0

1.1

3.87

1.26

u/ml

—

109

Congenital deformities of feet

255

1.02

0.00

1.0

1.1

6.24

3.52

u/ml

—

Protozoal diseases

105

1.05

0.00

1.0

1.1

0.34

3.96

u/ml

—

Other diseases of spinal cord

135

1.04

0.00

1.0

1.17

2.85

u/ml

—

Benign neoplasm: Caecum

227

1.01

0.00

1.0

0.97

2.14

u/ml

—

Fetus and newborn affected by maternal complications of pregnancy

195

1.03

0.00

1.2

0.33

3.73

u/ml

—

Other chromosome abnormalities, not elsewhere classified

102

0.98

0.00

1.3

1.2

4.24

4.72

u/ml

—

Benign neoplasm: Aortic body and other paraganglia

0.00

0.0

1.0

—

Perioral dermatitis, drug-induced

0.00

0.0

1.0

—

Induced delusional disorder

0.00

0.0

1.0

—

Benign neoplasm: Ciliary body

0.00

0.0

1.0

—

Carcinoma in situ of cervix uteri, exocervix

0.96

0.00

1.4

1.0

—

0.19

—

Benign neoplasm: Aortic body and other paraganglia

0.00

0.0

1.0

—

Pityriasis rosea

1.02

0.00

1.0

—

0.24

—

Arthropathy in Crohn disease

1.00

0.00

1.0

1.1

—

2.88

—

Other and unspecified hereditary haemolytic anaemias

0.00

0.0

1.0

—

Cerebral amyloid angiopathy

0.00

0.0

1.0

—

Benign lipomatous neoplasm of of intra-abdominal organs

0.00

0.0

1.0

—

Hereditary erythropoietic porphyria

0.00

0.0

1.0

—

Benign neoplasm: Caecum

230

1.00

0.00

1.0

1.1

0.97

2.28

u/ml

—

Disorders of sexual preference

0.00

0.0

1.1

—

Disorders of puberty, other/unspecified

0.98

0.00

1.0

1.1

—

4.22

—

Other acute viral hepatitis

0.88

0.00

1.3

1.1

—

3.44

u/ml

—

Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms

0.00

0.0

1.0

—

Linear scleroderma

0.00

0.0

1.0

—

Peutz-Jeghers syndrome

0.00

0.0

1.2

—

Fetal alcohol syndrome (dysmorphic)

0.00

0.0

1.0

—

Miliaria rubra

0.00

0.0

1.2

—

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

0.00

0.0

1.0

—

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

0.91

0.00

1.1

—

4.21

—

Arthropathy in ulcerative colitis

0.97

0.00

1.1

1.0

—

3.68

u/ml

—

Vascular dementia (multiple infarctions)

0.00

0.0

1.0

—

Pathological resorption of teeth

180

1.00

0.00

1.0

0.24

3.92

u/ml

—

Rhinophyma

0.00

0.0

1.0

—

Carcinoma in situ of cervix uteri, exocervix

1.02

0.00

1.4

1.0

—

0.21

—

Nephropathy induced by other drugs, medicaments and biological substances

0.00

0.0

1.0

—

Malignant neoplasm of lip

0.00

0.0

1.2

—

Injury of nerves at forearm level

0.93

0.00

1.0

1.1

—

2.52

—

Benign neoplasm: Ciliary body

0.00

0.0

1.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Horse dander IgE Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS